<document ID-DOI="10.1016/j.phytochem.2022.113362" ID-ISSN="1873-3700" ID-Zenodo-Dep="8234950" IM.illustrations_approvedBy="felipe" IM.metadata_approvedBy="felipe" IM.tables_requiresApprovalFor="GgImagineBatch" IM.taxonomicNames_approvedBy="felipe" IM.treatments_approvedBy="felipe" checkinTime="1691689140945" checkinUser="felipe" docAuthor="Saqallah, Fadi G. &amp; Abbas, Manal A. &amp; Wahab, Habibah A." docDate="2022" docId="FF84FFE7FFFF3D6AFFADFFD8FFCB5D5E" docName="Phytochemistry.202.113362.pdf" docOrigin="Phytochemistry (113362) 202" docSource="http://dx.doi.org/10.1016/j.phytochem.2022.113362" docStyle="DocumentStyle:F36D69FC8B198FBE91029DF9C24697D3.6:Phytochemistry.2020-.journal_article" docStyleId="F36D69FC8B198FBE91029DF9C24697D3" docStyleName="Phytochemistry.2020-.journal_article" docStyleVersion="6" docTitle="Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease" docVersion="3" lastPageNumber="19" pageNumber="1" updateTime="1699553736001" updateUser="plazi">
<mods:mods xmlns:mods="http://www.loc.gov/mods/v3">
<mods:titleInfo>
<mods:title>Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease</mods:title>
</mods:titleInfo>
<mods:name type="personal">
<mods:role>
<mods:roleTerm>Author</mods:roleTerm>
</mods:role>
<mods:namePart>Saqallah, Fadi G.</mods:namePart>
<mods:affiliation>* &amp; Pharmaceutical Design and Simulation (PhDS) Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia &amp; Discipline of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia</mods:affiliation>
</mods:name>
<mods:name type="personal">
<mods:role>
<mods:roleTerm>Author</mods:roleTerm>
</mods:role>
<mods:namePart>Abbas, Manal A.</mods:namePart>
</mods:name>
<mods:name type="personal">
<mods:role>
<mods:roleTerm>Author</mods:roleTerm>
</mods:role>
<mods:namePart>Wahab, Habibah A.</mods:namePart>
</mods:name>
<mods:typeOfResource>text</mods:typeOfResource>
<mods:relatedItem type="host">
<mods:titleInfo>
<mods:title>Phytochemistry</mods:title>
</mods:titleInfo>
<mods:part>
<mods:date>2022</mods:date>
<mods:detail type="series">
<mods:title>113362</mods:title>
</mods:detail>
<mods:detail type="pubDate">
<mods:number>2022-10-31</mods:number>
</mods:detail>
<mods:detail type="volume">
<mods:number>202</mods:number>
</mods:detail>
<mods:extent unit="page">
<mods:start>1</mods:start>
<mods:end>19</mods:end>
</mods:extent>
</mods:part>
</mods:relatedItem>
<mods:location>
<mods:url>http://dx.doi.org/10.1016/j.phytochem.2022.113362</mods:url>
</mods:location>
<mods:classification>journal article</mods:classification>
<mods:identifier type="DOI">10.1016/j.phytochem.2022.113362</mods:identifier>
<mods:identifier type="ISSN">1873-3700</mods:identifier>
<mods:identifier type="Zenodo-Dep">8234950</mods:identifier>
</mods:mods>
<paragraph blockId="0.[100,1291,448,526]" pageId="0" pageNumber="1">
<docTitle pageId="0" pageNumber="1">Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease</docTitle>
</paragraph>
<paragraph blockId="0.[100,900,559,591]" box="[100,900,559,591]" pageId="0" pageNumber="1">
<docAuthor box="[100,306,565,591]" pageId="0" pageNumber="1">Fadi G. Saqallah</docAuthor>
<superScript attach="right" box="[311,342,559,576]" fontSize="7" pageId="0" pageNumber="1">a, b</superScript>
<docAuthor box="[342,558,565,591]" pageId="0" pageNumber="1">, Manal A. Abbas</docAuthor>
<superScript attach="right" box="[563,592,559,576]" fontSize="7" pageId="0" pageNumber="1">c,d</superScript>
<docAuthor box="[592,848,565,591]" pageId="0" pageNumber="1">, Habibah A. Wahab</docAuthor>
<superScript attach="right" box="[852,900,560,577]" fontSize="7" pageId="0" pageNumber="1">
a, e, 
<docAuthorAffiliation box="[889,900,560,577]" pageId="0" pageNumber="1">*</docAuthorAffiliation>
</superScript>
</paragraph>
<paragraph blockId="0.[100,1173,614,723]" box="[100,1173,614,632]" pageId="0" pageNumber="1">
<superScript attach="left" box="[100,106,614,623]" fontSize="4" pageId="0" pageNumber="1">a</superScript>
<emphasis bold="true" box="[112,1173,617,632]" italics="true" pageId="0" pageNumber="1">
<docAuthorAffiliation box="[112,1173,617,632]" pageId="0" pageNumber="1">Pharmaceutical Design and Simulation (PhDS) Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia</docAuthorAffiliation>
</emphasis>
</paragraph>
<paragraph blockId="0.[100,1173,614,723]" box="[100,1035,637,655]" pageId="0" pageNumber="1">
<superScript attach="left" box="[100,107,637,647]" fontSize="4" pageId="0" pageNumber="1">b</superScript>
<emphasis bold="true" box="[112,1035,640,655]" italics="true" pageId="0" pageNumber="1">
<docAuthorAffiliation box="[112,1035,640,655]" pageId="0" pageNumber="1">Discipline of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia</docAuthorAffiliation>
</emphasis>
</paragraph>
<paragraph blockId="0.[100,1173,614,723]" box="[100,1087,660,678]" pageId="0" pageNumber="1">
<superScript attach="left" box="[100,106,660,669]" fontSize="4" pageId="0" pageNumber="1">c</superScript>
<emphasis bold="true" box="[111,1087,663,678]" italics="true" pageId="0" pageNumber="1">Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, 19328, Amman, Jordan</emphasis>
</paragraph>
<paragraph blockId="0.[100,1173,614,723]" pageId="0" pageNumber="1">
<superScript attach="left" box="[100,107,682,692]" fontSize="4" pageId="0" pageNumber="1">d</superScript>
<emphasis bold="true" box="[112,852,686,700]" italics="true" pageId="0" pageNumber="1">Pharmacological and Diagnostic Research Lab, Al-Ahliyya Amman University, 19328, Amman, Jordan</emphasis>
<superScript attach="left" box="[100,106,705,714]" fontSize="4" pageId="0" pageNumber="1">e</superScript>
<emphasis bold="true" box="[111,1044,709,723]" italics="true" pageId="0" pageNumber="1">Discipline of Pharmaceutical Technology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia</emphasis>
</paragraph>
<paragraph blockId="0.[100,309,795,812]" box="[100,309,795,812]" pageId="0" pageNumber="1">A R T I C L E I N F O</paragraph>
<paragraph blockId="0.[100,320,846,975]" box="[100,174,846,860]" pageId="0" pageNumber="1">
<emphasis bold="true" box="[100,174,846,860]" italics="true" pageId="0" pageNumber="1">Keywords:</emphasis>
</paragraph>
<paragraph blockId="0.[100,320,846,975]" box="[100,200,869,884]" pageId="0" pageNumber="1">Dengue virus</paragraph>
<paragraph blockId="0.[100,320,846,975]" pageId="0" pageNumber="1">NS2b/NS3 protease inhibitor Natural product</paragraph>
<paragraph blockId="0.[100,320,846,975]" box="[100,156,937,951]" pageId="0" pageNumber="1">
<emphasis bold="true" box="[100,156,937,951]" italics="true" pageId="0" pageNumber="1">In-silico</emphasis>
</paragraph>
<paragraph blockId="0.[100,320,846,975]" box="[100,267,961,975]" pageId="0" pageNumber="1">
<emphasis bold="true" box="[100,152,961,975]" italics="true" pageId="0" pageNumber="1">In-vitro</emphasis>
protease assay
</paragraph>
<paragraph blockId="0.[539,690,795,812]" box="[539,690,795,812]" pageId="0" pageNumber="1">A B S T R A C T</paragraph>
<paragraph blockId="0.[539,1489,847,1400]" pageId="0" pageNumber="1">
Dengue virus (DENV) is an arbovirus widespread through tropical and subtropical areas. It is transmitted to humans through 
<taxonomicName _evidence="catalogs" _step="genera" authorityName="Meigen" authorityYear="1818" box="[682,729,872,889]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="0" pageNumber="1" phylum="Arthropoda" rank="genus">
<emphasis bold="true" box="[682,729,872,889]" italics="true" pageId="0" pageNumber="1">Aedes</emphasis>
</taxonomicName>
mosquitoes. Infections with DENV can lead to a series of complications, including dengue fever, dengue haemorrhagic fever, or dengue shock syndrome, which might manifest through secondary infections because of a vulnerable immune system. To date, only one tetravalent DENV vaccine is approved to be administered to children whom have been previously DENV-infected and between 9 and 16 years of age. One of the key targets in discovering DENV antiviral agents is the NS2b/NS3 protease. This protease is a crucial enzyme complex for the proteolytic and cleavage activities of the translated polyprotein during DENV life cycle. Several studies were conducted to discover potential antivirals from natural sources or synthetic compounds and peptides. In this review, we describe the recent studies from the past five years dealing with isolated natural products as potential inhibitors of DENV with a greater focus on inhibiting the NS2b/NS3 protease. This review describes recent discoveries in anti-DENV potential of isolated phytochemicals belonging to different groups including fatty acids, glucosides, terpenes and terpenoids, flavonoids, phenolics, chalcones, acetamides, and peptides. Curcumin, quercetin, and myricetin were found to act as non-competitive inhibitors for the NS2b/NS3 protease enzyme. In some studies, the molecular targets of some of these compounds are yet to be identified using 
<emphasis bold="true" box="[1425,1487,1179,1196]" italics="true" pageId="0" pageNumber="1">in-silico</emphasis>
and 
<emphasis bold="true" box="[575,633,1204,1221]" italics="true" pageId="0" pageNumber="1">in-vitro</emphasis>
approaches. So far, none of the isolated natural products was tested clinically for the management of DENV infections. The discussed studies demonstrate that natural products are a rich source of potential antiDENV compounds. However, not all of these compounds were studied for their kinetic molecular mechanism and type of inhibition. 
<emphasis bold="true" box="[743,806,1280,1297]" italics="true" pageId="0" pageNumber="1">In-silico</emphasis>
studies provided an ample number of phytochemical hits to be tested experimentally as DENV protease inhibitors. In conclusion, derivatives of these natural products can be designed and synthesised, which could enhance their specificity and efficacy towards the protease. Other sources of natural products, such as fungi, bacterial toxins, marine organisms, and animals, should also be explored towards discovering more potential and effective DENV NS2b/NS3 protease inhibitors.
</paragraph>
<paragraph blockId="0.[100,1488,1539,1837]" pageId="0" pageNumber="1">
<emphasis bold="true" box="[132,247,1539,1556]" italics="true" pageId="0" pageNumber="1">Abbreviations:</emphasis>
Abbreviations: ATPase, adenosine triphosphatase; aq., aqueous/water; C, capsid protein; CC 
<subScript attach="left" box="[1040,1056,1546,1558]" fontSize="5" pageId="0" pageNumber="1">50</subScript>
, cytotoxic concentration 50%; DC-SIGN, dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin receptor; DCM, dichloromethane; DENV1, dengue virus serotype 1; DENV2, dengue virus serotype 2; DENV3, dengue virus serotype 3; DENV4, dengue virus serotype 4; DF, dengue fever; DHF, dengue haemorrhegic fever; DSS, dengue shock syndrome; E, envelope protein; EC 
<subScript attach="left" box="[278,294,1623,1635]" fontSize="5" pageId="0" pageNumber="1">50</subScript>
, effective concentration 50%; EtOAc, ethyl acetate; EtOH, ethanol; GC-MS, gas chromatography-mass spectrometry; HMGB1, high mobility group box 1; IC 
<subScript attach="right" box="[233,249,1648,1660]" fontSize="5" pageId="0" pageNumber="1">50</subScript>
, inhibitory concentration 50%; IL-5, interleukin-5; INF-β, interferon beta; IRCH, International Regulatory Cooperation for Herbal Medicines; ISG, interferon-stimulated gene; KD, dissociation constant; 
<subScript attach="left" box="[563,579,1667,1686]" fontSize="5" pageId="0" pageNumber="1">Ki</subScript>
, inhibition constant; 
<subScript attach="right" box="[765,790,1667,1686]" fontSize="5" pageId="0" pageNumber="1">Km</subScript>
, Michaelis constant; LC-MS/MS, liquid chromatography-mass spectrometry/mass spectrometry; MeOH, methanol; MR, mannose-binding receptor; MxA, human myxovirus resistance protein; NS1, non-structural protein 1; NS2sb/NS3pro, nonstructural protein 2b/non-structural protein 3 protease; NS3, non-structural protein 3; NS5, non-structural protein 5; ORF, open reading frame; prM, membrane precursor; RTPase, RNA 5 
<emphasis box="[324,328,1741,1752]" italics="true" pageId="0" pageNumber="1">
<superScript attach="none" box="[324,328,1741,1752]" fontSize="5" pageId="0" pageNumber="1">′</superScript>
</emphasis>
-triphosphatase; RdRp, RNA dependent-RNA polymerase; RT-PCR, real time-polymerase chain reaction; SIRT1, NAD-dependent deacetylase sirtuin-1; 
<subScript attach="left" box="[239,279,1769,1788]" fontSize="5" pageId="0" pageNumber="1">Vmax</subScript>
, maximum rate of reaction; WNV, West Nile Virus.
</paragraph>
<paragraph blockId="0.[100,1488,1539,1837]" box="[114,1444,1794,1811]" pageId="0" pageNumber="1">* Corresponding author. Discipline of Pharmaceutical Technology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia.</paragraph>
<paragraph blockId="0.[100,1488,1539,1837]" box="[132,1298,1820,1837]" pageId="0" pageNumber="1">
<emphasis bold="true" box="[132,271,1820,1837]" italics="true" pageId="0" pageNumber="1">E-mail addresses:</emphasis>
fadighassan92@gmail.com (F.G. Saqallah), m.abbas@ammanu.edu.jo (M.A. Abbas), habibahw@usm.my (H.A. Wahab).
</paragraph>
<paragraph blockId="1.[100,261,147,167]" box="[100,261,147,167]" pageId="1" pageNumber="2">
<emphasis bold="true" box="[100,261,147,167]" pageId="1" pageNumber="2">1. Introduction</emphasis>
</paragraph>
<paragraph blockId="1.[100,771,203,1980]" pageId="1" pageNumber="2">
Dengue is a mosquito-borne tropical and sub-tropical communicable viral disease caused by dengue virus (DENV) (Rodenhuis-Zybert et al., 2010). DENV is a member of the 
<taxonomicName _evidence="catalogs" _step="genera" box="[416,502,259,278]" class="Flasuviricetes" family="Flaviviridae" genus="Flavivirus" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="1" pageNumber="2" phylum="Kitrinoviricota" rank="genus">
<emphasis bold="true" box="[416,502,259,278]" italics="true" pageId="1" pageNumber="2">Flavivirus</emphasis>
</taxonomicName>
genus that belongs to 
<taxonomicName _evidence="catalogs" _step="family" class="Flasuviricetes" family="Flaviviridae" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="1" pageNumber="2" phylum="Kitrinoviricota" rank="family">Flaviviridae</taxonomicName>
family and consists of a single enveloped positive RNA strand (Malavige et al., 2004; Simmonds et al., 2017). DENV has five distinct serotypes (DENV1-5) (Joob and Wiwanitkit, 2016; Taylor-Robinson, 2016), with DENV2 being the most prevalent among the other serotypes (Y. K. Lee et al., 2007). DENV is considered as a prototype to recognise and study the 
<taxonomicName _evidence="catalogs" _step="genera" box="[242,328,426,445]" class="Flasuviricetes" family="Flaviviridae" genus="Flavivirus" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="1" pageNumber="2" phylum="Kitrinoviricota" rank="genus">
<emphasis bold="true" box="[242,328,426,445]" italics="true" pageId="1" pageNumber="2">Flavivirus</emphasis>
</taxonomicName>
genus structure and replication cycle (Lescar et al., 2018). DENV is an arbovirus, an acronym for ARthropod-BOrne VIRUS. This type of virus has a very complex life cycle because it requires more than one host to complete it. This unique characteristic is a major challenge in monitoring the spread of arboviruses. Therefore, it is important to study their life cycle, prophylaxis, and treatment (Sukhralia et al., 2018). Three species of the mosquitos’ genus 
<taxonomicName _evidence="catalogs" _step="genera" authorityName="Meigen" authorityYear="1818" box="[645,697,594,613]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="1" pageNumber="2" phylum="Arthropoda" rank="genus">
<emphasis bold="true" box="[645,697,594,613]" italics="true" pageId="1" pageNumber="2">Aedes</emphasis>
</taxonomicName>
are the main transmitting vectors of DENV; 
<emphasis bold="true" box="[453,764,622,641]" italics="true" pageId="1" pageNumber="2">
<taxonomicName _evidence="catalogs" _step="species1" baseAuthorityName="Linnaeus" baseAuthorityYear="1762" box="[453,577,622,641]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="1" pageNumber="2" phylum="Arthropoda" rank="species" species="aegypti">Aedes aegypti</taxonomicName>
, 
<taxonomicName _evidence="catalogs" _step="species1" authorityName="Marks" authorityYear="1954" box="[590,764,622,641]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="1" pageNumber="2" phylum="Arthropoda" rank="species" species="polynesiensis">Aedes polynesiensis</taxonomicName>
</emphasis>
, and 
<taxonomicName _evidence="catalogs" _step="species1" baseAuthorityName="Skuse" baseAuthorityYear="1894" box="[142,290,649,668]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="1" pageNumber="2" phylum="Arthropoda" rank="species" species="albopictus">
<emphasis bold="true" box="[142,290,649,668]" italics="true" pageId="1" pageNumber="2">Aedes albopictus</emphasis>
</taxonomicName>
. 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" baseAuthorityName="Linnaeus" baseAuthorityYear="1762" box="[303,394,650,669]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="1" pageNumber="2" phylum="Arthropoda" rank="species" species="aegypti">
<emphasis bold="true" box="[303,394,650,669]" italics="true" pageId="1" pageNumber="2">A. aegypti</emphasis>
</taxonomicName>
is considered the main DENV-infection causative agent (Malavige et al., 2004).
</paragraph>
<paragraph blockId="1.[100,771,203,1980]" pageId="1" pageNumber="2">
One approach to control DENV endemics is vector control which represents a principal method in controlling vector-borne diseases (Wilson et al., 2020). Vector control methods of 
<taxonomicName box="[570,657,761,781]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="1" pageNumber="2" phylum="Arthropoda" rank="species" species="undetermined">
<emphasis bold="true" box="[570,622,761,780]" italics="true" pageId="1" pageNumber="2">Aedes</emphasis>
sp.
</taxonomicName>
mosquitoes can be distinguished into three approaches which include environmental, biological, and chemical (Buhler et al., 2019). The environmental approach to control the spread of DENV is through waste management, the use of water-containers’ covers, and elimination of breeding spots (Buhler et al., 2019). On the other hand, biological measures include the use of 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSubSpecies" authorityName="de Barjac" authorityYear="1978" box="[371,654,928,947]" class="Insecta" family="Bacillidae" genus="Bacillus" kingdom="Animalia" order="Phasmida" pageId="1" pageNumber="2" phylum="Arthropoda" rank="subSpecies" species="thuringiensis" subSpecies="israelensis">
<emphasis bold="true" box="[371,654,928,947]" italics="true" pageId="1" pageNumber="2">Bacillus thuringiensis israelensis</emphasis>
</taxonomicName>
, which produces certain toxins that can kill insects larvae and fungi in water containers while expressing no effects on other organisms. Other reported biological measures include the use of copepods (
<taxonomicName box="[576,721,1012,1032]" class="Copepoda" family="Cyclopidae" genus="Mesocyclops" kingdom="Animalia" order="Cyclopoida" pageId="1" pageNumber="2" phylum="Arthropoda" rank="species" species="undetermined">
<emphasis bold="true" box="[576,686,1012,1031]" italics="true" pageId="1" pageNumber="2">Mesocyclops</emphasis>
sp.
</taxonomicName>
) and larvivorous fish (
<taxonomicName _evidence="catalogs" _step="species1" authorityName="Peters" authorityYear="1859" box="[268,431,1040,1059]" class="Insecta" family="Gelechiidae" genus="Poecilia" kingdom="Animalia" order="Lepidoptera" pageId="1" pageNumber="2" phylum="Arthropoda" rank="species" species="reticulata">
<emphasis bold="true" box="[268,431,1040,1059]" italics="true" pageId="1" pageNumber="2">Poecilia reticulata</emphasis>
</taxonomicName>
and 
<taxonomicName _evidence="catalogs" _step="species1" baseAuthorityName="Baird &amp; Girard" baseAuthorityYear="1853" box="[484,637,1040,1059]" family="Poeciliidae" genus="Gambusia" kingdom="Animalia" order="Cyprinodontiformes" pageId="1" pageNumber="2" phylum="Chordata" rank="species" species="affinis">
<emphasis bold="true" box="[484,637,1040,1059]" italics="true" pageId="1" pageNumber="2">Gambusia affinis</emphasis>
</taxonomicName>
), where they feed on the larvae of the mosquito before they turn into adults (Walton, 2007; Horstick et al., 2017). In contrast, chemical methods are the most used measures for vector control (Alkuriji et al., 2020). They include sprayable insecticides and fumigation through the application of synthetic pyrethroids, deltamethrin, 
<emphasis bold="true" box="[433,444,1180,1199]" italics="true" pageId="1" pageNumber="2">S</emphasis>
-bioallethrin, piperonyl butoxide, pyriproxyfen, and permethrin. Temephos (an organophosphate larvicide) and malathion (an organophosphate insecticide) are other chemical agents which have been used to treat water and control the larval habits of the mosquito (Horstick et al., 2017). A greener approach for controlling DENV vector is the 
<taxonomicName _evidence="catalogs" _step="genera" authorityName="Hertig" authorityYear="1936" box="[411,506,1319,1338]" class="Alphaproteobacteria" family="Anaplasmataceae" genus="Wolbachia" kingdom="Bacteria" order="Rickettsiales" pageId="1" pageNumber="2" phylum="Proteobacteria" rank="genus">
<emphasis bold="true" box="[411,506,1319,1338]" italics="true" pageId="1" pageNumber="2">Wolbachia</emphasis>
</taxonomicName>
-based strategy (Sim et al., 2020). 
<taxonomicName box="[172,304,1347,1367]" class="Alphaproteobacteria" family="Anaplasmataceae" genus="Wolbachia" kingdom="Bacteria" order="Rickettsiales" pageId="1" pageNumber="2" phylum="Proteobacteria" rank="species" species="undetermined">
<emphasis bold="true" box="[172,267,1347,1366]" italics="true" pageId="1" pageNumber="2">Wolbachia</emphasis>
sp.
</taxonomicName>
is a genus of a Gram-negative bacteria that is naturally present in some invertebrates and can prevent RNA viruses from replication. Hence, no offspring can develop if an infected male 
<taxonomicName _evidence="catalogs" _step="genera" authorityName="Meigen" authorityYear="1818" box="[100,152,1431,1450]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="1" pageNumber="2" phylum="Arthropoda" rank="genus">
<emphasis bold="true" box="[100,152,1431,1450]" italics="true" pageId="1" pageNumber="2">Aedes</emphasis>
</taxonomicName>
mosquito fertilises an uninfected female. On the contrary, if an uninfected male fertilises an infected female, the offspring will be bearing 
<emphasis bold="true" box="[178,279,1486,1505]" italics="true" pageId="1" pageNumber="2">
<taxonomicName _evidence="catalogs" _step="genera" authorityName="Hertig" authorityYear="1936" box="[178,274,1486,1505]" class="Alphaproteobacteria" family="Anaplasmataceae" genus="Wolbachia" kingdom="Bacteria" order="Rickettsiales" pageId="1" pageNumber="2" phylum="Proteobacteria" rank="genus">Wolbachia</taxonomicName>
,
</emphasis>
and the number of laid eggs will be less. This way, 
<taxonomicName _evidence="catalogs" _step="genera" authorityName="Hertig" authorityYear="1936" box="[100,195,1514,1533]" class="Alphaproteobacteria" family="Anaplasmataceae" genus="Wolbachia" kingdom="Bacteria" order="Rickettsiales" pageId="1" pageNumber="2" phylum="Proteobacteria" rank="genus">
<emphasis bold="true" box="[100,195,1514,1533]" italics="true" pageId="1" pageNumber="2">Wolbachia</emphasis>
</taxonomicName>
strategy can offer a safer and more economical approach to controlling the spread of mosquito-borne diseases (Alkuriji et al., 2020). Similarly, green pesticides from the plant kingdom were seen to prove their efficacy against 
<taxonomicName box="[301,398,1598,1618]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="1" pageNumber="2" phylum="Arthropoda" rank="species" species="undetermined">
<emphasis bold="true" box="[301,353,1598,1617]" italics="true" pageId="1" pageNumber="2">Aedes</emphasis>
spp.
</taxonomicName>
and their larvae. These include extracts of 
<taxonomicName _evidence="catalogs" _step="species1" box="[124,314,1626,1645]" class="Magnoliopsida" family="Lamiaceae" genus="Ocimum" kingdom="Plantae" order="Lamiales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="species" species="americanum">
<emphasis bold="true" box="[124,314,1626,1645]" italics="true" pageId="1" pageNumber="2">Ocimum americanum</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[392,494,1626,1645]" class="Magnoliopsida" family="Lamiaceae" kingdom="Plantae" order="Lamiales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="family">Lamiaceae</taxonomicName>
, leaf), 
<taxonomicName _evidence="catalogs" _step="species1" box="[556,697,1626,1645]" class="Magnoliopsida" family="Euphorbiaceae" genus="Jatropha" kingdom="Plantae" order="Malpighiales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="species" species="curcas">
<emphasis bold="true" box="[556,697,1626,1645]" italics="true" pageId="1" pageNumber="2">Jatropha curcas</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[100,242,1654,1673]" class="Magnoliopsida" family="Euphorbiaceae" kingdom="Plantae" order="Malpighiales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="family">Euphorbiaceae</taxonomicName>
, leaf), 
<taxonomicName _evidence="catalogs" _step="species1" box="[312,424,1654,1673]" class="Magnoliopsida" family="Rutaceae" genus="Citrus" kingdom="Plantae" order="Sapindales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="species" species="limon">
<emphasis bold="true" box="[312,424,1654,1673]" italics="true" pageId="1" pageNumber="2">Citrus limon</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[510,598,1654,1673]" class="Magnoliopsida" family="Rutaceae" kingdom="Plantae" order="Sapindales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="family">Rutaceae</taxonomicName>
, fruit peel), 
<taxonomicName _evidence="catalogs" _step="species1" class="Magnoliopsida" family="Moraceae" genus="Artocarpus" kingdom="Plantae" order="Rosales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="species" species="blancoi">
<emphasis bold="true" italics="true" pageId="1" pageNumber="2">Artocarpus blancoi</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[320,413,1682,1701]" class="Magnoliopsida" family="Moraceae" kingdom="Plantae" order="Rosales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="family">Moraceae</taxonomicName>
, leaf), 
<taxonomicName _evidence="catalogs" _step="species1" box="[486,623,1681,1701]" class="Liliopsida" family="Amaryllidaceae" genus="Allium" kingdom="Plantae" order="Asparagales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="species" species="sativum">
<emphasis bold="true" box="[486,623,1681,1701]" italics="true" pageId="1" pageNumber="2">Allium sativum</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" class="Liliopsida" family="Amaryllidaceae" kingdom="Plantae" order="Asparagales" pageId="1" pageNumber="2" phylum="Tracheophyta" rank="family">Amaryllidaceae</taxonomicName>
), in addition to some essential oils from ginger, oranges, lemongrass, rosemary, and thyme, among many others (Waliwitiya et al., 2009; Kalita et al., 2013; Maia et al., 2019; Pineda-Cortel et al., 2019; AlSalhi et al., 2020; Kurniasih et al., 2021; Dusi et al., 2022).
</paragraph>
<paragraph blockId="1.[100,771,203,1980]" lastBlockId="1.[818,1487,148,418]" pageId="1" pageNumber="2">Infection with DENV can result in a variant of complications and symptoms. These complications mainly vary between asymptomatic dengue fever (DF), mild DF, dengue haemorrhagic fever (DHF), or dengue shock syndrome (DSS) (Khetarpal and Khanna, 2016). The severity of these complications generally varies according to the infecting serotype. It has been reported that DENV2 infections are more severe than the other serotypes and are typically associated with DHF and DSS (Vicente et al., 2016; Wang et al., 2020). In contrast, DENV4 is reported to be generally the most clinically mild (Aryati et al., 2020). However, secondary infections might manifest during a DENV infection due to a vulnerable immune system or an accessible route of entry for another pathogen that might be viral, bacterial, or fungal (Manohar et al., 2020). In this context, DENV2 and DENV4 have been reported to manifest an increased complications’ severity due to the possible secondary infections compared to the infections by other serotypes (i.e., 1, 3, and 5) (Kyle and Harris, 2008).</paragraph>
<paragraph blockId="1.[818,1262,463,483]" box="[818,1262,463,483]" pageId="1" pageNumber="2">
<emphasis bold="true" box="[818,1262,463,483]" italics="true" pageId="1" pageNumber="2">
1.1. 
<taxonomicName _evidence="catalogs" _step="genera" box="[866,952,463,482]" class="Flasuviricetes" family="Flaviviridae" genus="Flavivirus" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="1" pageNumber="2" phylum="Kitrinoviricota" rank="genus">Flavivirus</taxonomicName>
structure and the replication cycle
</emphasis>
</paragraph>
<paragraph blockId="1.[818,1488,519,1180]" pageId="1" pageNumber="2">
<taxonomicName _evidence="catalogs" _step="genera" box="[849,935,519,538]" class="Flasuviricetes" family="Flaviviridae" genus="Flavivirus" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="1" pageNumber="2" phylum="Kitrinoviricota" rank="genus">
<emphasis bold="true" box="[849,935,519,538]" italics="true" pageId="1" pageNumber="2">Flavivirus</emphasis>
</taxonomicName>
positive RNA genome is a 5’-capped RNA (( 
<emphasis box="[1388,1405,522,538]" italics="true" pageId="1" pageNumber="2">+</emphasis>
)ssRNA). DENV was found to use human macrophages as host cells where it binds to the mannose-binding receptor (MR) and the dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) receptor (Lo et al., 2016). Once bound, the virus gets internalised via clathrin-mediated endocytosis, creating an endosome within the host cell’ s cytoplasm (Uno and Ross, 2018). The acidic environment of the endosome disrupts the envelop (E) protein leading to its fusion with the endosome membrane (Mukhopadhyay et al., 2005). Once the nucleocapsid is released into the cytoplasm, it dissociates, leaving the RNA to serve as a messenger-RNA (mRNA). The open reading frame (ORF) migrates to the rough endoplasmic reticulum and is translated into a large polyprotein. This polyprotein is cleaved co- and post-translationally into ten proteins (Bidet and Garcia-Blanco, 2018; Murugesan and Manoharan, 2020). This cleavage is hosted by two proteases; the host furin-type (or any other Golgi-localized proteases), and the viral serine protease embedded in the N-terminal domain of non-structural protein 3 (NS3pro). NS3pro requires non-structural protein 2b (NS2b) for its activity (Niyomrattanakit et al., 2004; Bollati et al., 2010). Upon cleavage, the N-terminus of the polyprotein yields the three structural proteins; E, prM, and C (Fig. 1). The rest of the N-terminus encodes seven non-structural (NS) proteins; NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5 (Fig. 2) (Niyomrattanakit et al., 2004; Bollati et al., 2010; Rodenhuis-Zybert et al., 2010; Murugesan and Manoharan, 2020).
</paragraph>
<paragraph blockId="1.[818,1335,1226,1245]" box="[818,1335,1226,1245]" pageId="1" pageNumber="2">
<emphasis bold="true" box="[818,1335,1226,1245]" italics="true" pageId="1" pageNumber="2">1.2. The role of NS2b/NS3pro in DENV replication cycle</emphasis>
</paragraph>
<paragraph blockId="1.[818,1488,1282,1552]" lastBlockId="2.[100,770,1653,1980]" lastPageId="2" lastPageNumber="3" pageId="1" pageNumber="2">
NS3 protein is a multifunctional protein that can act as a trypsin-like serine protease, ATPase, RTPase, and RNA helicase (Nasar et al., 2020). The N-terminus of NS3 (residues 1–180) is considered as the protease domain, while the rest of the protein (residues 180–618; the C-terminus) functions as the RNA helicase. Like any other trypsin-like serine protease, NS3pro has a catalytic triad which is made of HIS51, ASP75, and SER135 residues (Niyomrattanakit et al., 2004; Ganji and Kanyalkar, 2019). NS3pro was proven to require a co-factor; NS2b, for its functionality (Yusof et al., 2000; Leung et al., 2001), where NS2b provides structural stability for NS3pro and permits protein folding for a successful proteolytic activity (Leung et al., 2001). NS2b has a hydrophilic central region which behaves as a chaperone to stabilise the hydrophobic termini of NS3pro by surrounding it like a belt (Tomar et al., 2017). Both domains, the NS3pro and NS2b, are connected through a Gly 
<subScript attach="right" box="[133,142,1772,1786]" fontSize="6" pageId="2" pageNumber="3">4</subScript>
-Ser-Gly 
<subScript attach="left" box="[217,226,1772,1786]" fontSize="6" pageId="2" pageNumber="3">4</subScript>
linker (Leung et al., 2001; Luo et al., 2008). This NS2b/NS3pro is responsible for the cleavage of multiple proteins at the junctions of C-prM, NS2a-NS2b, NS2b-NS3, NS3-NS4a, and NS4b-NS5 (Tomar et al., 2017). Therefore, NS2b/NS3pro is a crucial enzyme complex for the proteolytic and cleavage activities of the translated polyprotein during the virus life cycle.
</paragraph>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234952" ID-Zenodo-Dep="8234952" httpUri="https://zenodo.org/record/8234952/files/figure.png" pageId="1" pageNumber="2" startId="1.[818,848,1939,1956]" targetBox="[824,1482,1594,1910]" targetPageId="1" targetType="figure">
<paragraph blockId="1.[818,1487,1939,1981]" pageId="1" pageNumber="2">
<emphasis bold="true" box="[818,875,1939,1956]" pageId="1" pageNumber="2">Fig. 1.</emphasis>
An illustration of dengue virus structure showing the lipid bilayer, the structural proteins, and the positive RNA strand.
</paragraph>
</caption>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234954" ID-Zenodo-Dep="8234954" httpUri="https://zenodo.org/record/8234954/files/figure.png" pageId="2" pageNumber="3" startId="2.[100,130,1544,1561]" targetBox="[341,1246,151,1515]" targetPageId="2" targetType="figure">
<paragraph blockId="2.[100,1487,1544,1613]" pageId="2" pageNumber="3">
<emphasis bold="true" box="[100,246,1544,1561]" pageId="2" pageNumber="3">
Fig. 2. 
<taxonomicName _evidence="catalogs" _step="genera" box="[169,246,1544,1561]" class="Flasuviricetes" family="Flaviviridae" genus="Flavivirus" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="2" pageNumber="3" phylum="Kitrinoviricota" rank="genus">
<emphasis bold="true" box="[169,246,1544,1561]" italics="true" pageId="2" pageNumber="3">Flavivirus</emphasis>
</taxonomicName>
</emphasis>
life cycle since its binding to the host’ s mannose-binding receptor (MR) and/or the dendritic cell-specific intercellular adhesion molecule-3- grabbing non-integrin (DC-SIGN) receptor, and the cleavage of the translated polyprotein into the structural (C; capsid, M; membrane, and E; envelope) and the non-structural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5).
</paragraph>
</caption>
<paragraph blockId="2.[100,770,1653,1980]" lastBlockId="2.[818,1488,1653,1980]" pageId="2" pageNumber="3">Several approaches were taken to prevent and limit DENV infections in the affected areas. These approaches vary between protective measures against the transmitting vectors and the search for infection inhibitors, whether they are synthesised chemical entities or isolates from natural sources. Thus, the search for antivirals from natural products continues. Noteworthy, multiple reviews were published earlier, covering isolated natural compounds’ activities towards DENV infections from prior to 2017 that we highly encourage researchers and readers to consider (Laille et al., 1998; Abd Kadir et al., 2013; Teixeira et al., 2014; Frederico et al., 2017; Oliveira et al., 2017). Throughout these reviews, multiple phytochemical classes were included from various plant families and species, covering all types of research approaches and multiple molecular targets.</paragraph>
<paragraph blockId="2.[818,1488,1653,1980]" lastBlockId="3.[100,770,148,390]" lastPageId="3" lastPageNumber="4" pageId="2" pageNumber="3">
This review intends to highlight the most recent studies and advances from the past five years, discussing new findings of known natural products or phytochemicals which have not been studied and described previously as DENV protease potential inhibitors. Covered studies include 
<emphasis bold="true" box="[243,392,231,250]" italics="true" pageId="3" pageNumber="4">in-silico, in-vitro,</emphasis>
and 
<emphasis bold="true" box="[436,496,231,250]" italics="true" pageId="3" pageNumber="4">in-vivo</emphasis>
evaluations related to the use of these natural products extracted from various sources. Each reported natural product is given a number to facilitate its appearance throughout the paper. A more detailed insight on isolated phytochemicals and their related 
<emphasis bold="true" box="[171,321,343,362]" italics="true" pageId="3" pageNumber="4">in-silico, in-vitro,</emphasis>
and 
<emphasis bold="true" box="[367,427,343,362]" italics="true" pageId="3" pageNumber="4">in-vivo</emphasis>
activities are summarised in Table 1 by the end of Section 2.
</paragraph>
<paragraph blockId="3.[100,474,426,446]" box="[100,474,426,446]" pageId="3" pageNumber="4">
<emphasis bold="true" box="[100,474,426,446]" pageId="3" pageNumber="4">2. Natural compounds as anti-DENV</emphasis>
</paragraph>
<paragraph blockId="3.[100,247,482,502]" box="[100,247,482,502]" pageId="3" pageNumber="4">
<emphasis bold="true" box="[100,247,482,502]" italics="true" pageId="3" pageNumber="4">2.1. Fatty acids</emphasis>
</paragraph>
<paragraph blockId="3.[100,770,538,1701]" pageId="3" pageNumber="4">
Based on earlier findings where Papaya’ s (
<taxonomicName _evidence="catalogs" _step="species1" box="[560,694,538,557]" class="Magnoliopsida" family="Caricaceae" genus="Carica" kingdom="Plantae" order="Brassicales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="species" species="papaya">
<emphasis bold="true" box="[560,694,538,557]" italics="true" pageId="3" pageNumber="4">Carica papaya</emphasis>
</taxonomicName>
, family 
<taxonomicName _evidence="catalogs" _step="family" box="[100,203,566,585]" class="Magnoliopsida" family="Caricaceae" kingdom="Plantae" order="Brassicales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="family">Caricaceae</taxonomicName>
) crude leaf extracts has been found to possess excellent antiDENV activity (Subenthiran et al., 2013; Adarsh et al., 2017; Shetty et al., 2019; Sarker et al., 2021), three fatty acids including oleic (1), stearic (2) and palmitic (3) acids (Fig. 3) were identified in the leaf extracts through GC-MS analysis. Induced-fit molecular docking studies showed a more favourable binding and a higher docking score of these fatty acids towards the 2M9P crystal structure of DENV2 NS2b/NS3pro compared to the 2FOM (Kutumbarao and Velmurugan, 2016). This effect might refer to the fact that 2FOM crystal structure has a gap in the loop region of the NS2b co-factor chain. Moreover, all the three compounds (1–3) were able to interact with the catalytic triad residues (HIS51, ASP75, and SER135), but not necessarily through hydrogen bonds, with (1) and (3) having nearly similar binding conformations at the active site of protease (Kutumbarao and Velmurugan, 2016).
</paragraph>
<paragraph blockId="3.[100,770,538,1701]" pageId="3" pageNumber="4">
Moreover, the MeOH extract of 
<taxonomicName _evidence="catalogs" _step="species1" box="[441,627,956,975]" class="Magnoliopsida" family="Sapindaceae" genus="Lepisanthes" kingdom="Plantae" order="Sapindales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="species" species="fruticosa">
<emphasis bold="true" box="[441,627,956,975]" italics="true" pageId="3" pageNumber="4">Lepisanthes fruticosa</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" class="Magnoliopsida" family="Sapindaceae" kingdom="Plantae" order="Sapindales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="family">Sapindaceae</taxonomicName>
) pulp was assayed against DENV2 NS2b/NS3pro at concentrations between 1 and 10 mg/mL. Results indicated 70% and 93% inhibition at the tested concentrations, respectively, with an IC 
<subScript attach="left" box="[682,700,1047,1061]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
of 1.73 mg/mL. Compounds (2) and (3) were referred to be among the active specialised metabolites which were responsible for the DENV2 protease inhibitory activity of 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[307,409,1124,1143]" class="Magnoliopsida" family="Sapindaceae" genus="Lepisanthes" kingdom="Plantae" order="Sapindales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="species" species="fruticosa">
<emphasis bold="true" box="[307,409,1124,1143]" italics="true" pageId="3" pageNumber="4">L. fruticosa</emphasis>
</taxonomicName>
as they contributed through a synergistic effect with two other flavonoids (Supian et al., 2021). Hence, this inhibitory activity against DENV2 NS2b/NS3pro was referred to the different structural flexibility in the NS2b co-factor domain. This means that the C-terminus of NS2b of DENV2, which provides some of the important residues in the main binding pocket of the protease, is susceptible to dissociation from the NS3 domain. This would benefit the DENV2 protease inhibitors as it impedes the correct alliance of the NS2b co-factor to the NS3 domain, which results in an inhibition of the DENV2 NS2b/NS3pro activity (Su et al., 2009; Supian et al., 2021).
</paragraph>
<paragraph blockId="3.[100,770,538,1701]" lastBlockId="3.[818,1488,148,251]" pageId="3" pageNumber="4">
Studying the anti-DENV activity of the stem and leaf extracts of 
<taxonomicName _evidence="catalogs" _step="species1" box="[100,252,1431,1450]" class="Magnoliopsida" family="Myrtaceae" genus="Syzygium" kingdom="Plantae" order="Myrtales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="species" species="grande">
<emphasis bold="true" box="[100,252,1431,1450]" italics="true" pageId="3" pageNumber="4">Syzygium grande</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[335,437,1431,1450]" class="Magnoliopsida" family="Myrtaceae" kingdom="Plantae" order="Myrtales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="family">Myrtaceae</taxonomicName>
), palmitic acid (3) was also identified as a major component among other secondary metabolites. Similarly, this fatty acid was thought to be responsible for the DENV2 protease inhibitory activity of the crude extracts, which was carried out 
<emphasis bold="true" box="[100,164,1542,1561]" italics="true" pageId="3" pageNumber="4">in-vitro</emphasis>
and revealed more than 90% inhibition with IC 
<subScript attach="right" box="[623,641,1549,1563]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
’s of 3.77 μg/ mL for the leaf extract, and 5.23 μg/mL for the stem extract (Zakaria et al., 2019). These findings can be supported by the earlier work of Santoyo et al. (2010), whom thought that (3) could express a synergistic antiviral activity with other identified phytochemicals from 
<taxonomicName _evidence="catalogs" _step="species1" class="Phaeophyceae" family="Himanthaliaceae" genus="Himanthalia" kingdom="Chromista" order="Fucales" pageId="3" pageNumber="4" phylum="Ochrophyta" rank="species" species="elongata">
<emphasis bold="true" italics="true" pageId="3" pageNumber="4">Himanthalia elongata</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" authorityName="De Toni" authorityYear="1891" baseAuthorityName="Kjellman" box="[258,421,1682,1701]" class="Phaeophyceae" family="Himanthaliaceae" kingdom="Chromista" order="Fucales" pageId="3" pageNumber="4" phylum="Ochrophyta" rank="family">Himanthaliaceae</taxonomicName>
), an edible seaweed, towards herpes simplex virus-1 (Santoyo et al., 2010). Still, and to our knowledge, no study was conducted considering (3) as a pure entity to be tested 
<emphasis bold="true" box="[1423,1487,176,195]" italics="true" pageId="3" pageNumber="4">in-vitro</emphasis>
for its NS2b/NS3pro inhibitory activity. Hence, more studies are required to confirm these claims and 
<emphasis bold="true" box="[1171,1240,231,250]" italics="true" pageId="3" pageNumber="4">in-silico</emphasis>
results.
</paragraph>
<paragraph blockId="3.[818,959,311,331]" box="[818,959,311,331]" pageId="3" pageNumber="4">
<emphasis bold="true" box="[818,959,311,331]" italics="true" pageId="3" pageNumber="4">2.2. Glucosides</emphasis>
</paragraph>
<paragraph blockId="3.[818,1488,367,1056]" pageId="3" pageNumber="4">
In a recent study by Saleem and co-workers, 
<taxonomicName _evidence="catalogs" _step="species1" box="[1288,1487,367,386]" class="Magnoliopsida" family="Myrtaceae" genus="Syzygium" kingdom="Plantae" order="Myrtales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="species" species="aromaticum">
<emphasis bold="true" box="[1288,1487,367,386]" italics="true" pageId="3" pageNumber="4">Syzygium aromaticum</emphasis>
</taxonomicName>
(clove, family 
<taxonomicName _evidence="catalogs" _step="family" box="[958,1058,395,414]" class="Magnoliopsida" family="Myrtaceae" kingdom="Plantae" order="Myrtales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="family">Myrtaceae</taxonomicName>
) demonstrated DENV-inhibition of 93.5% at 200 μg/mL. Fractionation of the 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[1119,1246,423,442]" class="Magnoliopsida" family="Myrtaceae" genus="Syzygium" kingdom="Plantae" order="Myrtales" pageId="3" pageNumber="4" phylum="Tracheophyta" rank="species" species="aromaticum">
<emphasis bold="true" box="[1119,1246,423,442]" italics="true" pageId="3" pageNumber="4">S. aromaticum</emphasis>
</taxonomicName>
’s EtOH extract in hexane, DCM, EtOAc and aq. has resulted in excellent inhibitions towards DENV2 NS2b/NS3pro of 93.0% (IC 
<subScript attach="left" box="[1142,1160,486,500]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
: 12.7 μg/mL), 99.1% (IC 
<subScript attach="left" box="[1391,1409,486,500]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
: 1.3 μg/ mL), and 99.3% (IC 
<subScript attach="left" box="[1011,1029,514,528]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
: 0.7 μg/mL) for DCM, EtOAc, and aq., respectively. Isolation and purification of the aq. fraction demonstrated the presence of three glucosides which are thought to be responsible for the anti-DENV activity of the plant. These glucosides included isobiflorin (4), biflorin (5), and eugeniin (6) (Fig. 4). The IC 
<subScript attach="left" box="[1306,1324,626,640]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
of each purified compound (4–6) was measured for their inhibition of DENV2-3 NS2b/ NS3pro’ s. Eugeniin (6) was identified as the most potent, with an IC 
<subScript attach="left" box="[1446,1464,681,695]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
of 94.7 nM against DENV2 protease. Meanwhile, the chromone C-glucosides (4) and (5) demonstrated moderate inhibitions with IC 
<subScript attach="right" box="[1382,1400,737,751]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
’s of 58.9 and 89.6 μM, respectively.
</paragraph>
<paragraph blockId="3.[818,1488,367,1056]" pageId="3" pageNumber="4">
On the other hand, (6) was found to possess an IC 
<subScript attach="left" box="[1351,1369,793,807]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
of 7.53 μM against DENV3 protease, whereas (4) and (5) had IC 
<subScript attach="left" box="[1301,1319,821,835]" fontSize="6" pageId="3" pageNumber="4">50</subScript>
values of 219 and 337 μM, respectively. Kinetically, compounds 4–6 were found to act as competitive inhibitors at the active sites of DENV2-3 proteases. Eugeniin (6) was found to have 
<subScript attach="left" box="[1047,1065,898,919]" fontSize="6" pageId="3" pageNumber="4">Ki</subScript>
values of 0.125 and 7.1 μM for DENV2-3, respectively. STD-NMR spectroscopy and molecular docking approaches were applied for DENV2-3 proteases. Findings of both approaches were in agreement as they showed all three compounds (4–6) interacted with various residues at the subsites (S1–S4) of the active site with binding energies of 6.8, 7.2, and 10.2 kcal/mol, for (4), (5),
</paragraph>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234956" ID-Zenodo-Dep="8234956" httpUri="https://zenodo.org/record/8234956/files/figure.png" pageId="3" pageNumber="4" startId="3.[818,848,1660,1677]" targetBox="[824,1481,1097,1632]" targetPageId="3" targetType="figure">
<paragraph blockId="3.[818,1487,1660,1702]" pageId="3" pageNumber="4">
<emphasis bold="true" box="[818,874,1660,1677]" pageId="3" pageNumber="4">Fig. 4.</emphasis>
Chemical structures of the glucosides (a) isobiflorin (4), biflorin (5), and (b) eugeniin (6).
</paragraph>
</caption>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234958" ID-Zenodo-Dep="8234958" box="[326,1262,1964,1981]" httpUri="https://zenodo.org/record/8234958/files/figure.png" pageId="3" pageNumber="4" startId="3.[326,356,1964,1981]" targetBox="[340,1247,1760,1937]" targetPageId="3" targetType="figure">
<paragraph blockId="3.[326,1262,1964,1981]" box="[326,1262,1964,1981]" pageId="3" pageNumber="4">
<emphasis bold="true" box="[326,384,1964,1981]" pageId="3" pageNumber="4">Fig. 3.</emphasis>
Chemical structures of the fatty acids (a) oleic acid (1), (b) stearic acid (2), and (c) palmitic acid (3).
</paragraph>
</caption>
<paragraph blockId="4.[100,503,148,167]" box="[100,503,148,167]" pageId="4" pageNumber="5">and (6), respectively (Saleem et al., 2019).</paragraph>
<paragraph blockId="4.[100,365,227,246]" box="[100,365,227,246]" pageId="4" pageNumber="5">
<emphasis bold="true" box="[100,365,227,246]" italics="true" pageId="4" pageNumber="5">2.3. Terpenes and terpenoids</emphasis>
</paragraph>
<paragraph blockId="4.[100,771,282,1641]" pageId="4" pageNumber="5">
Gedunin (7) (Fig. 5), a triterpene identified in Neem (
<taxonomicName _evidence="catalogs" _step="species1" class="Magnoliopsida" family="Meliaceae" genus="Azadirachta" kingdom="Plantae" order="Sapindales" pageId="4" pageNumber="5" phylum="Tracheophyta" rank="species" species="indica">
<emphasis bold="true" italics="true" pageId="4" pageNumber="5">Azadirachta indica</emphasis>
</taxonomicName>
, family 
<taxonomicName _evidence="catalogs" _step="family" box="[231,327,311,330]" class="Magnoliopsida" family="Meliaceae" kingdom="Plantae" order="Sapindales" pageId="4" pageNumber="5" phylum="Tracheophyta" rank="family">Meliaceae</taxonomicName>
) extracts, has recently been studied for its antiDENV activity in an 
<emphasis bold="true" box="[288,357,338,357]" italics="true" pageId="4" pageNumber="5">in-silico</emphasis>
study by Rao and Yeturu, 2020. Gedunin (7) was found to bind efficiently to the human proteins CD14, DAXX, DC-SIGN, and IL-5. These proteins are used by DENV to attach itself to the cell and facilitate its entry. On the other hand, (7) was found to have a good affinity towards the NS3 RNA polymerase, NS3 protease-helicase, capsid, and envelope proteins (Rao and Yeturu, 2020).
</paragraph>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234960" ID-Zenodo-Dep="8234960" httpUri="https://zenodo.org/record/8234960/files/figure.png" pageId="4" pageNumber="5" startId="4.[818,848,475,492]" targetBox="[824,1481,148,447]" targetPageId="4" targetType="figure">
<paragraph blockId="4.[818,1487,475,518]" pageId="4" pageNumber="5">
<emphasis bold="true" box="[818,875,475,492]" pageId="4" pageNumber="5">Fig. 6.</emphasis>
Chemical structures of (a) andrographolide (8) and (b) stachyonic acid A (9).
</paragraph>
</caption>
<paragraph blockId="4.[100,771,282,1641]" pageId="4" pageNumber="5">
Andrographolide (8) (Fig. 6, a) is a labdane diterpenoid isolated from 
<taxonomicName _evidence="catalogs" _step="species1" box="[100,321,533,552]" class="Magnoliopsida" family="Acanthaceae" genus="Andrographis" kingdom="Plantae" order="Lamiales" pageId="4" pageNumber="5" phylum="Tracheophyta" rank="species" species="paniculata">
<emphasis bold="true" box="[100,321,533,552]" italics="true" pageId="4" pageNumber="5">Andrographis paniculata</emphasis>
</taxonomicName>
(green chiretta, family 
<taxonomicName _evidence="catalogs" _step="family" box="[553,677,534,553]" class="Magnoliopsida" family="Acanthaceae" kingdom="Plantae" order="Lamiales" pageId="4" pageNumber="5" phylum="Tracheophyta" rank="family">Acanthaceae</taxonomicName>
). Andrographolide (8) is well documented for its use as an antiviral agent against herpes simplex virus (Wiart et al., 2005; Seubsasana et al., 2011), human immunodeficiency virus (Calabrese et al., 2000; Niranjan Reddy et al., 2005), hepatitis B and C viruses (H. Chen et al., 2014; J.-C. Lee et al., 2014), and influenza virus (J.-X. Chen et al., 2009; B. Yu et al., 2014). A study by Panraksa et al. (2017) has investigated the inhibitory activity of andrographolide (8) against four serotypes of DENV (DENV1-4) in HepG2 and HeLa cell lines. Results indicated no cytotoxicity of the diterpenoid on both cell lines when tested at various concentrations up to 100 μM. However, it has been found that (8) has no direct virucidal effect on the DENV when incubated with it before introducing it to the cells. Further assessment has revealed that (8) succeeded in reducing the percentage of infected cells to below 20% at a concentration of 100 μM in HepG2 and HeLa cells with EC 
<subScript attach="left" box="[425,443,931,945]" fontSize="6" pageId="4" pageNumber="5">50</subScript>
’s of 21.30 and 22.74 μM, respectively (Panraksa et al., 2017) and an IC 
<subScript attach="left" box="[463,481,959,973]" fontSize="6" pageId="4" pageNumber="5">50</subScript>
of 51 μM in infected Vero cells (Tan et al., 2019). Dose-dependent reductions in DENV2’s and DENV4’s E and NS3 proteins expressions and virus titer were reported in both cell lines when supplied with (8) 3 h post-infection (Panraksa et al., 2017). These findings suggest that (8) can be considered as a potential antiviral agent that would manage DENV infections or minimise its replication into the host’ s cells. Thus, andrographolide (8) can be a focal point to study further its mechanism of action and its pharmacokinetics and toxicity.
</paragraph>
<paragraph blockId="4.[100,771,282,1641]" pageId="4" pageNumber="5">
Stachyonic acid A (9) (Fig. 6, b) is another labdane diterpenoid isolated from 
<taxonomicName _evidence="catalogs" _step="species1" box="[238,450,1231,1250]" class="Magnoliopsida" family="Lamiaceae" genus="Basilicum" kingdom="Plantae" order="Lamiales" pageId="4" pageNumber="5" phylum="Tracheophyta" rank="species" species="polystachyon">
<emphasis bold="true" box="[238,450,1231,1250]" italics="true" pageId="4" pageNumber="5">Basilicum polystachyon</emphasis>
</taxonomicName>
(musk basil, family 
<taxonomicName _evidence="catalogs" _step="family" box="[657,761,1231,1250]" class="Magnoliopsida" family="Lamiaceae" kingdom="Plantae" order="Lamiales" pageId="4" pageNumber="5" phylum="Tracheophyta" rank="family">Lamiaceae</taxonomicName>
). Extracts of 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[211,354,1259,1278]" class="Magnoliopsida" family="Lamiaceae" genus="Basilicum" kingdom="Plantae" order="Lamiales" pageId="4" pageNumber="5" phylum="Tracheophyta" rank="species" species="polystachyon">
<emphasis bold="true" box="[211,354,1259,1278]" italics="true" pageId="4" pageNumber="5">B. polystachyon</emphasis>
</taxonomicName>
were reported with various biological and pharmacological activities, including antimicrobial, antioxidant, and cytotoxic effects. A recent study by Tan et al. (2019) has detailed the isolation and characterisation of (9). Right after, 
<emphasis bold="true" box="[552,616,1343,1362]" italics="true" pageId="4" pageNumber="5">in-vitro</emphasis>
evaluation of its activity along with a 95:5 mixture of satachyonic acid A (9) and stachyonic acid B against DENV infection in Vero cells was conducted. Results showed identical IC 
<subScript attach="left" box="[353,371,1434,1448]" fontSize="6" pageId="4" pageNumber="5">50</subScript>
values for both of pure (9) and in a mixture with stachyonic acid B of 1.4 μM. Noteworthy, (9) was found to be more potent when compared with andrographolide (8). Cytotoxicity evaluations in MCF7, SK-MEL-28, NFF, and Vero cells showed limited toxicity of the 95:5 stachyonic acid mixture compared to stachyonic acid A (9) alone and andrographolide (8). CC 
<subScript attach="left" box="[448,466,1573,1587]" fontSize="6" pageId="4" pageNumber="5">50</subScript>
values of the stachyonic acid mixture for each cell line were found to be at 96,
<emphasis box="[564,580,1594,1613]" italics="true" pageId="4" pageNumber="5">&gt;</emphasis>
198, 66, and 93 μM, respectively, whereas andrographolide (8) was found to possess higher
</paragraph>
<paragraph blockId="4.[818,1488,558,1331]" box="[818,1254,558,580]" pageId="4" pageNumber="5">
CC 
<subScript attach="left" box="[844,862,566,580]" fontSize="6" pageId="4" pageNumber="5">50</subScript>
in Vero cells of 51 μM (Tan et al., 2019).
</paragraph>
<paragraph blockId="4.[818,1488,558,1331]" pageId="4" pageNumber="5">It can be concluded that labdane terpenoids possess potent antiviral activity towards DENV. This activity varies according to the complexity of the compounds’ structures, along with its potential cytotoxicity. Still, further studies are required to investigate their structure-activity relationship and the molecular mechanism by which they interact with DENV NS2b/NS3pro.</paragraph>
<paragraph blockId="4.[818,1488,558,1331]" pageId="4" pageNumber="5">
<taxonomicName _evidence="catalogs" _step="species1" box="[849,1031,753,772]" class="Agaricomycetes" family="Ganodermataceae" genus="Ganoderma" kingdom="Fungi" order="Polyporales" pageId="4" pageNumber="5" phylum="Basidiomycota" rank="species" species="lucidum">
<emphasis bold="true" box="[849,1031,753,772]" italics="true" pageId="4" pageNumber="5">Ganoderma lucidum</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" authorityName="Donk" authorityYear="1948" baseAuthorityName="Donk" box="[1111,1281,754,773]" class="Agaricomycetes" family="Ganodermataceae" kingdom="Fungi" order="Polyporales" pageId="4" pageNumber="5" phylum="Basidiomycota" rank="family">Ganodermataceae</taxonomicName>
) is an oriental fungus belonging to family 
<taxonomicName _evidence="catalogs" _step="family" authorityName="Donk" authorityYear="1948" baseAuthorityName="Donk" box="[1013,1185,782,801]" class="Agaricomycetes" family="Ganodermataceae" kingdom="Fungi" order="Polyporales" pageId="4" pageNumber="5" phylum="Basidiomycota" rank="family">Ganodermataceae</taxonomicName>
. Traditionally, it is well known for its tonifying and antiaging effects and for enhancing memory, vital energy, and cardiac function (Wachtel-Galor et al., 2011). In the search for DENV NS2b/NS3pro inhibitors, Bharadwaj and co-workers conducted a virtual screening study on 22 known antiviral triterpenoids from 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[872,974,921,940]" class="Agaricomycetes" family="Ganodermataceae" genus="Ganoderma" kingdom="Fungi" order="Polyporales" pageId="4" pageNumber="5" phylum="Basidiomycota" rank="species" species="lucidum">
<emphasis bold="true" box="[872,974,921,940]" italics="true" pageId="4" pageNumber="5">G. lucidum</emphasis>
</taxonomicName>
against the protease. All triterpenoids were seen to possess significant binding affinities towards the NS2b/NS3pro except for ganoderic acid G (structure not shown). Among the screened phytochemicals, ganodermanontriol (10) (6.29 kcal/mol), lucidumol A (11) (5.99 kcal/mol), ganoderic acid C2 (12) (5.95 kcal/mol), and ganosporeric acid A (13) (5.98 kcal/mol) (Fig. 7) were selected as potential inhibitors of DENV protease. All four triterpenoids displayed hydrogen bond interactions with the catalytic residues and other conserved residues (PHE130, TYR150, ASN152, and GLY153), which are known to play a crucial role in substrate binding for DENV protease. MM/GBSA calculations showed relatively negative energy values for all four docked complexes of 24.47, 19.74, 19.04, 11.45 kcal/mol for 10–13, respectively (Bharadwaj et al., 2019).
</paragraph>
<paragraph blockId="4.[818,1488,558,1331]" lastBlockId="5.[100,770,148,390]" lastPageId="5" lastPageNumber="6" pageId="4" pageNumber="5">
Therefore, (10) and (12) were selected for further 
<emphasis bold="true" box="[1384,1448,1284,1303]" italics="true" pageId="4" pageNumber="5">in-vitro</emphasis>
investigations judging by their binding energy and complex stability through the molecular dynamics simulations. DENV2-infected A549 cell line was incubated with 25 or 50 μM of both compounds for 1 h. Results indicated 40 and 25% reductions in DENV2 titers at 50 and 25 μM, respectively, of ganodermanontriol (10). At the same time, there was no significant reduction in virus titers for ganoderic acid C2 (12) at both tested concentrations (Bharadwaj et al., 2019). Noteworthy, (10) has already been documented for its antiviral activity against human immunodeficiency-1 (Min et al., 1998), Epstein-Barr (Zheng and Chen, 2017), and influenza (Zhu et al., 2015) viruses.
</paragraph>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234962" ID-Zenodo-Dep="8234962" httpUri="https://zenodo.org/record/8234962/files/figure.png" pageId="4" pageNumber="5" startId="4.[818,848,1913,1930]" targetBox="[824,1481,1394,1886]" targetPageId="4" targetType="figure">
<paragraph blockId="4.[818,1487,1913,1981]" pageId="4" pageNumber="5">
<emphasis bold="true" box="[818,880,1913,1930]" pageId="4" pageNumber="5">Fig. 7.</emphasis>
Chemical structures of ganodermanontriol (10), lucidumol A (11), ganoderic acid C2 (12), and ganosporeric acid A (13). Wherein, () indicates a wedged bond; (- - -) indicates a hashed bond.
</paragraph>
</caption>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234964" ID-Zenodo-Dep="8234964" box="[250,621,1964,1981]" httpUri="https://zenodo.org/record/8234964/files/figure.png" pageId="4" pageNumber="5" startId="4.[250,280,1964,1981]" targetBox="[257,612,1682,1937]" targetPageId="4" targetType="figure">
<paragraph blockId="4.[250,621,1964,1981]" box="[250,621,1964,1981]" pageId="4" pageNumber="5">
<emphasis bold="true" box="[250,308,1964,1981]" pageId="4" pageNumber="5">Fig. 5.</emphasis>
Chemical structures of gedunin (7).
</paragraph>
</caption>
<paragraph blockId="5.[100,244,449,468]" box="[100,244,449,468]" pageId="5" pageNumber="6">
<emphasis bold="true" box="[100,244,449,468]" italics="true" pageId="5" pageNumber="6">2.4. Flavonoids</emphasis>
</paragraph>
<paragraph blockId="5.[132,770,505,524]" lastBlockId="5.[818,1488,148,1980]" pageId="5" pageNumber="6">
Flavonoids (Fig. 8, a) are amongst the most extensively studied and reported phytochemical classes as inhibitors of DENV NS2b/NS3pro, especially quercetin (14) (Fig. 8, b). Most recently, quercetin (14) has been reported again in the leaf extract of papaya which is believed to contribute to the anti-DENV activity of the tested extracts besides the fatty acids (see 2.1) (Salim et al., 2018). Furthermore, (14) was also found to obstruct SER137 phosphorylation in NS3pro, which may reduce DENV replication (Alomair et al., 2021). Additionally, (14) was identified in 
<taxonomicName _evidence="catalogs" _step="species1" box="[942,1089,343,362]" class="Magnoliopsida" family="Myrtaceae" genus="Psidium" kingdom="Plantae" order="Myrtales" pageId="5" pageNumber="6" phylum="Tracheophyta" rank="species" species="guajava">
<emphasis bold="true" box="[942,1089,343,362]" italics="true" pageId="5" pageNumber="6">Psidium guajava</emphasis>
</taxonomicName>
(common guava, family 
<taxonomicName _evidence="catalogs" _step="family" box="[1331,1431,343,362]" class="Magnoliopsida" family="Myrtaceae" kingdom="Plantae" order="Myrtales" pageId="5" pageNumber="6" phylum="Tracheophyta" rank="family">Myrtaceae</taxonomicName>
) bark extract and exhibited the most effective inhibition with an EC 
<subScript attach="left" box="[1397,1415,378,392]" fontSize="6" pageId="5" pageNumber="6">50</subScript>
of 19.2 μg/mL in DENV2-infected Vero cells when compared with other isolated compounds from the same extract (Trujillo-Correa et al., 2019).
</paragraph>
<paragraph blockId="5.[818,1488,148,1980]" pageId="5" pageNumber="6">
Pongamol (15) (Fig. 8, c), on the other hand, is another flavonoid that was recently reported in Neem’ s extract. Regarding its anti-DENV activity, (9) was found to come next after gedunin (7) (see 2.3), comparing its affinity towards the tested human and DENV proteins (Rao and Yeturu, 2020). Another 
<emphasis bold="true" box="[1175,1244,566,585]" italics="true" pageId="5" pageNumber="6">in-silico</emphasis>
study by Dwivedi and co-workers has evaluated the effectiveness of 49 Neem-derived flavonoids as potential inhibitors towards DENV2 NS2b/NS3pro. Molecular docking simulations revealed that kaempferol-3- 
<emphasis bold="true" box="[1269,1284,650,669]" italics="true" pageId="5" pageNumber="6">O</emphasis>
-rutinoside (16), rutin (17), hyperoside (18), and epicatechin (19) (Fig. 8, b and d) expressed higher binding affinities towards the protease where their binding energies were 9.56, 9.32, 7.88, and 7.62 kcal/mol, respectively (Table 1), in comparison to quercetin (14) (positive control, 6.94 kcal/mol). Additionally, all flavonoids were found to occupy the same catalytic region at the protein’ s active site. Molecular dynamics simulation results revealed binding strength and stability of the systems on the catalytic triad of DENV2 NS2b/NS3pro, except for rutin (17) (Dwivedi et al., 2021). Herein, it must be highlighted that rutin (quercetin-3- 
<emphasis bold="true" box="[855,870,929,948]" italics="true" pageId="5" pageNumber="6">O</emphasis>
-rutinoside) (17), a glycosidic derivative of quercetin (14), when tested 
<emphasis bold="true" box="[880,944,957,976]" italics="true" pageId="5" pageNumber="6">in-vitro</emphasis>
for its anti-DENV activity, it did not show significant inhibition towards DENV2 in Vero cells and had a CC 
<subScript attach="left" box="[1313,1331,992,1006]" fontSize="6" pageId="5" pageNumber="6">50</subScript>
value of
<emphasis box="[1423,1439,985,1004]" italics="true" pageId="5" pageNumber="6">&gt;</emphasis>
1000 μg/mL (Zandi et al., 2011) which agrees with Dwivedi et al. 
<emphasis bold="true" box="[1419,1488,1012,1031]" italics="true" pageId="5" pageNumber="6">in-silico</emphasis>
findings.
</paragraph>
<paragraph blockId="5.[818,1488,148,1980]" pageId="5" pageNumber="6">
Further 
<emphasis bold="true" box="[926,990,1068,1087]" italics="true" pageId="5" pageNumber="6">in-vitro</emphasis>
cytotoxicity assessment was conducted for (16) and (19) using BHK-21 cell line. It was reported that (16) possessed no significant cytotoxicity at a concentration range of 10–100 μM, while (19) demonstrated 20% cytotoxicity at 1 mM. In comparison, quercetin (14) (control) exhibited 100% toxicity at 100 μM. Conversely, the antiviral findings showed that (16) possessed maximum inhibition of 75.7% and 77.7% at 10 and 100 μM, respectively. In contrast, (19) exhibited a maximum inhibition of 66.2% towards the DENV2 infectivity at 1000 μM. Based on these 
<emphasis bold="true" box="[1011,1080,1291,1310]" italics="true" pageId="5" pageNumber="6">in-silico</emphasis>
and 
<emphasis bold="true" box="[1130,1194,1291,1310]" italics="true" pageId="5" pageNumber="6">in-vitro</emphasis>
findings, it was proposed that (16) and (19) are potential inhibitors of DENV2 NS2b/NS3pro (Dwivedi et al., 2021). Interestingly, (19) and (17) are the two flavonoids that are believed to contribute through a synergistic activity with fatty acids (2) and (3) in Supian et al. study described earlier (see 2.1) (Supian et al., 2021).
</paragraph>
<paragraph blockId="5.[818,1488,148,1980]" lastBlockId="6.[100,771,148,1980]" lastPageId="6" lastPageNumber="7" pageId="5" pageNumber="6">
Compound (20) [(2 
<emphasis bold="true" box="[1057,1068,1459,1478]" italics="true" pageId="5" pageNumber="6">S</emphasis>
)-7-(((2 
<emphasis bold="true" box="[1137,1148,1459,1478]" italics="true" pageId="5" pageNumber="6">S</emphasis>
,3 
<emphasis bold="true" box="[1166,1180,1459,1478]" italics="true" pageId="5" pageNumber="6">R</emphasis>
,4 
<emphasis bold="true" box="[1198,1209,1459,1478]" italics="true" pageId="5" pageNumber="6">S</emphasis>
,5 
<emphasis bold="true" box="[1227,1238,1459,1478]" italics="true" pageId="5" pageNumber="6">S</emphasis>
,6 
<emphasis bold="true" box="[1256,1270,1459,1478]" italics="true" pageId="5" pageNumber="6">R</emphasis>
)-6-((((3 
<emphasis bold="true" box="[1347,1358,1459,1478]" italics="true" pageId="5" pageNumber="6">S</emphasis>
,4 
<emphasis bold="true" box="[1376,1387,1459,1478]" italics="true" pageId="5" pageNumber="6">S</emphasis>
)-3,4-dihydroxy-4-(hydroxymethyl)-tetrahydrofuran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2 
<emphasis bold="true" box="[1013,1028,1515,1534]" italics="true" pageId="5" pageNumber="6">H</emphasis>
-pyran-2-yl)oxy)-5-hydroxy-2-(4-methoxyphenyl)chroman-4-one] (Fig. 8, b), a flavanone glycoside which was concluded to be the principal entity that demonstrated the anti-DENV activity of the 
<taxonomicName box="[961,1086,1599,1618]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="5" pageNumber="6" phylum="Tracheophyta" rank="species" species="undetermined">
<emphasis bold="true" box="[961,1039,1599,1618]" italics="true" pageId="5" pageNumber="6">Faramea</emphasis>
spp.
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[1170,1268,1598,1617]" class="Magnoliopsida" family="Rubiaceae" kingdom="Plantae" order="Gentianales" pageId="5" pageNumber="6" phylum="Tracheophyta" rank="family">Rubiaceae</taxonomicName>
) extract, was found to possess a cytoprotective action when assayed against DENV2-infected HepG2 cells at various doses (1–200 μg/mL). A dose-dependent viral load reduction was also found with an IC 
<subScript attach="left" box="[1193,1211,1689,1703]" fontSize="6" pageId="5" pageNumber="6">50</subScript>
of 13.1 μg/mL. Moreover, the number of infectious particles was significantly reduced by 97% in the 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[818,919,1737,1757]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="5" pageNumber="6" phylum="Tracheophyta" rank="species" species="bahiensis">
<emphasis bold="true" box="[818,919,1737,1757]" italics="true" pageId="5" pageNumber="6">F. bahiensis</emphasis>
</taxonomicName>
-treated cells at 50 μg/mL (Nascimento et al., 2017). In 2018, Barboza and co-workers conducted a study on the effects of 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[818,944,1793,1813]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="5" pageNumber="6" phylum="Tracheophyta" rank="species" species="hyacinthina">
<emphasis bold="true" box="[818,944,1793,1813]" italics="true" pageId="5" pageNumber="6">F. hyacinthina</emphasis>
</taxonomicName>
’s and 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[1006,1103,1794,1813]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="5" pageNumber="6" phylum="Tracheophyta" rank="species" species="truncata">
<emphasis bold="true" box="[1006,1103,1794,1813]" italics="true" pageId="5" pageNumber="6">F. truncata</emphasis>
</taxonomicName>
’s MeOH leaf extracts on DENV2-infected HepG2 cells. Results demonstrated no significant cytotoxicities for both extracts at 50 μg/mL. Significant reductions in the DENV2 infectious particles of 84 and 91% were seen at the same dose for 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[1322,1447,1877,1896]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="5" pageNumber="6" phylum="Tracheophyta" rank="species" species="hyacinthina">
<emphasis bold="true" box="[1322,1447,1877,1896]" italics="true" pageId="5" pageNumber="6">F. hyacinthina</emphasis>
</taxonomicName>
and 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[818,915,1905,1924]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="5" pageNumber="6" phylum="Tracheophyta" rank="species" species="truncate">
<emphasis bold="true" box="[818,915,1905,1924]" italics="true" pageId="5" pageNumber="6">F. truncate</emphasis>
</taxonomicName>
, respectively. The same flavanone glycoside (20) was identified and isolated in both extracts, along with two compounds of the same class which were undescribed previously and are with apiofuranoside glycosidic moieties (structures not shown) (Barboza et al., 2018). Although the molecular mechanism of how these identified flavanone glycoside inhibits DENV2 is still unknown, 
<taxonomicName box="[594,716,204,223]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="species" species="undetermined">
<emphasis bold="true" box="[594,672,204,223]" italics="true" pageId="6" pageNumber="7">Faramea</emphasis>
spp.
</taxonomicName>
holds great potential as a DENV inhibitor.
</paragraph>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234966" ID-Zenodo-Dep="8234966" httpUri="https://zenodo.org/record/8234966/files/figure.png" pageId="5" pageNumber="6" startId="5.[100,130,1837,1854]" targetBox="[106,764,568,1809]" targetPageId="5" targetType="figure">
<paragraph blockId="5.[100,770,1837,1981]" pageId="5" pageNumber="6">
<emphasis bold="true" box="[100,158,1837,1854]" pageId="5" pageNumber="6">Fig. 8.</emphasis>
(a) The general structure of a flavonoid. (b) Chemical structures of the flavonoids – quercetin (14), kaempferol-3- 
<emphasis bold="true" box="[496,510,1862,1879]" italics="true" pageId="5" pageNumber="6">O</emphasis>
-rutinoside (16), rutin (17), hyperoside (18), the chromanone derivative (20), myricetin (23), apigenin (24), and luteolin (25), (c) pongamol (15), (d) epicatechin (19), catechin (27), EGCG (29), hesperetin (32), and hesperidin (33), (e) amentoflavone (21), (f) curcumin (22), (g) delphinidin (26), and (h) rotenone (30).
</paragraph>
</caption>
<paragraph blockId="6.[100,771,148,1980]" pageId="6" pageNumber="7">
Amentoflavone (21) is a biflavone that can be found in several plant families, such as 
<taxonomicName _evidence="catalogs" _step="family" box="[266,412,287,306]" class="Lycopodiopsida" family="Selaginellaceae" kingdom="Plantae" order="Selaginellales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="family">Selaginellaceae</taxonomicName>
, 
<taxonomicName _evidence="catalogs" _step="family" box="[423,551,287,306]" class="Pinopsida" family="Cupressaceae" kingdom="Plantae" order="Pinales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="family">Cupressaceae</taxonomicName>
, 
<taxonomicName _evidence="catalogs" _step="family" box="[563,705,287,306]" class="Magnoliopsida" family="Euphorbiaceae" kingdom="Plantae" order="Malpighiales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="family">Euphorbiaceae</taxonomicName>
, 
<taxonomicName _evidence="catalogs" _step="family" class="Pinopsida" family="Podocarpaceae" kingdom="Plantae" order="Pinales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="family">Podocarpaceae</taxonomicName>
, and 
<taxonomicName _authorityPlausibility="NaN" _evidence="catalogs" _step="family" authority="(S. Yu et al., 2017)" baseAuthorityName="S. Yu" baseAuthorityYear="2017" box="[244,565,315,334]" class="Magnoliopsida" family="Calophyllaceae" kingdom="Plantae" order="Malpighiales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="family">Calophyllaceae (S. Yu et al., 2017)</taxonomicName>
. An 
<emphasis bold="true" box="[605,674,315,334]" italics="true" pageId="6" pageNumber="7">in-silico</emphasis>
study was initiated in 2020 to study 107 flavonoids from 47 plants as potential inhibitors for DENV protease. AutoDock was used to study the binding of the selected flavonoids against DENV1 and DENV4 proteases. Molecular docking results revealed that amentoflavone (21) (Fig. 8, e), quercetin-3- 
<emphasis bold="true" box="[138,153,454,473]" italics="true" pageId="6" pageNumber="7">O</emphasis>
-β- D-glucopyranoside, liquiritinapioside, silybin, and avicularin, ascendingly according to their binding energies (15.8 to 14.6 kcal/mol), were the lead flavonoids which bound to DENV1 protease. Similarly, amentoflavone (21), silymarin, avicularin, reynoutrin, and quercetin-3- 
<emphasis bold="true" box="[214,229,566,585]" italics="true" pageId="6" pageNumber="7">O</emphasis>
-β- D-glucopyranoside, ascendingly according to their binding energies (16.8 to 15.7 kcal/mol), were the lead flavonoids which bound to DENV4 protease (Jayadevappa et al., 2020). In the same study, the lead compound (21) was subjected to an 
<emphasis bold="true" box="[706,770,650,669]" italics="true" pageId="6" pageNumber="7">in-vitro</emphasis>
high-throughput protease assay. It also was measured for its cell cytotoxicity using HepG2 cells at various concentrations ranging from 5 to 25 μM. Quercetin (14) was used as a positive control in both 
<emphasis bold="true" box="[706,770,733,752]" italics="true" pageId="6" pageNumber="7">in-vitro</emphasis>
assays concentration. Amentoflavone (21) showed 53% inhibition of the DENV protease at a concentration of 25 μM compared to (14), which showed 63% inhibition at the same concentration. Amentoflavone (21) showed 20% toxicity at its highest tested concentration (25 μM), compared to (14), which had 40% toxicity at a similar concentration (Jayadevappa et al., 2020). An earlier study showed that amentoflavone (21) was also able to possess its anti-DENV activity by inhibiting the DENV NS5 RdRp (Coulerie et al., 2013). Hence, amentoflavone (21) is able to express its anti-DENV activity through its dual action on the NS2b/NS3pro and the NS5 RdRp.
</paragraph>
<paragraph blockId="6.[100,771,148,1980]" pageId="6" pageNumber="7">
Curcumin (22) (Fig. 8, f) is a flavonoid polyphenol that is present in abundance in turmeric (
<taxonomicName _evidence="catalogs" _step="species1" box="[326,460,1068,1087]" class="Liliopsida" family="Zingiberaceae" genus="Curcuma" kingdom="Plantae" order="Zingiberales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="species" species="longa">
<emphasis bold="true" box="[326,460,1068,1087]" italics="true" pageId="6" pageNumber="7">Curcuma longa</emphasis>
</taxonomicName>
, family 
<taxonomicName _evidence="catalogs" _step="family" authorityName="Martinov" authorityYear="1820" box="[537,670,1068,1087]" class="Liliopsida" family="Zingiberaceae" kingdom="Plantae" order="Zingiberales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="family">Zingiberaceae</taxonomicName>
) and has a limited bioavailability. Regarding its anti-DENV activity, (22) has been studied for its binding to the DENV2 NS2b/NS3pro as an allosteric inhibitor. 
<emphasis bold="true" box="[175,240,1152,1171]" italics="true" pageId="6" pageNumber="7">In-vitro</emphasis>
enzymatic assay has shown an IC 
<subScript attach="left" box="[548,566,1159,1173]" fontSize="6" pageId="6" pageNumber="7">50</subScript>
of 7.18 μM and a 
<subScript attach="left" box="[728,747,1152,1173]" fontSize="6" pageId="6" pageNumber="7">Ki</subScript>
of 4.35 μM. In the same study, it was noticed that since curcumin (22) inhibited DENV2 NS2b/NS3pro by changing 
<subScript attach="left" box="[523,567,1208,1229]" fontSize="6" pageId="6" pageNumber="7">Vmax</subScript>
but not 
<subScript attach="left" box="[647,673,1208,1229]" fontSize="6" pageId="6" pageNumber="7">Km</subScript>
, it was an indication that (22) acts as a non-competitive inhibitor of the enzyme (L. Lim et al., 2020). Additionally, two 
<emphasis bold="true" box="[474,538,1263,1282]" italics="true" pageId="6" pageNumber="7">in-vitro</emphasis>
studies scrutinised the anti-DENV2 activity of (22) in BHK-21 and Vero cell lines. Findings showed an EC 
<subScript attach="left" box="[236,254,1326,1340]" fontSize="6" pageId="6" pageNumber="7">50</subScript>
of 13.95 μM in BHK-21 cells. On the other hand, the CC 
<subScript attach="left" box="[127,145,1354,1368]" fontSize="6" pageId="6" pageNumber="7">50</subScript>
of (22) in DENV2-infected BHK-21 cells was 49.01 μM, while the highest safe concentration against Vero cells was 6.25 ppm (Marbawati and Umniyati, 2015; Balasubramanian et al., 2019). Molecular docking studies on the binding mode of (22) towards the DENV2 NS2b/NS3pro showed that the amino acid residues which construct the binding cavity of where curcumin (22) is bound do not overlap with the catalytic triad residues of the enzyme. This suggests that (22) can bind non-competitively to DENV2 protease at an allosteric binding site. Furthermore, molecular dynamics studies of the enzyme in its bound and unbound states indicated that (22) has caused conformational changes to NS2b, but not to the NS3 chain. That observation was a conformational hint to the NMR results from the same study. NMR results showed that once (22) binds to the DENV2 protease, the NS2b co-factor acts more dynamically in comparison to the NS3 domain of the enzyme (L. Lim et al., 2020). The same allosteric binding pocket was found in the Zika virus’ s NS2b/NS3pro (Roy et al., 2017).
</paragraph>
<paragraph blockId="6.[100,771,148,1980]" pageId="6" pageNumber="7">
Myricetin (23) (Fig. 8, b) is another plant flavonoid that has been studied for its activity as a DENV protease non-competitive-allosteric inhibitor with an IC 
<subScript attach="left" box="[291,309,1856,1870]" fontSize="6" pageId="6" pageNumber="7">50</subScript>
of 22.3 μM and a 
<subScript attach="left" box="[490,508,1850,1870]" fontSize="6" pageId="6" pageNumber="7">Ki</subScript>
of 4.7 μM (de Sousa et al., 2015). Myricetin (23) was assayed against DENV2 protease to find that its IC 
<subScript attach="left" box="[148,166,1912,1926]" fontSize="6" pageId="6" pageNumber="7">50</subScript>
is 8.46 μM while having a 
<subScript attach="left" box="[412,430,1906,1926]" fontSize="6" pageId="6" pageNumber="7">Ki</subScript>
value of 4.92 μM, which agrees with the previous study. Through the NMR study, (23) was found to bind to two different allosteric sites where one of them is where curcumin (22)
</paragraph>
<paragraph blockId="6.[818,1488,148,1980]" pageId="6" pageNumber="7">
binds in the inactive form of the enzyme. Yet, in this inactive form of the DENV2 protease, it was noticed that (23) was able to interact only with certain NS3 residues, including VAL72-ASP75, THR118-THR122, GLY151-VAL154, and ALA160-ALA166. However, in the active form of the DENV2 NS2b/NS3pro, myricetin (23) was found to bind only to one of the allosteric sites, leaving the allosteric site of curcumin (22) untouched (Dang et al., 2022). Molecular dynamics simulations of myricetin (23) in complex with the active form of DENV2 protease were executed, furtherly. Myricetin (23) binding to the protease has resulted in a significant increase of conformational dynamics in the NS2b co-factor, but only a trivial change in the NS3 domain. Moreover, simulation results suggested that the inactive form of the protease is less dynamic in comparison with the active form, while the binding of two myricetin (23) molecules to DENV2 NS2b/NS3pro inactive 
<taxonomicName _evidence="document" _step="nonLabeled6" box="[1401,1487,510,529]" form="has" pageId="6" pageNumber="7" rank="form">form has</taxonomicName>
locked the conformational dynamics of both NS3 domain and its co-factor (Dang et al., 2022).
</paragraph>
<paragraph blockId="6.[818,1488,148,1980]" pageId="6" pageNumber="7">
Apigenin (24) (Fig. 8, b) is one of the widespread flavonoids in the plant kingdom, which belongs to the flavone subclass. It has been reported that (24) was widely identified in the plant family 
<taxonomicName _evidence="catalogs" _step="family" box="[1380,1484,650,669]" class="Magnoliopsida" family="Asteraceae" kingdom="Plantae" order="Asterales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="family">Asteraceae</taxonomicName>
, especially in 
<emphasis bold="true" box="[937,1214,677,697]" italics="true" pageId="6" pageNumber="7">
<taxonomicName _evidence="catalogs" _step="genera" box="[937,1023,678,697]" class="Magnoliopsida" family="Asteraceae" genus="Artemisia" kingdom="Plantae" order="Asterales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="genus">Artemisia</taxonomicName>
, 
<taxonomicName _evidence="catalogs" _step="genera" box="[1032,1105,677,696]" class="Magnoliopsida" family="Asteraceae" genus="Achillea" kingdom="Plantae" order="Asterales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="genus">Achillea</taxonomicName>
, 
<taxonomicName _evidence="catalogs" _step="genera" box="[1114,1210,678,697]" class="Magnoliopsida" family="Asteraceae" genus="Matricaria" kingdom="Plantae" order="Asterales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="genus">Matricaria</taxonomicName>
,
</emphasis>
and 
<taxonomicName _evidence="catalogs" _step="genera" box="[1257,1355,678,697]" class="Magnoliopsida" family="Asteraceae" genus="Tanacetum" kingdom="Plantae" order="Asterales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="genus">
<emphasis bold="true" box="[1257,1355,678,697]" italics="true" pageId="6" pageNumber="7">Tanacetum</emphasis>
</taxonomicName>
genera. Other species under various families, such as 
<taxonomicName _authorityPlausibility="0.30552554" _evidence="catalogs" _step="family" authority=", Sideritis, Teucrium" authorityName="Sideritis, Teucrium" box="[1190,1484,706,725]" class="Magnoliopsida" family="Lamiaceae" kingdom="Plantae" order="Lamiales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="family">Lamiaceae, Sideritis, Teucrium</taxonomicName>
, and 
<taxonomicName _evidence="catalogs" _step="family" box="[857,946,733,752]" class="Magnoliopsida" family="Fabaceae" kingdom="Plantae" order="Fabales" pageId="6" pageNumber="7" phylum="Tracheophyta" rank="family">Fabaceae</taxonomicName>
, have also shown the presence of (24) in its aglycone form, and as 
<emphasis bold="true" box="[887,900,761,780]" italics="true" pageId="6" pageNumber="7">C</emphasis>
- and 
<emphasis bold="true" box="[957,972,761,780]" italics="true" pageId="6" pageNumber="7">O</emphasis>
-glucosides, glucuronides, 
<emphasis bold="true" box="[1223,1238,761,780]" italics="true" pageId="6" pageNumber="7">O</emphasis>
-methyl ethers, and acetylated derivatives (Salehi et al., 2019a). Apigenin (24) was assayed against DENV2 in LLC/MK2 cells. It was shown that (24) has an EC 
<subScript attach="left" box="[1469,1487,824,838]" fontSize="6" pageId="6" pageNumber="7">50</subScript>
value of 10.55 μM and a CC 
<subScript attach="left" box="[1100,1118,852,866]" fontSize="6" pageId="6" pageNumber="7">50</subScript>
of 82.82 μM (Hengphasatporn et al., 2021). Noteworthy, two earlier studies showed that (24) was able to bind to the DENV NS2b/NS3pro with decent binding energy values ranging between 7.7 and 6.62 kcal/mol while forming five hydrogen bond interactions (Shanmugapriya et al., 2016; Ghosh and Talukdar, 2019). Thus, apigenin (24) can be a potential inhibitor for the DENV protease, which requires further investigation.
</paragraph>
<paragraph blockId="6.[818,1488,148,1980]" pageId="6" pageNumber="7">
Luteolin (25) (Fig. 8, b) is a flavonoid that has been recently studied 
<emphasis bold="true" box="[818,882,1068,1087]" italics="true" pageId="6" pageNumber="7">in-vitro</emphasis>
for its ability to inhibit four serotypes of DENV. Huh7 cells were infected with DENV1-4 and treated with (25) showed EC 
<subScript attach="left" box="[1341,1359,1103,1117]" fontSize="6" pageId="6" pageNumber="7">50</subScript>
values of 7.2, 5.19, 5.69, and 8.38 μM for DENV1,2,3 and 4, respectively. Ten μM of luteolin (25) produced a 20-fold reduction of DENV2 infection compared to control in the same cell line. Moreover, (25) possessed EC 
<subScript attach="left" box="[1469,1487,1187,1201]" fontSize="6" pageId="6" pageNumber="7">50</subScript>
values of 39.16, 12.26, 14.04, and 9.36 μM in DENV2-infected A549, HEK-293T, BHK-21, and Vero cells, respectively. In the same study, (25) reduced viraemia in mice when tested 
<emphasis bold="true" box="[1182,1242,1263,1282]" italics="true" pageId="6" pageNumber="7">in-vivo</emphasis>
in type I and II interferon deficient 129/Sv mice (Peng et al., 2017). It was confirmed later that one of the prospected targets of (25) is the DENV NS22/NS3pro, where it yielded a lowest energy of binding of 7.7 kcal/mol (Ghosh and Talukdar, 2019). Thus, luteolin (25) is another flavonoid that can act as a potential inhibitor of DENV protease.
</paragraph>
<paragraph blockId="6.[818,1488,148,1980]" pageId="6" pageNumber="7">
A study by V´azquez-Calvo et al. (2017) has screened the effects of delphinidin (26) (Fig. 8, g), cyanidin, catechin (27) (Fig. 8, d), epicatechin (19) (Fig. 8, d), epigallocatechin, and epigallocatechin gallate (EGCG) (29) (Fig. 8, d) against three members of the 
<taxonomicName _evidence="catalogs" _step="family" box="[1305,1417,1514,1533]" class="Flasuviricetes" family="Flaviviridae" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="6" pageNumber="7" phylum="Kitrinoviricota" rank="family">Flaviviridae</taxonomicName>
family; WNV, Zika virus, and DENV2. Both delphinidin (26) and EGCG (29) were found to significantly inhibit DENV2 infection in Vero cells at a concentration as low as 10 μM while expressing no evident cytotoxicities. Their antiviral effect was found to be virucidal, acting on the virus itself in a dose-dependent manner, and not through altering the endosomal pH of cells and affecting the virus fusion. Similarly, (26) and (29) were found to demonstrate virucidal effects against WNV and Zika virus (V´azquez-Calvo et al., 2017).
</paragraph>
<paragraph blockId="6.[818,1488,148,1980]" pageId="6" pageNumber="7">In a high-throughput screening study by Raekiansyah et al. (2018), a series of flavonoids were assayed against DENV2 in Vero cells. These compounds included catechin (27), epicatechin (19), epigallocatechin, epicatechin gallate, EGCG (29), delphinidin (26), cyanidin, myricetin (23), rutin (17), quercetin (14), rotenone (30) (Fig. 8, h), and the phenolic compound gallic acid (31) (Fig. 9, a, see 2.5). Results showed more than 90% inhibition of DENV infection in cells for epicatechin gallate, EGCG (29), quercetin (14), and rotenone (30) when tested at</paragraph>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234968" ID-Zenodo-Dep="8234968" httpUri="https://zenodo.org/record/8234968/files/figure.png" pageId="7" pageNumber="8" startId="7.[100,130,803,820]" targetBox="[106,764,148,775]" targetPageId="7" targetType="figure">
<paragraph blockId="7.[100,770,803,871]" pageId="7" pageNumber="8">
<emphasis bold="true" box="[100,160,803,820]" pageId="7" pageNumber="8">Fig. 9.</emphasis>
Chemical structures of the phenolic compounds (a) gallic acid (31), methyl orsellinate (34), resveratrol (35), gingerol (36), anacardic acid (37), and cardol triene (38), (b) tatanan A (39).
</paragraph>
</caption>
<paragraph blockId="7.[100,770,911,1963]" pageId="7" pageNumber="8">
100 μM. However, quercetin (14) and rotenone (30) showed a significant reduction in cell viability of approximately 40% and less at the same concentration. This suggested that the inhibitory effect of the latter compounds was due to cell toxicity. Thus, they were excluded from further assessment. Moreover, EGCG (29) was found to express 50% and above inhibition towards DENV2 at concentrations between 30 and 100 μM. On the other hand, epicatechin gallate (structure not shown) was less potent where it only had its inhibitory effects at doses of more than 60 μM. RT-PCR and RNA measurements revealed that (29) inhibits the viral entry into the cell by acting on the virus particle itself and not the host cells. Besides, the EC 
<subScript attach="left" box="[338,356,1198,1212]" fontSize="6" pageId="7" pageNumber="8">50</subScript>
’s of (29) were assessed in Vero cells for four serotypes of DENV (DENV1-4). The EC 
<subScript attach="left" box="[477,495,1226,1240]" fontSize="6" pageId="7" pageNumber="8">50</subScript>
’s were found to be at 14.8, 18.0, 11.2, and 13.6 μM for DENV1-4, respectively. Although (29) possessed excellent 
<emphasis bold="true" box="[290,354,1274,1293]" italics="true" pageId="7" pageNumber="8">in-vitro</emphasis>
inhibition of DENV infection (Raekiansyah et al., 2018) and Zika virus’ s protease (H.-j. Lim et al., 2017), it was found to have no or negligible effect against other 
<emphasis bold="true" box="[568,671,1330,1349]" italics="true" pageId="7" pageNumber="8">Flaviviruses</emphasis>
, including Japanese encephalitis and yellow fever viruses (Raekiansyah et al., 2018).
</paragraph>
<paragraph blockId="7.[100,770,911,1963]" pageId="7" pageNumber="8">
An 
<emphasis bold="true" box="[163,227,1414,1433]" italics="true" pageId="7" pageNumber="8">in-vitro</emphasis>
enzyme assay study by Sulaiman et al. (2019) investigated the role of catechin (27) and epicatechin (19) identified in the DCM extract of 
<taxonomicName _evidence="catalogs" _step="species1" box="[200,377,1469,1488]" class="Magnoliopsida" family="Lauraceae" genus="Endiandra" kingdom="Plantae" order="Laurales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="species" species="kingiana">
<emphasis bold="true" box="[200,377,1469,1488]" italics="true" pageId="7" pageNumber="8">Endiandra kingiana</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[462,559,1470,1489]" class="Magnoliopsida" family="Lauraceae" kingdom="Plantae" order="Laurales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="family">Lauraceae</taxonomicName>
) in inhibiting DENV2 NS2b/NS3pro. Their results showed 62.02% and 69.92% inhibition for (27) and (19), respectively, with IC 
<subScript attach="left" box="[423,441,1533,1547]" fontSize="6" pageId="7" pageNumber="8">50</subScript>
values of 184.13 and 170.10 μM, in the same order. Further molecular docking simulations showed that epicatechin (19) had the highest binding affinity towards DENV2 NS2b/NS3pro due to its four hydrogen bond interactions (Sulaiman et al., 2019). These results are in agreement with findings described earlier by Dwivedi et al. (2021).
</paragraph>
<paragraph blockId="7.[100,770,911,1963]" pageId="7" pageNumber="8">
Hesperetin (32) and hesperidin (33) (Fig. 8, d) are two flavanones which occur in the 
<taxonomicName _evidence="catalogs" _step="genera" box="[281,333,1721,1740]" class="Magnoliopsida" family="Rutaceae" genus="Citrus" kingdom="Plantae" order="Sapindales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="genus">
<emphasis bold="true" box="[281,333,1721,1740]" italics="true" pageId="7" pageNumber="8">Citrus</emphasis>
</taxonomicName>
fruit (family 
<taxonomicName _evidence="catalogs" _step="family" box="[460,550,1721,1740]" class="Magnoliopsida" family="Rutaceae" kingdom="Plantae" order="Sapindales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="family">Rutaceae</taxonomicName>
). Hesperidin (33) is the glycoside conjugated with disaccharide rutinose, whereas hesperetin (32) is an aglycone. Both flavonoids were reported to inhibit the protease in Zika and Chikungunya viruses (Ahmadi et al., 2016; Eberle et al., 2021a). A recent study by Eberle and co-workers demonstrated an 
<emphasis bold="true" box="[100,164,1860,1879]" italics="true" pageId="7" pageNumber="8">in-vitro</emphasis>
enzymatic inhibition assay where (32) showed 55% inhibition towards DENV2 protease, while (33) was only able to express 30% inhibition at 10 μM for both compounds. Further investigations showed that both compounds, (32) and (33), were able to inhibit DENV2
</paragraph>
<paragraph blockId="7.[818,1488,147,529]" pageId="7" pageNumber="8">
protease non-competitively by 100% at a concentration of 140 μM. The IC 
<subScript attach="left" box="[838,856,183,197]" fontSize="6" pageId="7" pageNumber="8">50</subScript>
’s of (32) and (33) were calculated as 4.7 and 55.7 μM, respectively. Tryptophan fluorescence spectroscopy allowed the researchers to calculate KD values of both flavonoids as 18.7 and 20.9 μM for hesperetin (32) and hesperidin (33), respectively. Further molecular dynamics simulations were carried out to show that both molecules bind to a hydrophobic allosteric pocket of NS3pro that is located near the NS2b co-factor interaction area. Hesperetin (32) was found to bind with a binding energy of 23.1 kcal/mol, whereas hesperidin (33) binds at
</paragraph>
<paragraph blockId="7.[818,1488,147,529]" pageId="7" pageNumber="8">
37.4 kcal/mol (Eberle et al., 2021b). Consequently, these flavonoids exhibit promising anti-DENV activity towards the virus protease via a non-competitive mechanism of action. Further 
<emphasis bold="true" box="[1297,1357,454,473]" italics="true" pageId="7" pageNumber="8">in-vivo</emphasis>
and clinical evaluations are highly encouraged to investigate their cytotoxicity and potential adverse effects.
</paragraph>
<paragraph blockId="7.[818,949,567,587]" box="[818,949,567,587]" pageId="7" pageNumber="8">
<emphasis bold="true" box="[818,949,567,587]" italics="true" pageId="7" pageNumber="8">2.5. Phenolics</emphasis>
</paragraph>
<paragraph blockId="7.[818,1488,624,1982]" pageId="7" pageNumber="8">
Gallic acid (31) (Fig. 9, a) was among the screened natural product in the study of Raekiansyah et al. (2018). At 100 μM (~17 μg/mL) concentration, (31) was able to inhibit DENV2 infection in Vero cells by 95% while maintaining cell viability at around 50% (Raekiansyah et al., 2018). Hence, this also suggested that the inhibitory effect of (31) was due to cell toxicity at the tested concentration. One year later, Trujillo-Correa and co-workers were able to identify the presence of (31) 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[818,910,819,838]" class="Magnoliopsida" family="Myrtaceae" genus="Psidium" kingdom="Plantae" order="Myrtales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="species" species="guajava">
<emphasis bold="true" box="[818,910,819,838]" italics="true" pageId="7" pageNumber="8">P. guajava</emphasis>
</taxonomicName>
bark extract. Through their 
<emphasis bold="true" box="[1175,1239,819,838]" italics="true" pageId="7" pageNumber="8">in-vitro</emphasis>
testing in DENV2-infected Vero cells, (31) decreased viral infection significantly when supplied pre-DENV2 infection by 52.6%. In contrast, (31) inhibited DENV2 infection in Vero cells by 67.3% when supplied post-DENV2 infection. Noteworthy, the CC 
<subScript attach="left" box="[1003,1021,938,952]" fontSize="6" pageId="7" pageNumber="8">50</subScript>
of (31) was found at 543.4 μg/mL and its EC 
<subScript attach="left" box="[1445,1463,938,952]" fontSize="6" pageId="7" pageNumber="8">50</subScript>
at 25.8 μg/mL (Trujillo-Correa et al., 2019). These conflicting results might be a result of the incubation time performed in each experiment. In the study by Raekiansyah et al., the incubation period was carried out for five days, whereas in Trujillo-Correa et al. study, the incubation period was 24 h only. This leaves the door open for more investigations on the effectiveness of gallic acid (31), its molecular target, and how its cytotoxicity can relate to its anti-DENV activity.
</paragraph>
<paragraph blockId="7.[818,1488,624,1982]" pageId="7" pageNumber="8">Methyl orsellinate (34) (Fig. 9, a) was among the few compounds screened by Sulaiman et al. (2019) for their inhibitory activity towards DENV2 NS2b/NS3pro. Results showed that (34) possessed only 16.42% inhibition. Thus, it was excluded from further investigations. Nonetheless, gallic acid (31) and methyl orsellinate (34) share the same chemical scaffold as phenols, yet both seem ineffective in inhibiting DENV NS2b/NS3pro. Therefore, further assessment is required to study these molecules and other natural products that share the same scaffold on other molecular targets in the DENV, such as C and E proteins.</paragraph>
<paragraph blockId="7.[818,1488,624,1982]" lastBlockId="8.[100,771,148,1841]" lastPageId="8" lastPageNumber="9" pageId="7" pageNumber="8">
Resveratrol (35) (Fig. 9, a) is a naturally occurring non-flavonoid polyphenol known for its beneficial biological effects on the human body. Resveratrol (35) is found in multiple plant sources, including and most famously, mulberries (
<taxonomicName _evidence="catalogs" _step="species1" box="[1100,1206,1488,1508]" class="Magnoliopsida" family="Moraceae" genus="Morus" kingdom="Plantae" order="Rosales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="species" species="alba">
<emphasis bold="true" box="[1100,1206,1488,1508]" italics="true" pageId="7" pageNumber="8">Morus alba</emphasis>
</taxonomicName>
, family 
<taxonomicName _evidence="catalogs" _step="family" box="[1297,1392,1488,1507]" class="Magnoliopsida" family="Moraceae" kingdom="Plantae" order="Rosales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="family">Moraceae</taxonomicName>
), peanuts (
<taxonomicName _evidence="catalogs" _step="species1" box="[826,985,1516,1535]" class="Magnoliopsida" family="Fabaceae" genus="Arachis" kingdom="Plantae" order="Fabales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="species" species="hypogaea">
<emphasis bold="true" box="[826,985,1516,1535]" italics="true" pageId="7" pageNumber="8">Arachis hypogaea</emphasis>
</taxonomicName>
, family 
<taxonomicName _evidence="catalogs" _step="family" box="[1068,1159,1516,1535]" class="Magnoliopsida" family="Fabaceae" kingdom="Plantae" order="Fabales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="family">Fabaceae</taxonomicName>
), and grapes (
<taxonomicName _evidence="catalogs" _step="species1" box="[1298,1412,1516,1535]" class="Magnoliopsida" family="Vitaceae" genus="Vitis" kingdom="Plantae" order="Vitales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="species" species="vinifera">
<emphasis bold="true" box="[1298,1412,1516,1535]" italics="true" pageId="7" pageNumber="8">Vitis vinifera</emphasis>
</taxonomicName>
, family 
<taxonomicName _evidence="catalogs" _step="family" box="[818,900,1544,1563]" class="Magnoliopsida" family="Vitaceae" kingdom="Plantae" order="Vitales" pageId="7" pageNumber="8" phylum="Tracheophyta" rank="family">Vitaceae</taxonomicName>
) (Kulkarni and Cant´o, 2015). This polyphenol has been studied for its anti-DENV activity in Huh7 cells, where the cells were treated with (35) pre- and post-DENV2 infection. There was a significant reduction in the viral titer in the treated group at various concentrations, especially at 80 and 100 μM, with no significant cytotoxic effects. Western blot analyses revealed a decrement in DENV2 NS3 production. Additionally, inductions of INF-β levels and activation of MxA and ISG56 were noticed. Resveratrol (35) was also found to inhibit the HMGB1 via induction of SIRT1 (Zainal et al., 2017). It is noteworthy that (35) was also able to inhibit Zika virus in Huh7 cells. Resveratrol (35) managed to reduce the viral foci formation by up to 97% at a concentration of 100 μM with 99% cell viability (Mohd et al., 2019). However, some synthesised analogues of (35) affected viral RNA translation and replication. Yet, the actual mechanism of how (35) expresses its anti-DENV activity is still to be elucidated further (Han et al., 2017). It is worth mentioning that (35) is a helicase inhibitor of hepatitis C virus that belongs to the same family of DENV (S. Lee et al., 2016).
</paragraph>
<paragraph blockId="8.[100,771,148,1841]" pageId="8" pageNumber="9">
Gingerol (36) (Fig. 9, a) is a phenolic compound abundantly found in the 
<taxonomicName _evidence="catalogs" _step="family" authorityName="Martinov" authorityYear="1820" box="[138,269,203,222]" class="Liliopsida" family="Zingiberaceae" kingdom="Plantae" order="Zingiberales" pageId="8" pageNumber="9" phylum="Tracheophyta" rank="family">Zingiberaceae</taxonomicName>
family. It has been studied for its antioxidant, antiinflammatory, and anticancer effects (C.-Y. Chen et al., 2018; Liang et al., 2018; Nafees et al., 2021). An earlier study showed that (36) expressed a virucidal effect towards Chikungunya virus in HepG2 cells with no cytotoxic effects at concentrations of less than 0.2 mM (Hayati et al., 2021). Recently, a molecular docking study by Rahman et al. (2021) showed that (36) was able to bind to DENV NS2b/NS3pro with a binding energy of 6.1 kcal/mol (Rahman et al., 2021). Whereas 
<emphasis bold="true" box="[706,770,399,418]" italics="true" pageId="8" pageNumber="9">in-vitro</emphasis>
investigation of (36) in DENV1-infected A549 cells demonstrated an IC 
<subScript attach="left" box="[752,770,434,448]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
of 0.032 mM when supplied after viral entry, and an IC 
<subScript attach="left" box="[624,642,462,476]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
of 0.038 mM on full-time treatment. Therefore, gingerol (36) holds the potential as an inhibitor towards DENV infections. However, further 
<emphasis bold="true" box="[664,728,510,529]" italics="true" pageId="8" pageNumber="9">in-vitro</emphasis>
investigations are required on other cell lines infected with various serotypes of DENV, which would allow a deeper insight on the molecular mechanism by which (36) expresses its anti-DENV activity.
</paragraph>
<caption ID-DOI="http://doi.org/10.5281/zenodo.8234970" ID-Zenodo-Dep="8234970" httpUri="https://zenodo.org/record/8234970/files/figure.png" pageId="8" pageNumber="9" startId="8.[818,848,358,375]" targetBox="[824,1481,148,330]" targetPageId="8" targetType="figure">
<paragraph blockId="8.[818,1487,358,401]" pageId="8" pageNumber="9">
<emphasis bold="true" box="[818,886,358,375]" pageId="8" pageNumber="9">Fig. 10.</emphasis>
Chemical structures of (a) Melatonin (40) and (b) the benzofuranone derivative (41).
</paragraph>
</caption>
<paragraph blockId="8.[100,771,148,1841]" pageId="8" pageNumber="9">
A mixture of phenolic lipids was characterised in the cashew’ s nutshell and was found to consist mainly of anacardic acid, cardanol, and cardol head groups with saturated, monoene, diene, and triene tails. These phenolic lipids were assayed for their anti-DENV2 activity in Vero cells at 10 and 25 μM. DENV2 was inhibited by 97.95, 65.30, and 95.91% at 10 μM of anacardic acid (37) (Fig. 9, a), cardanol, and cardol, respectively. However, at 25 μM all phenolic lipids inhibited the virus by 
<emphasis box="[131,147,820,836]" italics="true" pageId="8" pageNumber="9">≥</emphasis>
99%. Anacardic and cardol trienes showed the highest CC 
<subScript attach="left" box="[710,728,824,838]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
’s of 115.13 and 207.30 μM, respectively. Interestingly, an inverse relationship was found between the degree of saturation of the hydrocarbon tails of the molecules and their CC 
<subScript attach="left" box="[371,389,908,922]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
’s. Cardol triene (38) (Fig. 9, a) alone was further investigated in THP-1, HEK-293, and HepG2 cells for its cytotoxicity. A higher CC 
<subScript attach="left" box="[294,312,964,978]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
value of (38) indicated its safety. In addition, the saturated anacardic acid (37) was found to possess the highest activity among the anacardic acid homologues with an EC 
<subScript attach="left" box="[579,597,1019,1033]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
of 4.31 μM and a lower CC 
<subScript attach="left" box="[189,207,1047,1061]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
of 66.33 μM, indicating possible cytotoxicity. In contrast, (38) showed an EC 
<subScript attach="left" box="[277,295,1075,1089]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
value of 7.13 μM while having the highest CC 
<subScript attach="left" box="[728,746,1075,1089]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
of 207.30 μM. RT-PCR results showed that (38) was able to decrease intracellular RNA and virion particles in the early and late stages of infections (1- and 48-h measurements) (Kanyaboon et al., 2018).
</paragraph>
<paragraph blockId="8.[100,771,148,1841]" pageId="8" pageNumber="9">
An earlier study by Hundt et al. (2015) investigated the antiviral activity of anacardic acid (37) on hepatitis C virus, which belongs to the same family of DENV and Zika virus; 
<taxonomicName _evidence="catalogs" _step="family" box="[470,585,1236,1255]" class="Flasuviricetes" family="Flaviviridae" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="8" pageNumber="9" phylum="Kitrinoviricota" rank="family">Flaviviridae</taxonomicName>
. The study demonstrated that (37) affected hepatitis C virus entry, replication, translation, and secretion in a dose-dependent manner with no significant cytotoxic effects (Hundt et al., 2015). Yet, the effects of these polyphenols and their lipids have to be investigated on other targets in the 
<taxonomicName _evidence="catalogs" _step="genera" box="[684,770,1347,1366]" class="Flasuviricetes" family="Flaviviridae" genus="Flavivirus" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="8" pageNumber="9" phylum="Kitrinoviricota" rank="genus">
<emphasis bold="true" box="[684,770,1347,1366]" italics="true" pageId="8" pageNumber="9">Flavivirus</emphasis>
</taxonomicName>
genus.
</paragraph>
<paragraph blockId="8.[100,771,148,1841]" pageId="8" pageNumber="9">
Tatanan A (39) (Fig. 9, b), a lignan isolated from 
<taxonomicName _evidence="catalogs" _step="species1" box="[627,770,1403,1422]" class="Liliopsida" family="Acoraceae" genus="Acorus" kingdom="Plantae" order="Acorales" pageId="8" pageNumber="9" phylum="Tracheophyta" rank="species" species="calamus">
<emphasis bold="true" box="[627,770,1403,1422]" italics="true" pageId="8" pageNumber="9">Acorus calamus</emphasis>
</taxonomicName>
(sweet flag, family 
<taxonomicName _evidence="catalogs" _step="family" authorityName="Martinov" authorityYear="1820" box="[289,390,1431,1450]" class="Liliopsida" family="Acoraceae" kingdom="Plantae" order="Acorales" pageId="8" pageNumber="9" phylum="Tracheophyta" rank="family">Acoraceae</taxonomicName>
), was tested against DENV2 in BHK-21 cells. Results showed that (39) has a very potent anti-DENV activity at 40 μM that is even superior to that of ribavirin, an antiviral used for the treatment of 
<taxonomicName _evidence="document" _step="document" box="[230,323,1514,1533]" class="Flasuviricetes" family="Flaviviridae" genus="Flavivirus" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="8" pageNumber="9" phylum="Kitrinoviricota" rank="genus">Flavivirus</taxonomicName>
infections. Further assessment involving (39) was carried out at a concentration range between 2.5 and 10 μM. Tatanan A (39) possessed negligible cytotoxicity on the tested cell line. On the other hand, its inhibitory activity towards DENV was dosedependent with an EC 
<subScript attach="left" box="[311,329,1633,1647]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
of 3.9 μM. Tatanan A (39) exhibited its activity by targeting DENV2’s mRNA when given post-infection to the cells. It was found to inhibit DENV2 replication in stages between posttranslation and viral RNA genome replication, most noticeably at 2 h post-infection. RT-PCR showed that (39) reduced the expression of E and NS1 proteins (Yao et al., 2018). Yet, further investigations are required on other cell lines, which would assess its cytotoxicity furtherly, and assess its effectiveness as a protease inhibitor.
</paragraph>
<paragraph blockId="8.[100,272,1878,1898]" box="[100,272,1878,1898]" pageId="8" pageNumber="9">
<emphasis bold="true" box="[100,272,1878,1898]" italics="true" pageId="8" pageNumber="9">2.6. Miscellaneous</emphasis>
</paragraph>
<paragraph blockId="8.[100,770,1935,1982]" lastBlockId="8.[818,1488,442,1604]" pageId="8" pageNumber="9">
Melatonin (40) (Fig. 10, a) is an acetamide hormone that is secreted by the pineal gland to regulate the circadian rhythm. It was documented that (40) was also detected in various medicinal and dietary plants such as apples, barley, beans, cucumber, grapes, lupine, maize, potatoes, rice, and tomatoes, among others (Salehi et al., 2019b). It has been reported that melatonin (40) at concentrations of 1000, 500, and 250 μM (which were determined to be as subtoxic concentrations) decreased the viral titer in DENV2-infected Huh7 cells by 99.77, 98.11, and 95.62%, respectively. These findings were compared to 
<emphasis bold="true" box="[1250,1265,609,628]" italics="true" pageId="8" pageNumber="9">N</emphasis>
-acetyl cysteine (used as a reference, 20 mM), which only reduced the viral titer by 73.65%. The IC 
<subScript attach="left" box="[838,856,672,686]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
of (40) was 134.9 μM, while no significant change in cell viability was noticed. Nonetheless, (40) reduced the viral titer in four serotypes of DENV (DENV1-4) with various inhibitory levels, plus in other cell lines besides the Huh7, namely, A549, EA.hy.926, and U937. Melatonin (40) inhibited DENV replication and production at the post-entry stage. This was concluded as cell line experiments showed no effect of (40) when supplied at the pre- or co-infection stages. The mechanism of action on how (40) inhibits the DENV infection is not fully understood. However, and through RT-PCR, it is suspected that (40) affects RNA and protein translation. Yet, it was found that the antiviral activity of (40) is partly originated from its ability to activate the SIRT1 pathway (Morchang et al., 2021).
</paragraph>
<paragraph blockId="8.[818,1488,442,1604]" pageId="8" pageNumber="9">On the contrary, melatonin (40) was assayed against DENV2 virus in HEK293T/17 and HepG2 cell lines at concentrations between 0.0001 and 10 mM. A slight inhibitory effect was noticed in HEK293T/17 cells, while no inhibitory effects were seen in HepG2. Thus, it was concluded that (40) increased the burden of DENV infection (Paemanee et al., 2018). These inconsistent findings raise a massive question about the efficacy of melatonin (40) towards DENV infections. However, these differences might be referred to the different cell lines which were used in each study, the multiplicity of infection, melatonin (40) concentration, or the followed procedure.</paragraph>
<paragraph blockId="8.[818,1488,442,1604]" pageId="8" pageNumber="9">
Moreover, a benzofuranone derivative (41) (Fig. 10, b) was identified and isolated successfully from 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[1155,1257,1306,1326]" class="Magnoliopsida" family="Lauraceae" genus="Endiandra" kingdom="Plantae" order="Laurales" pageId="8" pageNumber="9" phylum="Tracheophyta" rank="species" species="kingiana">
<emphasis bold="true" box="[1155,1257,1306,1326]" italics="true" pageId="8" pageNumber="9">E. kingiana</emphasis>
</taxonomicName>
’s DCM bark extract. 
<emphasis bold="true" italics="true" pageId="8" pageNumber="9">Invitro</emphasis>
assessment against DENV2 NS2b/NS3pro showed that (41) was able to inhibit the protease by 61.23%, with an IC 
<subScript attach="left" box="[1320,1338,1369,1383]" fontSize="6" pageId="8" pageNumber="9">50</subScript>
of 403.14 μM. Molecular docking showed that (41) was inferior with its binding affinity towards NS2b/NS3pro to the binding affinities of epicatechin (19) and catechin (27), which were also identified in the same extract. Herein, (41) demonstrated the weakest binding affinity as it managed to bind through two hydrogen bonds only at the S1 subpocket (Sulaiman et al., 2019). This weak binding affinity and inferior percentage of inhibition of (41) might be influenced by the long unsaturated aliphatic chain that the compound bears.
</paragraph>
<paragraph blockId="8.[818,1161,1641,1660]" box="[818,1161,1641,1660]" pageId="8" pageNumber="9">
<emphasis bold="true" box="[818,1161,1641,1660]" pageId="8" pageNumber="9">3. Natural peptides as anti-DENV</emphasis>
</paragraph>
<paragraph blockId="8.[818,1488,1697,1967]" pageId="8" pageNumber="9">
Several peptides have been studied previously for their inhibitory activity towards DENV. These peptides include protegrin-1 from swine white blood cells (Rothan et al., 2012a), conotoxins, a mixture of peptide neurotoxins produced by cone snails (Xu et al., 2012), and retrocyclin-1, which is a recombinant primate peptide synthesised in 
<taxonomicName _authorityPlausibility="NaN" _evidence="catalogs" _step="species1" authority="(Rothan et al., 2012 b)" baseAuthorityName="Rothan" baseAuthorityYear="2012" box="[818,1179,1836,1856]" class="Gammaproteobacteria" family="Enterobacteriaceae" genus="Escherichia" kingdom="Bacteria" order="Enterobacteriales" pageId="8" pageNumber="9" phylum="Proteobacteria" rank="species" species="coli">
<emphasis bold="true" box="[818,956,1836,1855]" italics="true" pageId="8" pageNumber="9">Escherichia coli</emphasis>
(Rothan et al., 2012b)
</taxonomicName>
. A profound review on peptides that are able to inhibit 
<taxonomicName _evidence="catalogs" _step="genera" box="[1031,1117,1864,1883]" class="Flasuviricetes" family="Flaviviridae" genus="Flavivirus" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="8" pageNumber="9" phylum="Kitrinoviricota" rank="genus">
<emphasis bold="true" box="[1031,1117,1864,1883]" italics="true" pageId="8" pageNumber="9">Flavivirus</emphasis>
</taxonomicName>
’s NS2b/NS3pro was published recently by Wahaab and co-workers (Wahaab et al., 2022). Herein, we review a few more natural isolated peptides which were studied recently, including peptides from 
<taxonomicName _evidence="catalogs" _step="species1" box="[1049,1184,1948,1967]" class="Magnoliopsida" family="Fabaceae" genus="Acacia" kingdom="Plantae" order="Fabales" pageId="8" pageNumber="9" phylum="Tracheophyta" rank="species" species="catechu">
<emphasis bold="true" box="[1049,1184,1948,1967]" italics="true" pageId="8" pageNumber="9">Acacia catechu</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="label" _step="labeledHigher" box="[1264,1389,1948,1967]" class="Magnoliopsida" family="Leguminosae" higherTaxonomySource="GBIF" kingdom="Plantae" order="Fabales" pageId="8" pageNumber="9" phylum="Tracheophyta" rank="family">Leguminosae</taxonomicName>
) and fish.
</paragraph>
<caption pageId="9" pageNumber="10" startId="9.[100,150,150,166]" targetType="table">
<paragraph blockId="9.[100,1471,150,1959]" box="[100,167,150,167]" pageId="9" pageNumber="10">
<emphasis bold="true" box="[100,167,150,167]" pageId="9" pageNumber="10">Table 1</emphasis>
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[100,1221,176,193]" pageId="9" pageNumber="10">Anti-DENV activity of isolated natural small molecules which were recently reported as potential inhibitors of DENV NS2b/NS3pro.</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[116,1353,213,227]" pageId="9" pageNumber="10">Phytochemical Compound Type of Study Docking Score/Binding Experimental Findings Toxicity Ref.</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[116,844,235,250]" pageId="9" pageNumber="10">
Class 
<taxonomicName _evidence="label" _step="labeledHigher" box="[659,714,236,250]" class="Energy" pageId="9" pageNumber="10" rank="class">Energy</taxonomicName>
/ 
<emphasis bold="true" box="[719,774,235,249]" italics="true" pageId="9" pageNumber="10">in-silico</emphasis>
Remarks
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
Phenolics Agnuside (aglycone) 
<emphasis bold="true" box="[507,563,270,284]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 133.1 kJ/mol Powers and Setzer NS2b/NS3pro) (2016)
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
Caffeic acid 
<emphasis bold="true" box="[507,563,316,330]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 6.0 kcal/mol Ghosh and NS2b/NS3pro) Talukdar (2019) Chlorogenic acid 
<emphasis bold="true" box="[507,563,362,376]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 7.3 kcal/mol Ghosh and NS2b/NS3pro) Talukdar (2019) Ferulic acid 
<emphasis bold="true" box="[507,563,407,421]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 5.9 kcal/mol Ghosh and NS2b/NS3pro) Talukdar (2019) Gingerol 
<emphasis bold="true" box="[507,563,453,467]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 6.1 kcal/mol IC 
<subScript attach="left" box="[936,950,460,470]" fontSize="4" pageId="9" pageNumber="10">50</subScript>
<emphasis box="[955,969,455,467]" italics="true" pageId="9" pageNumber="10">=</emphasis>
0.032 mM (when Rahman et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1373,476,490]" pageId="9" pageNumber="10">NS2b/NS3pro) supplied after virus (2021)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1424,499,513]" pageId="9" pageNumber="10">
<emphasis bold="true" box="[507,559,499,513]" italics="true" pageId="9" pageNumber="10">In-vitro</emphasis>
(DENV1 entry) Halim (2017)
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
in A549) IC 
<subScript attach="left" box="[936,950,528,538]" fontSize="4" pageId="9" pageNumber="10">50</subScript>
<emphasis box="[955,969,524,536]" italics="true" pageId="9" pageNumber="10">=</emphasis>
0.038 mM (when supplied full-time)
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[266,1428,567,582]" pageId="9" pageNumber="10">
Hibiscus acid 
<emphasis bold="true" box="[507,563,567,581]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 5.7 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1373,590,605]" pageId="9" pageNumber="10">NS2b/NS3pro) (2021)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
Resveratrol 
<emphasis bold="true" box="[507,559,613,627]" italics="true" pageId="9" pageNumber="10">In-vitro</emphasis>
(DENV2 Significant reduction in No significant Zainal et al. (2017) in Huh7) viral titer at 80 and 100 cytotoxicity was
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[920,1197,658,675]" pageId="9" pageNumber="10">μM. noticed.</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[920,1032,682,696]" pageId="9" pageNumber="10">Decreased NS3</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[920,1089,705,719]" pageId="9" pageNumber="10">production in DENV2.</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">It induced INF-β levels and activated MxA and</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[920,972,773,787]" pageId="9" pageNumber="10">ISG56.</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
Rosmarinic acid 
<emphasis bold="true" box="[507,563,796,810]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV4 59.86 (docking) Rani et al. (2022) NS2b47/ 63.52 kcal/mol (MM/GBSA)
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,569,842,856]" pageId="9" pageNumber="10">NS3pro)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[266,1428,864,879]" pageId="9" pageNumber="10">
Zingerone 
<emphasis bold="true" box="[507,563,864,878]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 5.7 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1373,887,901]" pageId="9" pageNumber="10">NS2b/NS3pro) (2021)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[116,1428,910,925]" pageId="9" pageNumber="10">
Terpenes Carvacrol 
<emphasis bold="true" box="[507,563,910,924]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 5.5 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
NS2b/NS3pro) (2021) Dithymoquinone 
<emphasis bold="true" box="[507,563,956,970]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 7.3 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1373,979,993]" pageId="9" pageNumber="10">NS2b/NS3pro) (2021)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[266,1428,1001,1016]" pageId="9" pageNumber="10">
Sageone 
<emphasis bold="true" box="[507,563,1001,1015]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 6.9 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1373,1025,1039]" pageId="9" pageNumber="10">NS2b/NS3pro) (2021)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
Solophenol D 
<emphasis bold="true" box="[507,563,1047,1061]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 138.5 kJ/mol Powers and Setzer NS2b/NS3pro) (2016) Thymohydroquinone 
<emphasis bold="true" box="[507,563,1093,1107]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 5.4 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1373,1116,1130]" pageId="9" pageNumber="10">NS2b/NS3pro) (2021)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[266,1428,1139,1153]" pageId="9" pageNumber="10">
Thymol 
<emphasis bold="true" box="[507,563,1139,1153]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 5.4 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
NS2b/NS3pro) (2021) Thymoquinone 
<emphasis bold="true" box="[507,563,1184,1198]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 5.6 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
NS2b/NS3pro) (2021) Umbelliprenin 
<emphasis bold="true" box="[507,563,1230,1244]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 134.5 kJ/mol Powers and Setzer NS2b/NS3pro) (2016)
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[116,1434,1276,1290]" pageId="9" pageNumber="10">
Terpenoids Andrographolide 
<emphasis bold="true" box="[507,559,1276,1290]" italics="true" pageId="9" pageNumber="10">In-vitro</emphasis>
Dose-dependent No significant Panraksa et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1373,1299,1313]" pageId="9" pageNumber="10">(DENV1-4 in reductions in DENV2 cytotoxicity was (2017)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">HepG2 and and DENV4 envelop and noticed in HepG2 Tan et al. (2019) HeLa) NS3 proteins expression and HeLa lines up to</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1200,1366,1383]" pageId="9" pageNumber="10">
<emphasis bold="true" box="[507,559,1367,1381]" italics="true" pageId="9" pageNumber="10">In-vitro</emphasis>
(DENV and in virus titer in both 100 μM.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,992,1390,1404]" pageId="9" pageNumber="10">in Vero) cell lines.</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[920,1105,1413,1429]" pageId="9" pageNumber="10">
EC 
<subScript attach="left" box="[940,954,1419,1429]" fontSize="4" pageId="9" pageNumber="10">50</subScript>
values of 21.30 and
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[920,1102,1435,1452]" pageId="9" pageNumber="10">22.74 μM in HepG2 and</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[920,1103,1459,1473]" pageId="9" pageNumber="10">HeLa cells, respectively.</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
IC 
<subScript attach="left" box="[936,950,1488,1498]" fontSize="4" pageId="9" pageNumber="10">50</subScript>
<emphasis box="[955,969,1483,1495]" italics="true" pageId="9" pageNumber="10">=</emphasis>
51 μM in Vero cells.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[266,1428,1527,1542]" pageId="9" pageNumber="10">
Desacetylnimbin 
<emphasis bold="true" box="[507,563,1527,1541]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 5.24 kcal/mol Dwivedi et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
NS2b/NS3pro) (2016) Desacetylsalannin 
<emphasis bold="true" box="[507,563,1573,1587]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 3.43 kcal/mol Dwivedi et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1373,1596,1610]" pageId="9" pageNumber="10">NS2b/NS3pro) (2016)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[266,1428,1618,1633]" pageId="9" pageNumber="10">
Nimbin 
<emphasis bold="true" box="[507,563,1618,1632]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 5.56 kcal/mol Dwivedi et al.
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,1373,1641,1655]" pageId="9" pageNumber="10">NS2b/NS3pro) (2016)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[266,1449,1663,1681]" pageId="9" pageNumber="10">
Stachyonic acid A 
<emphasis bold="true" box="[507,559,1664,1678]" italics="true" pageId="9" pageNumber="10">In-vitro</emphasis>
(DENV IC 
<subScript attach="left" box="[936,950,1671,1681]" fontSize="4" pageId="9" pageNumber="10">50</subScript>
<emphasis box="[955,969,1666,1678]" italics="true" pageId="9" pageNumber="10">=</emphasis>
1.4 μM Tan et al. (2019)
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,569,1687,1701]" pageId="9" pageNumber="10">in Vero)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
Flavonoids Alpinumisoflavone 
<emphasis bold="true" box="[507,563,1710,1724]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 10.45 kcal/mol Qamar et al. (2017) NS2b/NS3pro)
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
Amentoflavone 
<emphasis bold="true" box="[507,563,1755,1769]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 15.8 kcal/mol 53% inhibition at 25 μM 20% toxicity at 25 Jayadevappa et al. NS2b/NS3pro) μM (2020)
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,626,1801,1816]" pageId="9" pageNumber="10">
<emphasis bold="true" box="[507,559,1801,1815]" italics="true" pageId="9" pageNumber="10">In-vitro</emphasis>
(DENV2
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[507,585,1824,1838]" pageId="9" pageNumber="10">in HepG2)</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" pageId="9" pageNumber="10">
Apigenin 
<emphasis bold="true" box="[507,563,1847,1861]" italics="true" pageId="9" pageNumber="10">In-silico</emphasis>
(DENV 6.62 to 7.7 kcal/mol EC 
<subScript attach="left" box="[940,954,1854,1864]" fontSize="4" pageId="9" pageNumber="10">50</subScript>
<emphasis box="[960,974,1849,1861]" italics="true" pageId="9" pageNumber="10">=</emphasis>
10.55 μM CC 
<subScript attach="left" box="[1157,1171,1854,1864]" fontSize="4" pageId="9" pageNumber="10">50</subScript>
<emphasis box="[1176,1190,1849,1861]" italics="true" pageId="9" pageNumber="10">=</emphasis>
82.82 μM Shanmugapriya NS2b/NS3pro) et al. (2016) 
<emphasis bold="true" box="[507,559,1893,1907]" italics="true" pageId="9" pageNumber="10">In-vitro</emphasis>
(DENV2 Ghosh and in LLC/MK2) Talukdar (2019)
</paragraph>
<paragraph blockId="9.[100,1471,150,1959]" box="[1294,1471,1945,1959]" pageId="9" pageNumber="10">
(
<emphasis bold="true" box="[1300,1465,1945,1959]" italics="true" pageId="9" pageNumber="10">continued on next page</emphasis>
)
</paragraph>
</caption>
<caption pageId="10" pageNumber="11" startId="10.[100,150,150,166]" targetType="table">
<paragraph blockId="10.[100,1471,150,1980]" box="[100,267,150,167]" pageId="10" pageNumber="11">
<emphasis bold="true" box="[100,167,150,167]" pageId="10" pageNumber="11">Table 1</emphasis>
(
<emphasis bold="true" box="[180,258,150,167]" italics="true" pageId="10" pageNumber="11">continued</emphasis>
)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[116,1353,187,201]" pageId="10" pageNumber="11">Phytochemical Compound Type of Study Docking Score/Binding Experimental Findings Toxicity Ref.</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[116,844,210,224]" pageId="10" pageNumber="11">
Class 
<taxonomicName _evidence="label" _step="labeledHigher" box="[659,714,210,224]" class="Energy" pageId="10" pageNumber="11" rank="class">Energy</taxonomicName>
/ 
<emphasis bold="true" box="[719,774,210,224]" italics="true" pageId="10" pageNumber="11">in-silico</emphasis>
Remarks
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Hengphasatporn et al. (2021) Avicularin 
<emphasis bold="true" box="[507,563,290,304]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 14.6 kcal/mol Jayadevappa et al. NS2b/NS3pro) (2020)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Bellidifolin 
<emphasis bold="true" box="[507,563,336,350]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 5.07 kcal/mol Shanmugapriya NS2b/NS3pro) et al. (2016) Bicalein 
<emphasis bold="true" box="[507,563,382,396]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 5.91 kcal/mol Shanmugapriya NS2b/NS3pro) et al. (2016) Chartaceone A2 
<emphasis bold="true" box="[507,563,428,442]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 129.8 kJ/mol Powers and Setzer NS2b/NS3pro) (2016)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Chrysin 
<emphasis bold="true" box="[507,563,473,487]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 6.51 kcal/mol Shanmugapriya NS2b/NS3pro) et al. (2016) Cyanidin 3-glucoside 
<emphasis bold="true" box="[507,563,519,533]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 8.0 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1373,542,556]" pageId="10" pageNumber="11">NS2b/NS3pro) (2021)</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Curcumin 
<emphasis bold="true" box="[507,563,565,579]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV MD simulation showed that It is a non-competitive CC 
<subScript attach="left" box="[1157,1171,571,581]" fontSize="4" pageId="10" pageNumber="11">50</subScript>
<emphasis box="[1176,1190,567,579]" italics="true" pageId="10" pageNumber="11">=</emphasis>
49.01 μM in (Lim et al., 2020) NS2b/NS3pro) curcumin binds to an allosteric inhibitor. BHK-21 cells. Balasubramanian 
<emphasis bold="true" box="[507,559,611,625]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV2 site and leads to unfolding of 
<subScript attach="left" box="[920,935,611,627]" fontSize="4" pageId="10" pageNumber="11">Ki</subScript>
<emphasis box="[939,953,613,625]" italics="true" pageId="10" pageNumber="11">=</emphasis>
4.35 μM (enzyme The highest safe et al. (2019) NS2b/NS3pro) the β- hairpin of the C-terminal assay) concentration Marbawati and 
<emphasis bold="true" box="[507,559,656,670]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV2 NS2b, thus disrupting the IC 
<subScript attach="left" box="[936,950,663,673]" fontSize="4" pageId="10" pageNumber="11">50</subScript>
<emphasis box="[955,969,658,670]" italics="true" pageId="10" pageNumber="11">=</emphasis>
7.18 μM (enzyme against Vero cells Umniyati, (2015) in BHK-21) active conformation of the assay) was 6.25 ppm.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1050,701,718]" pageId="10" pageNumber="11">
<emphasis bold="true" box="[507,559,702,716]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV2 protease. EC 
<subScript attach="left" box="[940,954,708,718]" fontSize="4" pageId="10" pageNumber="11">50</subScript>
<emphasis box="[960,974,704,716]" italics="true" pageId="10" pageNumber="11">=</emphasis>
13.95 μM
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,569,725,739]" pageId="10" pageNumber="11">in Vero)</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Delphinidin 
<emphasis bold="true" box="[507,559,748,762]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV2 Virucidal effect at 10 No significant V´azquez-Calvo in Vero) μM. cytotoxicity was et al. (2017)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[920,1197,793,808]" pageId="10" pageNumber="11">It does not alter noticed.</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[920,1034,816,831]" pageId="10" pageNumber="11">endosomal pH.</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[266,1428,839,854]" pageId="10" pageNumber="11">
Epicatechin 
<emphasis bold="true" box="[507,563,839,853]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 7.62 kcal/mol 66.2% viral inhibition at 20% cytotoxicity on Dwivedi et al.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1373,861,878]" pageId="10" pageNumber="11">NS2b/NS3pro) 1000 μM. the BHK-21 cells at 1 (2021)</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1171,885,899]" pageId="10" pageNumber="11">
<emphasis bold="true" box="[507,559,885,899]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV2 mM.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,592,908,922]" pageId="10" pageNumber="11">in BHK-21)</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Epigallocatechin gallate 
<emphasis bold="true" box="[507,559,930,944]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV2 Virucidal effect at 10 No significant V´azquez-Calvo in Vero) μM. cytotoxicity was et al. (2017)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[920,1461,976,990]" pageId="10" pageNumber="11">Does not alter noticed. Raekiansyah et al.</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[920,1373,999,1013]" pageId="10" pageNumber="11">endosomal pH. (2018)</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[920,1066,1022,1036]" pageId="10" pageNumber="11">
<emphasis box="[920,933,1022,1036]" italics="true" pageId="10" pageNumber="11">&gt;</emphasis>
90% inhibition of
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[920,1100,1045,1059]" pageId="10" pageNumber="11">DENV2 infection at 100</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[920,950,1066,1083]" pageId="10" pageNumber="11">μM.</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Euchrestaflavanone A 
<emphasis bold="true" box="[507,563,1090,1104]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 134.7 kJ/mol Powers and Setzer NS2b/NS3pro) (2016) Flemiflavanone D 
<emphasis bold="true" box="[507,563,1136,1150]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 136.5 kJ/mol Powers and Setzer NS2b/NS3pro) (2016)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Gelangin 
<emphasis bold="true" box="[507,563,1182,1196]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 6.42 kcal/mol Shanmugapriya NS2b/NS3pro) et al. (2016) Glabridin 
<emphasis bold="true" box="[507,563,1227,1241]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 7.4 kcal/mol Rahman et al.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
NS2b/NS3pro) (2021) Glicoisoflavanone 
<emphasis bold="true" box="[507,563,1273,1287]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 10.02 kcal/mol Qamar et al. (2017) NS2b/NS3pro)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Globuxanthone 
<emphasis bold="true" box="[507,563,1319,1333]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 3.93 kcal/mol Shanmugapriya NS2b/NS3pro) et al. (2016) Glycyrrhisoflavone 
<emphasis bold="true" box="[507,563,1364,1378]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 133.3 kJ/mol Powers and Setzer NS2b/NS3pro) (2016)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Hesperetin 
<emphasis bold="true" box="[507,563,1410,1424]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 23.1 kcal/mol (non- 55% inhibition at 10 μM. Eberle et al. (2021) NS2b/NS3pro) competitive) 100% inhibition at 140
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,950,1455,1472]" pageId="10" pageNumber="11">
<emphasis bold="true" box="[507,559,1456,1470]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV μM.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1027,1478,1495]" pageId="10" pageNumber="11">
NS2b/NS3pro) IC 
<subScript attach="left" box="[936,950,1485,1495]" fontSize="4" pageId="10" pageNumber="11">50</subScript>
<emphasis box="[955,969,1481,1493]" italics="true" pageId="10" pageNumber="11">=</emphasis>
4.7 μM
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Hesperidin 
<emphasis bold="true" box="[507,563,1501,1515]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 37.4 kcal/mol (non- 30% inhibition at 10 μM. Eberle et al. (2021) NS2b/NS3pro) competitive) 100% inhibition at 140
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,950,1546,1563]" pageId="10" pageNumber="11">
<emphasis bold="true" box="[507,559,1547,1561]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV μM.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1036,1569,1587]" pageId="10" pageNumber="11">
NS2b/NS3pro) IC 
<subScript attach="left" box="[936,950,1577,1587]" fontSize="4" pageId="10" pageNumber="11">50</subScript>
<emphasis box="[955,969,1572,1584]" italics="true" pageId="10" pageNumber="11">=</emphasis>
55.7 μM
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
5-Hydroxybowdichione 
<emphasis bold="true" box="[507,563,1593,1607]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 12.11 kcal/mol Qamar et al. (2017) NS2b/NS3pro)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[266,1428,1639,1653]" pageId="10" pageNumber="11">
Hyperoside 
<emphasis bold="true" box="[507,563,1639,1653]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 7.88 kcal/mol Dwivedi et al.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1373,1662,1676]" pageId="10" pageNumber="11">NS2b/NS3pro) (2021)</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Kaempferol 
<emphasis bold="true" box="[507,563,1684,1698]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 7.1 kcal/mol It is a non-competitive Ghosh and NS2b/NS3pro) inhibitor. Talukdar (2019) 
<emphasis bold="true" box="[507,559,1730,1744]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV2 
<subScript attach="left" box="[920,935,1731,1747]" fontSize="4" pageId="10" pageNumber="11">Ki</subScript>
<emphasis box="[939,953,1732,1744]" italics="true" pageId="10" pageNumber="11">=</emphasis>
22.3 μM (enzyme de Sousa et al.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1373,1753,1767]" pageId="10" pageNumber="11">NS2b/NS3pro) assay) (2015)</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
IC 
<subScript attach="left" box="[936,950,1782,1792]" fontSize="4" pageId="10" pageNumber="11">50</subScript>
<emphasis box="[955,969,1778,1790]" italics="true" pageId="10" pageNumber="11">=</emphasis>
37.8 μM (enzyme assay)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[266,1428,1821,1836]" pageId="10" pageNumber="11">
Kaempferol-3- 
<emphasis bold="true" box="[373,385,1822,1836]" italics="true" pageId="10" pageNumber="11">O</emphasis>
-rutinoside 
<emphasis bold="true" box="[507,563,1821,1835]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 9.56 kcal/mol 77.7% inhibition at 100 No significant Dwivedi et al.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1373,1843,1860]" pageId="10" pageNumber="11">NS2b/NS3pro) μM cytotoxicity till 100 (2021)</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,1291,1866,1883]" pageId="10" pageNumber="11">
<emphasis bold="true" box="[507,559,1867,1881]" italics="true" pageId="10" pageNumber="11">In-vitro</emphasis>
(DENV2 μM on BHK-21 cells.
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[507,592,1890,1904]" pageId="10" pageNumber="11">in BHK-21)</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" pageId="10" pageNumber="11">
Kushenol K 
<emphasis bold="true" box="[507,563,1913,1927]" italics="true" pageId="10" pageNumber="11">In-silico</emphasis>
(DENV 11.30 Qamar et al. (2019) NS2b/NS3pro)
</paragraph>
<paragraph blockId="10.[100,1471,150,1980]" box="[1294,1471,1965,1980]" pageId="10" pageNumber="11">
(
<emphasis bold="true" box="[1300,1465,1965,1980]" italics="true" pageId="10" pageNumber="11">continued on next page</emphasis>
)
</paragraph>
</caption>
<paragraph blockId="11.[100,1471,150,1980]" box="[100,267,150,167]" pageId="11" pageNumber="12">
<emphasis bold="true" box="[100,167,150,167]" pageId="11" pageNumber="12">Table 1</emphasis>
(
<emphasis bold="true" box="[180,258,150,167]" italics="true" pageId="11" pageNumber="12">continued</emphasis>
)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[116,1353,187,201]" pageId="11" pageNumber="12">Phytochemical Compound Type of Study Docking Score/Binding Experimental Findings Toxicity Ref.</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[116,844,210,224]" pageId="11" pageNumber="12">
Class 
<taxonomicName _evidence="label" _step="labeledHigher" box="[659,714,210,224]" class="Energy" pageId="11" pageNumber="12" rank="class">Energy</taxonomicName>
/ 
<emphasis bold="true" box="[719,774,210,224]" italics="true" pageId="11" pageNumber="12">in-silico</emphasis>
Remarks
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Kushenol W 
<emphasis bold="true" box="[507,563,245,259]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 11.68 Qamar et al. (2019) NS2b/NS3pro)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Liquiritinapioside 
<emphasis bold="true" box="[507,563,290,304]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 15.0 kcal/mol Jayadevappa et al. NS2b/NS3pro) (2020)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Luteolin 
<emphasis bold="true" box="[507,563,336,350]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 7.7 kcal/mol EC 
<subScript attach="left" box="[940,954,343,353]" fontSize="4" pageId="11" pageNumber="12">50</subScript>
values of 7.2, 5.19, Ghosh and NS2b/NS3pro) 5.69 and 8.38 μM for Talukdar (2019) 
<emphasis bold="true" box="[507,559,382,396]" italics="true" pageId="11" pageNumber="12">In-vitro</emphasis>
DENV1,2,3 and 4, Peng et al. (2017) (DENV1-4 in respectively, in Huh7
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[507,959,428,442]" pageId="11" pageNumber="12">Huh7) cells.</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
<emphasis bold="true" box="[507,559,451,465]" italics="true" pageId="11" pageNumber="12">In-vitro</emphasis>
(DENV2 10 μM of luteolin in various cells) produced 20-fold
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[507,1072,496,511]" pageId="11" pageNumber="12">
<emphasis bold="true" box="[507,556,496,510]" italics="true" pageId="11" pageNumber="12">In-vivo</emphasis>
(129/Sv reduction of DENV2
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">mice deficient infection compared to in type I and II control in Huh7 cells.</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[507,1081,565,581]" pageId="11" pageNumber="12">
interferon EC 
<subScript attach="left" box="[940,954,571,581]" fontSize="4" pageId="11" pageNumber="12">50</subScript>
values of 39.16,
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[507,1105,588,602]" pageId="11" pageNumber="12">receptors) 12.26, 14.04, and 9.36 in</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[920,1092,611,625]" pageId="11" pageNumber="12">DENV2-infected A549,</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[920,1104,633,648]" pageId="11" pageNumber="12">HEK-293T, BHK-21, and</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[920,1100,656,671]" pageId="11" pageNumber="12">Vero cells, respectively.</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">10 μM of luteolin had no effect in DENV2-infected</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[920,1077,725,739]" pageId="11" pageNumber="12">A549, BHK-21, HEK-</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[920,1003,748,762]" pageId="11" pageNumber="12">293T cells.</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">Luteolin was shown to reduce viraemia in mice.</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Luteolin-7- 
<emphasis bold="true" box="[349,361,816,830]" italics="true" pageId="11" pageNumber="12">O</emphasis>
-glucoside 
<emphasis bold="true" box="[507,563,816,830]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 14.4 kcal/mol Jayadevappa et al. NS2b/NS3pro) (2020)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Myricetin 
<emphasis bold="true" box="[507,563,862,876]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV MD simulation showed that It is a non-competitive Dang et al. (2022) NS2b/NS3pro) myricetin can allosterically inhibitor. de Sousa et al. 
<emphasis bold="true" box="[507,559,908,922]" italics="true" pageId="11" pageNumber="12">In-vitro</emphasis>
(DENV2 inhibit the protease by 
<subScript attach="left" box="[920,935,908,924]" fontSize="4" pageId="11" pageNumber="12">Ki</subScript>
<emphasis box="[939,953,910,922]" italics="true" pageId="11" pageNumber="12">=</emphasis>
4.7 μM (2015) NS2b/NS3pro) disrupting the active IC 
<subScript attach="left" box="[936,950,937,947]" fontSize="4" pageId="11" pageNumber="12">50</subScript>
<emphasis box="[955,969,932,944]" italics="true" pageId="11" pageNumber="12">=</emphasis>
22.3 μM
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">conformation and by locking the protease in the inactive conformation.</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
<emphasis bold="true" box="[507,563,1022,1036]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 7.5 kcal/mol Ghosh and NS2b/NS3pro) Talukdar (2019) Phellodendroside 
<emphasis bold="true" box="[507,563,1067,1081]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 63 Shimu et al. (2022) NS2b/NS3pro)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Prunectin 
<emphasis bold="true" box="[507,563,1113,1127]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 11.37 kcal/mol Qamar et al. (2017) NS2b/NS3pro)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Quercetin 
<emphasis bold="true" box="[507,563,1159,1173]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 6.24 to 7.40 kcal/mol It is a non-competitive 40% toxicity at 25 Dwivedi et al. NS2b/NS3pro) inhibitor. μM in HepG2 cells. (2021)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
<emphasis bold="true" box="[507,559,1205,1219]" italics="true" pageId="11" pageNumber="12">In-vitro</emphasis>
(DENV2 
<subScript attach="left" box="[920,935,1205,1221]" fontSize="4" pageId="11" pageNumber="12">Ki</subScript>
<emphasis box="[939,953,1207,1219]" italics="true" pageId="11" pageNumber="12">=</emphasis>
25.7 μM (enzyme CC 
<subScript attach="left" box="[1157,1171,1211,1221]" fontSize="4" pageId="11" pageNumber="12">50</subScript>
value of Shanmugapriya NS2b/NS3pro) assay) 155.38 μg/mL in et al. (2016) 
<emphasis bold="true" box="[507,559,1250,1264]" italics="true" pageId="11" pageNumber="12">In-vitro</emphasis>
(DENV2 IC 
<subScript attach="left" box="[936,950,1257,1267]" fontSize="4" pageId="11" pageNumber="12">50</subScript>
<emphasis box="[955,969,1252,1264]" italics="true" pageId="11" pageNumber="12">=</emphasis>
43.6 μM (enzyme BHK-21 cells. Ghosh and in HepG2) assay) Talukdar (2019) 
<emphasis bold="true" box="[507,559,1296,1310]" italics="true" pageId="11" pageNumber="12">In-vitro</emphasis>
(DENV2 63% inhibition at 25 μM de Sousa et al.
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[507,1373,1319,1333]" pageId="11" pageNumber="12">in BHK-21) quercetin in DENV2- (2015)</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
<emphasis bold="true" box="[507,559,1342,1356]" italics="true" pageId="11" pageNumber="12">In-vitro</emphasis>
(DENV2 infected HepG2 cells. Jayadevappa et al. in Vero) IC 
<subScript attach="left" box="[936,950,1371,1381]" fontSize="4" pageId="11" pageNumber="12">50</subScript>
of 467.27 mg/mL in (2020)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[920,1469,1387,1402]" pageId="11" pageNumber="12">DENV2-infected BHK- Chiow et al. (2016)</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[920,1464,1410,1425]" pageId="11" pageNumber="12">21 cells. Zandi et al. (2011)</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[920,1084,1432,1450]" pageId="11" pageNumber="12">
IC 
<subScript attach="left" box="[936,950,1440,1450]" fontSize="4" pageId="11" pageNumber="12">50</subScript>
of 35.7 μg/mL in
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">DENV2-infected Vero cells.</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Quercetin-3- 
<emphasis bold="true" box="[361,373,1502,1516]" italics="true" pageId="11" pageNumber="12">O</emphasis>
-β- D- 
<emphasis bold="true" box="[507,563,1501,1515]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 15.1 kcal/mol Jayadevappa et al. glucopyranoside NS2b/NS3pro) (2020) Quercetin-7- 
<emphasis bold="true" box="[361,373,1547,1561]" italics="true" pageId="11" pageNumber="12">O</emphasis>
-rutinoside 
<emphasis bold="true" box="[507,563,1547,1561]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 54.1 Shimu et al. (2022) NS2b/NS3pro)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Quercimeritrin 
<emphasis bold="true" box="[507,563,1593,1607]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 59.5 Shimu et al. (2022) NS2b/NS3pro)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Reynoutrin 
<emphasis bold="true" box="[507,563,1639,1653]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 14.6 kcal/mol Jayadevappa et al. NS2b/NS3pro) (2020)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Rhamnazin 
<emphasis bold="true" box="[507,563,1684,1698]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 6.16 kcal/mol Shanmugapriya NS2b/NS3pro) et al. (2016) Rhodiolin 
<emphasis bold="true" box="[507,563,1730,1744]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 133.9 kJ/mol Powers and Setzer NS2b/NS3pro) (2016)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
Rutin 
<emphasis bold="true" box="[507,563,1776,1790]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 9.32 kcal/mol Did not inhibit DENV2 CC 
<subScript attach="left" box="[1157,1171,1782,1792]" fontSize="4" pageId="11" pageNumber="12">50</subScript>
<emphasis box="[1176,1189,1776,1790]" italics="true" pageId="11" pageNumber="12">&gt;</emphasis>
1000 μg/mL Dwivedi et al. NS2b/NS3pro) replication in Vero cells. (2021)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
<emphasis bold="true" box="[507,559,1822,1836]" italics="true" pageId="11" pageNumber="12">In-vitro</emphasis>
(DENV2 Zandi et al. (2011) in Vero)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" pageId="11" pageNumber="12">
<emphasis bold="true" box="[507,563,1867,1881]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 6.82 kcal/mol Shanmugapriya NS2b/NS3pro) et al. (2016) Scutallarein 
<emphasis bold="true" box="[507,563,1913,1927]" italics="true" pageId="11" pageNumber="12">In-silico</emphasis>
(DENV 14.1 kcal/mol Jayadevappa et al. NS2b/NS3pro) (2020)
</paragraph>
<paragraph blockId="11.[100,1471,150,1980]" box="[1294,1471,1965,1980]" pageId="11" pageNumber="12">
(
<emphasis bold="true" box="[1300,1465,1965,1980]" italics="true" pageId="11" pageNumber="12">continued on next page</emphasis>
)
</paragraph>
<paragraph blockId="12.[100,267,150,167]" box="[100,267,150,167]" pageId="12" pageNumber="13">
<emphasis bold="true" box="[100,167,150,167]" pageId="12" pageNumber="13">Table 1</emphasis>
(
<emphasis bold="true" box="[180,258,150,167]" italics="true" pageId="12" pageNumber="13">continued</emphasis>
)
</paragraph>
<paragraph pageId="12" pageNumber="13">
<table box="[116,1471,187,1744]" gridcols="7" gridrows="68" pageId="12" pageNumber="13">
<tr box="[116,1471,187,201]" gridrow="0" pageId="12" pageNumber="13">
<th box="[116,229,187,201]" gridcol="0" gridrow="0" pageId="12" pageNumber="13">Phytochemical</th>
<th box="[266,464,187,201]" gridcol="1" gridrow="0" pageId="12" pageNumber="13">Compound</th>
<th box="[507,619,187,201]" gridcol="2" gridrow="0" pageId="12" pageNumber="13">Type of Study</th>
<th box="[659,883,187,201]" gridcol="3" gridrow="0" pageId="12" pageNumber="13">Docking Score/Binding</th>
<th box="[920,1089,187,201]" gridcol="4" gridrow="0" pageId="12" pageNumber="13">Experimental Findings</th>
<th box="[1135,1196,187,201]" gridcol="5" gridrow="0" pageId="12" pageNumber="13">Toxicity</th>
<th box="[1322,1471,187,201]" gridcol="6" gridrow="0" pageId="12" pageNumber="13">Ref.</th>
</tr>
<tr box="[116,1471,210,224]" gridrow="1" pageId="12" pageNumber="13" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<th box="[116,229,210,224]" gridcol="0" gridrow="1" pageId="12" pageNumber="13">Class</th>
<td box="[659,883,210,224]" gridcol="3" gridrow="1" pageId="12" pageNumber="13">
<taxonomicName _evidence="label" _step="labeledHigher" box="[659,714,210,224]" class="Energy" pageId="12" pageNumber="13" rank="class">Energy</taxonomicName>
/ 
<emphasis bold="true" box="[719,774,210,224]" italics="true" pageId="12" pageNumber="13">in-silico</emphasis>
Remarks
</td>
</tr>
<tr box="[116,1471,245,259]" gridrow="2" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,245,259]" gridcol="1" gridrow="2" pageId="12" pageNumber="13">Silybin</td>
<td box="[507,619,245,259]" gridcol="2" gridrow="2" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,245,259]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,245,259]" gridcol="3" gridrow="2" pageId="12" pageNumber="13">14.7 kcal/mol</td>
<td box="[1322,1471,245,259]" gridcol="6" gridrow="2" pageId="12" pageNumber="13">Jayadevappa et al.</td>
</tr>
<tr box="[116,1471,268,282]" gridrow="3" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,268,282]" gridcol="2" gridrow="3" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,268,282]" gridcol="6" gridrow="3" pageId="12" pageNumber="13">(2020)</td>
</tr>
<tr box="[116,1471,290,305]" gridrow="4" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,290,305]" gridcol="1" gridrow="4" pageId="12" pageNumber="13">Silyhermin</td>
<td box="[507,619,290,305]" gridcol="2" gridrow="4" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,290,304]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,290,305]" gridcol="3" gridrow="4" pageId="12" pageNumber="13">142.9 kJ/mol</td>
<td box="[1322,1471,290,305]" gridcol="6" gridrow="4" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,314,328]" gridrow="5" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,314,328]" gridcol="2" gridrow="5" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,314,328]" gridcol="6" gridrow="5" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,336,351]" gridrow="6" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,336,351]" gridcol="1" gridrow="6" pageId="12" pageNumber="13">Silymarin</td>
<td box="[507,619,336,351]" gridcol="2" gridrow="6" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,336,350]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,336,351]" gridcol="3" gridrow="6" pageId="12" pageNumber="13">14.3 kcal/mol</td>
<td box="[1322,1471,336,351]" gridcol="6" gridrow="6" pageId="12" pageNumber="13">Jayadevappa et al.</td>
</tr>
<tr box="[116,1471,359,373]" gridrow="7" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,359,373]" gridcol="2" gridrow="7" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,359,373]" gridcol="6" gridrow="7" pageId="12" pageNumber="13">(2020)</td>
</tr>
<tr box="[116,1471,380,396]" gridrow="8" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,380,396]" gridcol="1" gridrow="8" pageId="12" pageNumber="13">
5,7,3 
<emphasis box="[304,308,380,388]" italics="true" pageId="12" pageNumber="13">′</emphasis>
,4 
<emphasis box="[323,327,380,388]" italics="true" pageId="12" pageNumber="13">′</emphasis>
<emphasis box="[328,333,382,396]" italics="true" pageId="12" pageNumber="13">-</emphasis>
</td>
<td box="[507,619,380,396]" gridcol="2" gridrow="8" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,382,396]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,380,396]" gridcol="3" gridrow="8" pageId="12" pageNumber="13">10.53 kcal/mol</td>
<td box="[1322,1471,380,396]" gridcol="6" gridrow="8" pageId="12" pageNumber="13">Qamar et al. (2017)</td>
</tr>
<tr box="[116,1471,405,419]" gridrow="9" pageId="12" pageNumber="13" rowspan-0="1" rowspan-3="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[266,464,405,419]" gridcol="1" gridrow="9" pageId="12" pageNumber="13">Tetrahydroxyisoflavone</td>
<td box="[507,619,405,419]" gridcol="2" gridrow="9" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
</tr>
<tr box="[116,1471,428,442]" gridrow="10" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,428,442]" gridcol="1" gridrow="10" pageId="12" pageNumber="13">Uncinanone B</td>
<td box="[507,619,428,442]" gridcol="2" gridrow="10" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,428,442]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,428,442]" gridcol="3" gridrow="10" pageId="12" pageNumber="13">12.16 kcal/mol</td>
<td box="[1322,1471,428,442]" gridcol="6" gridrow="10" pageId="12" pageNumber="13">Qamar et al. (2017)</td>
</tr>
<tr box="[116,1471,451,465]" gridrow="11" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[507,619,451,465]" gridcol="2" gridrow="11" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
</tr>
<tr box="[116,1471,473,488]" gridrow="12" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,473,488]" gridcol="1" gridrow="12" pageId="12" pageNumber="13">Wogonin</td>
<td box="[507,619,473,488]" gridcol="2" gridrow="12" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,473,487]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,473,488]" gridcol="3" gridrow="12" pageId="12" pageNumber="13">6.12 kcal/mol</td>
<td box="[1322,1471,473,488]" gridcol="6" gridrow="12" pageId="12" pageNumber="13">Shanmugapriya</td>
</tr>
<tr box="[116,1471,496,511]" gridrow="13" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,496,511]" gridcol="2" gridrow="13" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,496,511]" gridcol="6" gridrow="13" pageId="12" pageNumber="13">et al. (2016)</td>
</tr>
<tr box="[116,1471,518,534]" gridrow="14" pageId="12" pageNumber="13" rowspan-4="1" rowspan-5="1">
<th box="[116,229,518,534]" gridcol="0" gridrow="14" pageId="12" pageNumber="13">Isoflavonoids</th>
<td box="[266,464,518,534]" gridcol="1" gridrow="14" pageId="12" pageNumber="13">
4 
<emphasis box="[276,280,518,526]" italics="true" pageId="12" pageNumber="13">′</emphasis>
<emphasis box="[280,303,519,534]" italics="true" pageId="12" pageNumber="13">
- 
<emphasis bold="true" box="[286,303,519,534]" italics="true" pageId="12" pageNumber="13">O -</emphasis>
</emphasis>
</td>
<td box="[507,619,518,534]" gridcol="2" gridrow="14" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,519,533]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,518,534]" gridcol="3" gridrow="14" pageId="12" pageNumber="13">140.4 kJ/mol</td>
<td box="[1322,1471,518,534]" gridcol="6" gridrow="14" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,542,556]" gridrow="15" pageId="12" pageNumber="13" rowspan-0="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,542,556]" gridcol="1" gridrow="15" pageId="12" pageNumber="13">methylglycyrrhisoflavone</td>
<td box="[507,619,542,556]" gridcol="2" gridrow="15" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,542,556]" gridcol="6" gridrow="15" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,563,579]" gridrow="16" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,563,579]" gridcol="1" gridrow="16" pageId="12" pageNumber="13">
4 
<emphasis box="[276,280,563,571]" italics="true" pageId="12" pageNumber="13">′</emphasis>
<emphasis box="[280,303,565,579]" italics="true" pageId="12" pageNumber="13">
- 
<emphasis bold="true" box="[286,303,565,579]" italics="true" pageId="12" pageNumber="13">O -</emphasis>
</emphasis>
</td>
<td box="[507,619,563,579]" gridcol="2" gridrow="16" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,565,579]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,563,579]" gridcol="3" gridrow="16" pageId="12" pageNumber="13">134.0 kJ/mol</td>
<td box="[1322,1471,563,579]" gridcol="6" gridrow="16" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,588,602]" gridrow="17" pageId="12" pageNumber="13" rowspan-0="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,588,602]" gridcol="1" gridrow="17" pageId="12" pageNumber="13">methylneobavaisoflavone</td>
<td box="[507,619,588,602]" gridcol="2" gridrow="17" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,588,602]" gridcol="6" gridrow="17" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,610,625]" gridrow="18" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,610,625]" gridcol="1" gridrow="18" pageId="12" pageNumber="13">8-prenylmucronulatol</td>
<td box="[507,619,610,625]" gridcol="2" gridrow="18" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,610,624]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,610,625]" gridcol="3" gridrow="18" pageId="12" pageNumber="13">135.7 kJ/mol</td>
<td box="[1322,1471,610,625]" gridcol="6" gridrow="18" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,633,647]" gridrow="19" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,633,647]" gridcol="2" gridrow="19" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,633,647]" gridcol="6" gridrow="19" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,656,671]" gridrow="20" pageId="12" pageNumber="13" rowspan-4="1" rowspan-5="1">
<th box="[116,229,656,671]" gridcol="0" gridrow="20" pageId="12" pageNumber="13">Flavanolignans</th>
<td box="[266,464,656,671]" gridcol="1" gridrow="20" pageId="12" pageNumber="13">Isosilandrin A</td>
<td box="[507,619,656,671]" gridcol="2" gridrow="20" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,656,670]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,656,671]" gridcol="3" gridrow="20" pageId="12" pageNumber="13">135.4 kJ/mol</td>
<td box="[1322,1471,656,671]" gridcol="6" gridrow="20" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,679,693]" gridrow="21" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,679,693]" gridcol="2" gridrow="21" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,679,693]" gridcol="6" gridrow="21" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,702,716]" gridrow="22" pageId="12" pageNumber="13" rowspan-4="1" rowspan-5="1">
<th box="[116,229,702,716]" gridcol="0" gridrow="22" pageId="12" pageNumber="13">Glucosinolates</th>
<td box="[266,464,702,716]" gridcol="1" gridrow="22" pageId="12" pageNumber="13">benzylglucosinolate</td>
<td box="[507,619,702,716]" gridcol="2" gridrow="22" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,702,716]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,702,716]" gridcol="3" gridrow="22" pageId="12" pageNumber="13">7.4 kcal/mol</td>
<td box="[1322,1471,702,716]" gridcol="6" gridrow="22" pageId="12" pageNumber="13">Ghosh and</td>
</tr>
<tr box="[116,1471,725,739]" gridrow="23" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,725,739]" gridcol="2" gridrow="23" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,725,739]" gridcol="6" gridrow="23" pageId="12" pageNumber="13">Talukdar (2019)</td>
</tr>
<tr box="[116,1471,747,762]" gridrow="24" pageId="12" pageNumber="13" rowspan-4="1" rowspan-5="1">
<th box="[116,229,747,762]" gridcol="0" gridrow="24" pageId="12" pageNumber="13">Fatty acids</th>
<td box="[266,464,747,762]" gridcol="1" gridrow="24" pageId="12" pageNumber="13">9-Octadecenamide</td>
<td box="[507,619,747,762]" gridcol="2" gridrow="24" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,747,761]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,747,762]" gridcol="3" gridrow="24" pageId="12" pageNumber="13">5.0 kcal/mol</td>
<td box="[1322,1471,747,762]" gridcol="6" gridrow="24" pageId="12" pageNumber="13">Ghosh and</td>
</tr>
<tr box="[116,1471,771,785]" gridrow="25" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,771,785]" gridcol="2" gridrow="25" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,771,785]" gridcol="6" gridrow="25" pageId="12" pageNumber="13">Talukdar (2019)</td>
</tr>
<tr box="[116,1471,793,807]" gridrow="26" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,793,807]" gridcol="1" gridrow="26" pageId="12" pageNumber="13">Oleic acid</td>
<td box="[507,619,793,807]" gridcol="2" gridrow="26" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,793,807]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,793,807]" gridcol="3" gridrow="26" pageId="12" pageNumber="13">Higher binding affinity</td>
<td box="[1322,1471,793,807]" gridcol="6" gridrow="26" pageId="12" pageNumber="13">Kutumbarao and</td>
</tr>
<tr box="[116,1471,816,830]" gridrow="27" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,816,830]" gridcol="2" gridrow="27" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[659,883,816,830]" gridcol="3" gridrow="27" pageId="12" pageNumber="13">towards 2M9P crystal</td>
<td box="[1322,1471,816,830]" gridcol="6" gridrow="27" pageId="12" pageNumber="13">Velmurugan (2016)</td>
</tr>
<tr box="[116,1471,839,854]" gridrow="28" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[659,883,839,854]" gridcol="3" gridrow="28" pageId="12" pageNumber="13">structure compared to 2FOM.</td>
</tr>
<tr box="[116,1471,862,876]" gridrow="29" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[659,883,862,876]" gridcol="3" gridrow="29" pageId="12" pageNumber="13">Interacts with all three</td>
</tr>
<tr box="[116,1471,885,899]" gridrow="30" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[659,883,885,899]" gridcol="3" gridrow="30" pageId="12" pageNumber="13">catalytic residues.</td>
</tr>
<tr box="[116,1471,907,922]" gridrow="31" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,907,922]" gridcol="1" gridrow="31" pageId="12" pageNumber="13">Palmitic acid</td>
<td box="[507,619,907,922]" gridcol="2" gridrow="31" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,907,921]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,907,922]" gridcol="3" gridrow="31" pageId="12" pageNumber="13">Higher binding affinity</td>
<td box="[1322,1471,907,922]" gridcol="6" gridrow="31" pageId="12" pageNumber="13">Kutumbarao and</td>
</tr>
<tr box="[116,1471,930,945]" gridrow="32" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,930,945]" gridcol="2" gridrow="32" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[659,883,930,945]" gridcol="3" gridrow="32" pageId="12" pageNumber="13">towards 2M9P crystal</td>
<td box="[1322,1471,930,945]" gridcol="6" gridrow="32" pageId="12" pageNumber="13">Velmurugan (2016)</td>
</tr>
<tr box="[116,1471,953,968]" gridrow="33" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[659,883,953,968]" gridcol="3" gridrow="33" pageId="12" pageNumber="13">structure compared to 2FOM.</td>
</tr>
<tr box="[116,1471,976,990]" gridrow="34" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[659,883,976,990]" gridcol="3" gridrow="34" pageId="12" pageNumber="13">Interacts with all three</td>
</tr>
<tr box="[116,1471,999,1013]" gridrow="35" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[659,883,999,1013]" gridcol="3" gridrow="35" pageId="12" pageNumber="13">catalytic residues.</td>
</tr>
<tr box="[116,1471,1022,1036]" gridrow="36" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1022,1036]" gridcol="1" gridrow="36" pageId="12" pageNumber="13">Stearic acid</td>
<td box="[507,619,1022,1036]" gridcol="2" gridrow="36" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1022,1036]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1022,1036]" gridcol="3" gridrow="36" pageId="12" pageNumber="13">Higher binding affinity</td>
<td box="[1322,1471,1022,1036]" gridcol="6" gridrow="36" pageId="12" pageNumber="13">Kutumbarao and</td>
</tr>
<tr box="[116,1471,1045,1059]" gridrow="37" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,1045,1059]" gridcol="2" gridrow="37" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[659,883,1045,1059]" gridcol="3" gridrow="37" pageId="12" pageNumber="13">towards 2M9P crystal</td>
<td box="[1322,1471,1045,1059]" gridcol="6" gridrow="37" pageId="12" pageNumber="13">Velmurugan (2016)</td>
</tr>
<tr box="[116,1471,1068,1082]" gridrow="38" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[659,883,1068,1082]" gridcol="3" gridrow="38" pageId="12" pageNumber="13">structure compared to 2FOM.</td>
</tr>
<tr box="[116,1471,1090,1105]" gridrow="39" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[659,883,1090,1105]" gridcol="3" gridrow="39" pageId="12" pageNumber="13">Interacts with all three</td>
</tr>
<tr box="[116,1471,1113,1127]" gridrow="40" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-2="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[659,883,1113,1127]" gridcol="3" gridrow="40" pageId="12" pageNumber="13">catalytic residues.</td>
</tr>
<tr box="[116,1471,1136,1150]" gridrow="41" pageId="12" pageNumber="13" rowspan-4="1" rowspan-5="1">
<th box="[116,229,1136,1150]" gridcol="0" gridrow="41" pageId="12" pageNumber="13">Chalcones</th>
<td box="[266,464,1136,1150]" gridcol="1" gridrow="41" pageId="12" pageNumber="13">Balsacone A</td>
<td box="[507,619,1136,1150]" gridcol="2" gridrow="41" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1136,1150]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1136,1150]" gridcol="3" gridrow="41" pageId="12" pageNumber="13">142.2 kJ/mol</td>
<td box="[1322,1471,1136,1150]" gridcol="6" gridrow="41" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1159,1173]" gridrow="42" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,1159,1173]" gridcol="2" gridrow="42" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1159,1173]" gridcol="6" gridrow="42" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1181,1196]" gridrow="43" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1181,1196]" gridcol="1" gridrow="43" pageId="12" pageNumber="13">Balsacone B</td>
<td box="[507,619,1181,1196]" gridcol="2" gridrow="43" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1181,1195]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1181,1196]" gridcol="3" gridrow="43" pageId="12" pageNumber="13">155.2 kJ/mol</td>
<td box="[1322,1471,1181,1196]" gridcol="6" gridrow="43" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1205,1219]" gridrow="44" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,1205,1219]" gridcol="2" gridrow="44" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1205,1219]" gridcol="6" gridrow="44" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1227,1242]" gridrow="45" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1227,1242]" gridcol="1" gridrow="45" pageId="12" pageNumber="13">Balsacone C</td>
<td box="[507,619,1227,1242]" gridcol="2" gridrow="45" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1227,1241]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1227,1242]" gridcol="3" gridrow="45" pageId="12" pageNumber="13">144.0 kJ/mol</td>
<td box="[1322,1471,1227,1242]" gridcol="6" gridrow="45" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1250,1264]" gridrow="46" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,1250,1264]" gridcol="2" gridrow="46" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1250,1264]" gridcol="6" gridrow="46" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1273,1288]" gridrow="47" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1273,1288]" gridcol="1" gridrow="47" pageId="12" pageNumber="13">Kanzonol Y</td>
<td box="[507,619,1273,1288]" gridcol="2" gridrow="47" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1273,1287]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1273,1288]" gridcol="3" gridrow="47" pageId="12" pageNumber="13">156.8 kJ/mol</td>
<td box="[1322,1471,1273,1288]" gridcol="6" gridrow="47" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1296,1310]" gridrow="48" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,1296,1310]" gridcol="2" gridrow="48" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1296,1310]" gridcol="6" gridrow="48" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1317,1333]" gridrow="49" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1317,1333]" gridcol="1" gridrow="49" pageId="12" pageNumber="13">
3,4,2 
<emphasis box="[304,308,1317,1325]" italics="true" pageId="12" pageNumber="13">′</emphasis>
,4 
<emphasis box="[323,327,1317,1325]" italics="true" pageId="12" pageNumber="13">′</emphasis>
,6 
<emphasis box="[342,346,1317,1325]" italics="true" pageId="12" pageNumber="13">′</emphasis>
<emphasis box="[347,352,1319,1333]" italics="true" pageId="12" pageNumber="13">-</emphasis>
</td>
<td box="[507,619,1317,1333]" gridcol="2" gridrow="49" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1319,1333]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1317,1333]" gridcol="3" gridrow="49" pageId="12" pageNumber="13">135.5 kJ/mol</td>
<td box="[1322,1471,1317,1333]" gridcol="6" gridrow="49" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1342,1356]" gridrow="50" pageId="12" pageNumber="13" rowspan-0="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1342,1356]" gridcol="1" gridrow="50" pageId="12" pageNumber="13">Pentamethoxychalcone</td>
<td box="[507,619,1342,1356]" gridcol="2" gridrow="50" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1342,1356]" gridcol="6" gridrow="50" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1364,1379]" gridrow="51" pageId="12" pageNumber="13" rowspan-4="1" rowspan-5="1">
<th box="[116,229,1364,1379]" gridcol="0" gridrow="51" pageId="12" pageNumber="13">Coumarins</th>
<td box="[266,464,1364,1379]" gridcol="1" gridrow="51" pageId="12" pageNumber="13">Safficinolide</td>
<td box="[507,619,1364,1379]" gridcol="2" gridrow="51" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1364,1378]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1364,1379]" gridcol="3" gridrow="51" pageId="12" pageNumber="13">6.3 kcal/mol</td>
<td box="[1322,1471,1364,1379]" gridcol="6" gridrow="51" pageId="12" pageNumber="13">Rahman et al.</td>
</tr>
<tr box="[116,1471,1388,1402]" gridrow="52" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,1388,1402]" gridcol="2" gridrow="52" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1388,1402]" gridcol="6" gridrow="52" pageId="12" pageNumber="13">(2021)</td>
</tr>
<tr box="[116,1471,1410,1425]" gridrow="53" pageId="12" pageNumber="13" rowspan-4="1" rowspan-5="1">
<th box="[116,229,1410,1425]" gridcol="0" gridrow="53" pageId="12" pageNumber="13">Alkaloids</th>
<td box="[266,464,1410,1425]" gridcol="1" gridrow="53" pageId="12" pageNumber="13">
Canthin-6-one 9- 
<emphasis bold="true" box="[393,405,1410,1424]" italics="true" pageId="12" pageNumber="13">O</emphasis>
-beta-
</td>
<td box="[507,619,1410,1425]" gridcol="2" gridrow="53" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1410,1424]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1410,1425]" gridcol="3" gridrow="53" pageId="12" pageNumber="13">12.26</td>
<td box="[1322,1471,1410,1425]" gridcol="6" gridrow="53" pageId="12" pageNumber="13">Qamar et al. (2019)</td>
</tr>
<tr box="[116,1471,1433,1447]" gridrow="54" pageId="12" pageNumber="13" rowspan-0="1" rowspan-3="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[266,464,1433,1447]" gridcol="1" gridrow="54" pageId="12" pageNumber="13">glucopyranoside</td>
<td box="[507,619,1433,1447]" gridcol="2" gridrow="54" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
</tr>
<tr box="[116,1471,1456,1471]" gridrow="55" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1456,1471]" gridcol="1" gridrow="55" pageId="12" pageNumber="13">3,4-Dehydro-5-</td>
<td box="[507,619,1456,1471]" gridcol="2" gridrow="55" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1456,1470]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1456,1471]" gridcol="3" gridrow="55" pageId="12" pageNumber="13">131.6 kJ/mol</td>
<td box="[1322,1471,1456,1471]" gridcol="6" gridrow="55" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1479,1493]" gridrow="56" pageId="12" pageNumber="13" rowspan-0="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1479,1493]" gridcol="1" gridrow="56" pageId="12" pageNumber="13">carboxystrictosidine</td>
<td box="[507,619,1479,1493]" gridcol="2" gridrow="56" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1479,1493]" gridcol="6" gridrow="56" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1502,1516]" gridrow="57" pageId="12" pageNumber="13" rowspan-0="1" rowspan-2="1" rowspan-3="1" rowspan-4="1" rowspan-5="1" rowspan-6="1">
<td box="[266,464,1502,1516]" gridcol="1" gridrow="57" pageId="12" pageNumber="13">(aglycone)</td>
</tr>
<tr box="[116,1471,1523,1539]" gridrow="58" pageId="12" pageNumber="13" rowspan-4="1" rowspan-5="1">
<th box="[116,229,1523,1539]" gridcol="0" gridrow="58" pageId="12" pageNumber="13">Stilbenoid</th>
<td box="[266,464,1523,1539]" gridcol="1" gridrow="58" pageId="12" pageNumber="13">
3-Acetoxy-4 
<emphasis box="[357,361,1523,1531]" italics="true" pageId="12" pageNumber="13">′</emphasis>
,5-dihydroxy-
</td>
<td box="[507,619,1523,1539]" gridcol="2" gridrow="58" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1524,1538]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1523,1539]" gridcol="3" gridrow="58" pageId="12" pageNumber="13">139.8 kJ/mol</td>
<td box="[1322,1471,1523,1539]" gridcol="6" gridrow="58" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1546,1562]" gridrow="59" pageId="12" pageNumber="13" rowspan-0="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1546,1562]" gridcol="1" gridrow="59" pageId="12" pageNumber="13">
3 
<emphasis box="[276,280,1546,1554]" italics="true" pageId="12" pageNumber="13">′</emphasis>
-prenyldihydrostilbene
</td>
<td box="[507,619,1546,1562]" gridcol="2" gridrow="59" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1546,1562]" gridcol="6" gridrow="59" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1570,1585]" gridrow="60" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1570,1585]" gridcol="1" gridrow="60" pageId="12" pageNumber="13">Licobenzofuran</td>
<td box="[507,619,1570,1585]" gridcol="2" gridrow="60" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1570,1584]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1570,1585]" gridcol="3" gridrow="60" pageId="12" pageNumber="13">141.6 kJ/mol</td>
<td box="[1322,1471,1570,1585]" gridcol="6" gridrow="60" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1593,1607]" gridrow="61" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,1593,1607]" gridcol="2" gridrow="61" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1593,1607]" gridcol="6" gridrow="61" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1614,1631]" gridrow="62" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1614,1631]" gridcol="1" gridrow="62" pageId="12" pageNumber="13">
3,3 
<emphasis box="[290,294,1614,1622]" italics="true" pageId="12" pageNumber="13">′</emphasis>
,4,5 
<emphasis box="[323,327,1614,1622]" italics="true" pageId="12" pageNumber="13">′</emphasis>
-Tetrahydroxy-5-
</td>
<td box="[507,619,1614,1631]" gridcol="2" gridrow="62" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1616,1630]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1614,1631]" gridcol="3" gridrow="62" pageId="12" pageNumber="13">143.6 kJ/mol</td>
<td box="[1322,1471,1614,1631]" gridcol="6" gridrow="62" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1639,1653]" gridrow="63" pageId="12" pageNumber="13" rowspan-0="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1639,1653]" gridcol="1" gridrow="63" pageId="12" pageNumber="13">prenylbibenzyl</td>
<td box="[507,619,1639,1653]" gridcol="2" gridrow="63" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1639,1653]" gridcol="6" gridrow="63" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1660,1676]" gridrow="64" pageId="12" pageNumber="13" rowspan-0="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1660,1676]" gridcol="1" gridrow="64" pageId="12" pageNumber="13">
3,3 
<emphasis box="[290,294,1660,1668]" italics="true" pageId="12" pageNumber="13">′</emphasis>
,5 
<emphasis box="[309,313,1660,1668]" italics="true" pageId="12" pageNumber="13">′</emphasis>
-Trihydroxy-4-
</td>
<td box="[507,619,1660,1676]" gridcol="2" gridrow="64" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1661,1675]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1660,1676]" gridcol="3" gridrow="64" pageId="12" pageNumber="13">141.2 kJ/mol</td>
<td box="[1322,1471,1660,1676]" gridcol="6" gridrow="64" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1684,1699]" gridrow="65" pageId="12" pageNumber="13" rowspan-0="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[266,464,1684,1699]" gridcol="1" gridrow="65" pageId="12" pageNumber="13">methoxy-5-prenylbibenzyl</td>
<td box="[507,619,1684,1699]" gridcol="2" gridrow="65" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1684,1699]" gridcol="6" gridrow="65" pageId="12" pageNumber="13">(2016)</td>
</tr>
<tr box="[116,1471,1707,1722]" gridrow="66" pageId="12" pageNumber="13" rowspan-4="1" rowspan-5="1">
<th box="[116,229,1707,1722]" gridcol="0" gridrow="66" pageId="12" pageNumber="13">Iridoid</th>
<td box="[266,464,1707,1722]" gridcol="1" gridrow="66" pageId="12" pageNumber="13">Nishindaside (aglycone)</td>
<td box="[507,619,1707,1722]" gridcol="2" gridrow="66" pageId="12" pageNumber="13">
<emphasis bold="true" box="[507,563,1707,1721]" italics="true" pageId="12" pageNumber="13">In-silico</emphasis>
(DENV
</td>
<td box="[659,883,1707,1722]" gridcol="3" gridrow="66" pageId="12" pageNumber="13">137.7 kJ/mol</td>
<td box="[1322,1471,1707,1722]" gridcol="6" gridrow="66" pageId="12" pageNumber="13">Powers and Setzer</td>
</tr>
<tr box="[116,1471,1730,1744]" gridrow="67" pageId="12" pageNumber="13" rowspan-0="1" rowspan-1="1" rowspan-3="1" rowspan-4="1" rowspan-5="1">
<td box="[507,619,1730,1744]" gridcol="2" gridrow="67" pageId="12" pageNumber="13">NS2b/NS3pro)</td>
<td box="[1322,1471,1730,1744]" gridcol="6" gridrow="67" pageId="12" pageNumber="13">(2016)</td>
</tr>
</table>
</paragraph>
<paragraph blockId="12.[100,770,1799,1957]" pageId="12" pageNumber="13">
In a study by Panya and co-workers in 2019, thirty-three Thai medicinal plants were extracted for their peptides and assayed against DENV2 in Vero cells. Results showed six plant-derived peptide extracts from 
<taxonomicName _evidence="catalogs" _step="species1" box="[150,336,1882,1901]" class="Magnoliopsida" family="Acanthaceae" genus="Thunbergia" kingdom="Plantae" order="Lamiales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="species" species="laurifolia">
<emphasis bold="true" box="[150,336,1882,1901]" italics="true" pageId="12" pageNumber="13">Thunbergia laurifolia</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[415,536,1882,1901]" class="Magnoliopsida" family="Acanthaceae" kingdom="Plantae" order="Lamiales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="family">Acanthaceae</taxonomicName>
), 
<taxonomicName _evidence="catalogs" _step="species1" box="[553,697,1882,1901]" class="Magnoliopsida" family="Ebenaceae" genus="Diospyros" kingdom="Plantae" order="Ericales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="species" species="mollis">
<emphasis bold="true" box="[553,697,1882,1901]" italics="true" pageId="12" pageNumber="13">Diospyros mollis</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[100,201,1910,1929]" class="Magnoliopsida" family="Ebenaceae" kingdom="Plantae" order="Ericales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="family">Ebenaceae</taxonomicName>
), 
<taxonomicName _evidence="catalogs" _step="species1" box="[222,443,1910,1929]" class="Magnoliopsida" family="Acanthaceae" genus="Andrographis" kingdom="Plantae" order="Lamiales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="species" species="paniculata">
<emphasis bold="true" box="[222,443,1910,1929]" italics="true" pageId="12" pageNumber="13">Andrographis paniculata</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[530,651,1910,1929]" class="Magnoliopsida" family="Acanthaceae" kingdom="Plantae" order="Lamiales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="family">Acanthaceae</taxonomicName>
), 
<taxonomicName _evidence="catalogs" _step="species1" class="Magnoliopsida" family="Fabaceae" genus="Senna" kingdom="Plantae" order="Fabales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="species" species="garrettiana">
<emphasis bold="true" italics="true" pageId="12" pageNumber="13">Senna garrettiana</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="label" _step="labeledHigher" box="[250,377,1938,1957]" class="Magnoliopsida" family="Leguminosae" higherTaxonomySource="GBIF" kingdom="Plantae" order="Fabales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="family">Leguminosae</taxonomicName>
), and 
<taxonomicName _evidence="catalogs" _step="species1" box="[434,568,1938,1957]" class="Magnoliopsida" family="Fabaceae" genus="Acacia" kingdom="Plantae" order="Fabales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="species" species="catechu">
<emphasis bold="true" box="[434,568,1938,1957]" italics="true" pageId="12" pageNumber="13">Acacia catechu</emphasis>
</taxonomicName>
to possess the lowest
</paragraph>
<paragraph blockId="12.[818,1488,1798,1957]" lastBlockId="13.[100,771,147,1366]" lastPageId="13" lastPageNumber="14" pageId="12" pageNumber="13">
IC 
<subScript attach="left" box="[838,856,1806,1820]" fontSize="6" pageId="12" pageNumber="13">50</subScript>
’s of 1.54, 2.40, 2.31, 0.31, 0.25, and 0.18 μg/mL, respectively, at concentrations of 10 μM for the first three plants, and 1 μM for the latter three plants. These concentrations were based on the cytotoxicity of each plant and were chosen to achieve cell viability of at least 90%. Further measurements of the viral titer and foci formation showed that 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[818,923,1938,1957]" class="Magnoliopsida" family="Acanthaceae" genus="Thunbergia" kingdom="Plantae" order="Lamiales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="species" species="laurifolia">
<emphasis bold="true" box="[818,923,1938,1957]" italics="true" pageId="12" pageNumber="13">T. laurifolia</emphasis>
</taxonomicName>
and 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[969,1063,1938,1957]" class="Magnoliopsida" family="Fabaceae" genus="Acacia" kingdom="Plantae" order="Fabales" pageId="12" pageNumber="13" phylum="Tracheophyta" rank="species" species="catechu">
<emphasis bold="true" box="[969,1063,1938,1957]" italics="true" pageId="12" pageNumber="13">A. catechu</emphasis>
</taxonomicName>
could significantly act as anti-DENV2 
<emphasis bold="true" box="[1423,1487,1938,1957]" italics="true" pageId="12" pageNumber="13">in-vitro</emphasis>
in a dose-dependent manner. Remarkably, 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[503,597,147,167]" class="Magnoliopsida" family="Fabaceae" genus="Acacia" kingdom="Plantae" order="Fabales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="species" species="catechu">
<emphasis bold="true" box="[503,597,147,167]" italics="true" pageId="13" pageNumber="14">A. catechu</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[675,763,148,167]" class="Magnoliopsida" family="Fabaceae" kingdom="Plantae" order="Fabales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="family">Fabaceae</taxonomicName>
) peptide extract was found to reduce the virus titer in Vero cells by more than 100-fold at a dose of 1.25 μg/mL; thus, it was chosen for further investigations. Time-of-addition assessment showed that peptide extract of 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[126,221,259,278]" class="Magnoliopsida" family="Fabaceae" genus="Acacia" kingdom="Plantae" order="Fabales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="species" species="catechu">
<emphasis bold="true" box="[126,221,259,278]" italics="true" pageId="13" pageNumber="14">A. catechu</emphasis>
</taxonomicName>
was able to inhibit DENV infection only when given as a pre- or co-infection treatment by 1000- and 10-fold reduction in virus titer, respectively.
</paragraph>
<paragraph blockId="13.[100,771,147,1366]" pageId="13" pageNumber="14">
These interesting findings of 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[419,517,343,362]" class="Magnoliopsida" family="Fabaceae" genus="Acacia" kingdom="Plantae" order="Fabales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="species" species="catechu">
<emphasis bold="true" box="[419,517,343,362]" italics="true" pageId="13" pageNumber="14">A. catechu</emphasis>
</taxonomicName>
’s peptide extract allowed them to explore the DENV-inhibitory activity of this extract towards four serotypes of DENV (DENV1-4). The inhibitory activity was most potent in DENV3, while the least inhibitory effect was seen in DENV2. Four peptides, 15-amino acids in length, were characterised and identified in the 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[135,228,482,501]" class="Magnoliopsida" family="Fabaceae" genus="Acacia" kingdom="Plantae" order="Fabales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="species" species="catechu">
<emphasis bold="true" box="[135,228,482,501]" italics="true" pageId="13" pageNumber="14">A. catechu</emphasis>
</taxonomicName>
peptide extract using HPLC and LC-MS/MS (structures not shown). All four peptides were found to share the same N-terminus sequence of ASP–HIS–VAL-THR-PRO-ASP-ILE-ALA-TYR-ASN-PRO, which is thought to be a feature responsible for their activity as antiDENV. Moreover, confirmational anti-DENV testing of these isolated peptides was conducted. No signs of cytotoxicity have been noticed at doses between 0.01 μM and 1 mM. Only two peptides were found to be responsible for the anti-DENV activity, which was judged by measuring foci reduction (Panya et al., 2019).
</paragraph>
<paragraph blockId="13.[100,771,147,1366]" pageId="13" pageNumber="14">
Results of Panya et al. showed a broader focus on natural-sourced isolated peptides and proteins, which are believed to be the future of medicine, instead of looking only at small molecules. However, further assessment is required to study the target of these peptides and how they act and behave on a molecular level. Thus, further initiatives with these peptides can be undertaken for 
<emphasis bold="true" box="[399,459,873,892]" italics="true" pageId="13" pageNumber="14">in-vivo</emphasis>
or through clinical trials.
</paragraph>
<paragraph blockId="13.[100,771,147,1366]" pageId="13" pageNumber="14">In the same study of Kutumbarao in 2016, they investigated the activity of two fish-isolated tetra-reverse-peptides; SER-MET–HIS–GLY and GLY–HIS–MET-SER (structures not shown). Through induced-fit molecular docking, their binding energies were found to be 79.9 and</paragraph>
<paragraph blockId="13.[100,771,147,1366]" pageId="13" pageNumber="14">73.4 kcal/mol, respectively. Both peptides possessed hydrogen bond interactions with HIS and SER residues while maintaining non-bonded interactions with other residues at the binding pocket. Additionally, both peptides were found to interact with both chains of the protease; NS2b and NS3, with a binding conformation that is very similar to that of the co-crystallised control molecule. Molecular dynamics studies of the peptides revealed a consistent binding throughout the whole 30 ns of simulations (Kutumbarao and Velmurugan, 2016).</paragraph>
<paragraph blockId="13.[100,771,147,1366]" pageId="13" pageNumber="14">It can be concluded that naturally isolated inhibitors of DENV2 NS2b/NS3pro are not limited to plant sources. This provides the opportunity to search for other phytochemicals and peptides or proteins from animal and marine sources that can interact with the protease to disturb and inhibit its integrity and activity.</paragraph>
<paragraph blockId="13.[100,539,1405,1424]" box="[100,539,1405,1424]" pageId="13" pageNumber="14">
<emphasis bold="true" box="[100,539,1405,1424]" pageId="13" pageNumber="14">4. Dietary supplements and nutraceuticals</emphasis>
</paragraph>
<paragraph blockId="13.[100,770,1460,1982]" pageId="13" pageNumber="14">
Although herbal remedies and folklore medicine still have a great influence in many cultures around the world, there is no herbal medicine or supplement that has been developed and approved for the treatment and management of DENV infections (Trujillo-Correa et al., 2019; Dhiman et al., 2022). Still, many of the aforementioned phytochemicals have already been standardised and commercially available for various indications and not specifically for DENV infections. This agrees with our personal communication with a number of community pharmacies (Penang, Malaysia – July 2022) that DENV-infected people can alleviate some of their symptoms and strengthen their immune systems via a group of micronutrients (zinc, vitamin C, and vitamin D) and sometimes by using some of the commercially available herbal supplements, which include papaya leaf extracts, 
<taxonomicName _evidence="catalogs" _step="species1" box="[391,576,1795,1814]" class="Agaricomycetes" family="Ganodermataceae" genus="Ganoderma" kingdom="Fungi" order="Polyporales" pageId="13" pageNumber="14" phylum="Basidiomycota" rank="species" species="lucidum">
<emphasis bold="true" box="[391,576,1795,1814]" italics="true" pageId="13" pageNumber="14">Ganoderma lucidum</emphasis>
</taxonomicName>
extracts, curcumin, berberine, and resveratrol. Additionally, grapefruit seed extract that is rich in flavonoids (especially naringenin) is also being used for the management of DENV infections in some countries based on evidence published earlier in 2017 (Frabasile et al., 2017).
</paragraph>
<paragraph blockId="13.[100,770,1460,1982]" lastBlockId="13.[818,1488,148,1980]" pageId="13" pageNumber="14">
A recent article by NutraIngredients-Asia was published announcing that a nutraceutical and functional food company from New Zealand was planning to launch their papaya supplement that is to be used as an adjunctive treatment of DENV infections. The supplement is extracted from the papaya variant 
<emphasis box="[1071,1195,203,223]" italics="true" pageId="13" pageNumber="14">
“ 
<emphasis bold="true" box="[1082,1182,203,222]" italics="true" pageId="13" pageNumber="14">Wakatengu</emphasis>
”
</emphasis>
which is known for its high content of polyphenols and micronutrients (Koe, 2021). Moreover, another study was published recently claiming the formulation tablets of 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[818,912,287,306]" class="Magnoliopsida" family="Caricaceae" genus="Carica" kingdom="Plantae" order="Brassicales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="species" species="papaya">
<emphasis bold="true" box="[818,912,287,306]" italics="true" pageId="13" pageNumber="14">C. papaya</emphasis>
</taxonomicName>
and 
<taxonomicName _evidence="catalogs" _step="species1" box="[966,1121,287,306]" class="Magnoliopsida" family="Burseraceae" genus="Boswellia" kingdom="Plantae" order="Sapindales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="species" species="serrata">
<emphasis bold="true" box="[966,1121,287,306]" italics="true" pageId="13" pageNumber="14">Boswellia serrata</emphasis>
</taxonomicName>
(family 
<taxonomicName _evidence="catalogs" _step="family" box="[1207,1322,287,306]" class="Magnoliopsida" family="Burseraceae" kingdom="Plantae" order="Sapindales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="family">Burseraceae</taxonomicName>
) extracts for the management of DENV infections. 
<emphasis bold="true" box="[1156,1221,315,334]" italics="true" pageId="13" pageNumber="14">In-vitro</emphasis>
assessment of the tablets’ content release revealed 96.61% and 97.22% was released of each plant extract, respectively, at 120 min (Bhatia and Pansare, 2021). Noteworthy, 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[897,984,399,418]" class="Magnoliopsida" family="Burseraceae" genus="Boswellia" kingdom="Plantae" order="Sapindales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="species" species="serrata">
<emphasis bold="true" box="[897,984,399,418]" italics="true" pageId="13" pageNumber="14">B. serrata</emphasis>
</taxonomicName>
is known for preventing thrombocytopenia due to its boswellic acid content (Tawfik, 2016).
</paragraph>
<paragraph blockId="13.[818,1488,148,1980]" pageId="13" pageNumber="14">
These formulations of 
<taxonomicName _evidence="catalog+fontStyle" _step="styledSpecies" box="[1058,1148,454,474]" class="Magnoliopsida" family="Caricaceae" genus="Carica" kingdom="Plantae" order="Brassicales" pageId="13" pageNumber="14" phylum="Tracheophyta" rank="species" species="papaya">
<emphasis bold="true" box="[1058,1148,454,474]" italics="true" pageId="13" pageNumber="14">C. papaya</emphasis>
</taxonomicName>
leaf extracts and their use for DENV management can be attributed to the clinical study that was conducted in south India on 100 patients with confirmed cases of DENV infections to assess the effects of 1500 mg per day, peroral, of papaya leaf extract (formulated as capsules) on their medical condition. Results showed a significant increase in platelet count and a reduced need for platelet transfusion in the study group. Except for some gastrointestinal disturbances, no significant side effects were noticed (Adarsh et al., 2017). A similar finding was seen in another clinical study with thirty DENV-infected children (age 1–16 years old) where the dosage regimen was between 825 and 3300 mg per day, according to the child’ s age, for five days (Shetty et al., 2019). Although these studies showed a potential anti-DENV activity of papaya leaves, more research is required to monitor the effectiveness of different dosage regimens and to assess the possible acute and chronic adverse effects of papaya leaves’ extracts on the human body on an extended duration of treatment. In addition, more studies are required to isolate and investigate other active components which might contribute to the anti-DENV activity of papaya leaves.
</paragraph>
<paragraph blockId="13.[818,1488,148,1980]" pageId="13" pageNumber="14">
In contrast, andrographolide was reported for its extremely poor solubility in acidic and alkaline aqueous environments, which impacts its bioavailability if administered orally (Malarvizhi, 2019). This has led to the formulation of various pharmaceutical preparations, including microspheres, microemulsion, liposomes, niosomes, and nanoparticles, and were reviewed recently by Adiguna and co-workers (Adiguna et al., 2021). Similarly, curcumin was reported for its poor solubility and rapid hydrolysis which makes it also of low bioavailability. Many efforts were taken to formulate curcumin into a suitable oral formulation. In light of the current topic, a research paper was published in 2020 claiming the encapsulation of curcumin in a nanoemulsion that is targeted against DENV. Results showed that nano-formulated curcumin exhibited higher 
<emphasis bold="true" box="[818,882,1291,1310]" italics="true" pageId="13" pageNumber="14">in-vitro</emphasis>
cytotoxicity which was referred to the higher cellular uptake of the active compound. Regardless, no significant difference was noticed between the nano-formula and curcumin solution in supressing DENV infectivity and replication where curcumin was shown to be mostly effective against DENV1 and DENV2 serotypes (Nabila et al., 2020).
</paragraph>
<paragraph blockId="13.[818,1488,148,1980]" pageId="13" pageNumber="14">Furthermore, although herbal supplements are available commercially as adjunctive options for the management of varssious symptoms and conditions, the regulations and quality control measurements are not as strict as chemically synthesised drugs (Balekundri and Mannur, 2020). Herbal medicines are usually taken without enough supervision and in inconsistent concentration. This can highly impact the efficacy and safety of herbal preparations due to the presence of contaminants and other biologically active phytochemicals, especially in the case of crude extracts, which might be carcinogenic, mutagenic, or genotoxic (van Wyk and Prinsloo, 2020). Most importantly, people taking herbal medicines in conjunction with their medicines for the management of various health conditions are usually not paying enough attention towards the possible herb-drug interactions which might occur (Brantley et al., 2014). Therefore, regulations for herbal medicines are essential to minimise the discrepancies in the methods followed to prepare, formulate, and advertise for herbal products, which would ensure quality, safety, and efficacy of the final product (Sahoo et al., 2010).</paragraph>
<paragraph blockId="13.[818,1488,148,1980]" lastBlockId="14.[100,771,148,725]" lastPageId="14" lastPageNumber="15" pageId="13" pageNumber="14">In 2004, guidelines for the regulation of herbal medicines in the South-East Asia Region were put. These guidelines classified herbal medicines into four categories; indigenous herbal medicines, herbal medicines in systems, modified herbal medicines, and imported products with a herbal medicine base. For each category, the minimum requirements for assessment of safety and efficacy of herbal medicines were specified. On one hand, major safety concerns which shall be provided as part of the regulations to commercialise a herbal medicine include acute and long-term toxicities, organ-targeted toxicity, immunotoxicity, embryo/fetal and prenatal toxicity, mutagenicity/genotoxicity, and carcinogenicity. On the other hand, these guidelines specified the quality assurance, pharmacovigilance, and control of advertisements for any herbal medicinal product (WHO, 2004). Later in 2006, the International Regulatory Cooperation for Herbal Medicines (IRCH) global network was established by members representing sixteen countries. IRCH aims to maintain the quality and safety of herbal medicines through improved regulations. By 2017, the total number of IRCH members became thirty-four, including thirty-one countries and three regional and sub-regional parties, which include the Association of Southeast Asian Nations, the European Medicines Agency, and the Latin American Parliament (WHO, 2022). A comprehensive and detailed summary of the regulations of herbal and complementary medicines was published earlier, covering all regions and countries around the globe (Reddy and Alex, 2017).</paragraph>
<paragraph blockId="14.[100,584,763,782]" box="[100,584,763,782]" pageId="14" pageNumber="15">
<emphasis bold="true" box="[100,584,763,782]" pageId="14" pageNumber="15">5. Concluding remarks and future perspectives</emphasis>
</paragraph>
<paragraph blockId="14.[100,771,819,1982]" pageId="14" pageNumber="15">
Nature is a rich source of natural compounds that can be used to manage various ailments and infectious diseases. This review has described the recent discoveries in anti-DENV potentials of recently reported isolated phytochemicals and peptides. Except for very few, these isolated natural products were tested against DENV NS2b/NS3pro. Their testing included mostly 
<emphasis bold="true" box="[406,475,958,977]" italics="true" pageId="14" pageNumber="15">in-silico</emphasis>
and 
<emphasis bold="true" box="[533,597,958,977]" italics="true" pageId="14" pageNumber="15">in-vitro</emphasis>
experimentation. Thus, more investigations are required towards the compounds which were not verified for their type of inhibitory activity and their molecular target.
</paragraph>
<paragraph blockId="14.[100,771,819,1982]" pageId="14" pageNumber="15">
On the other hand, most of the reported isolated compounds are flavonoids, which show great potentials (except for rutin) to be developed and studied further as DENV protease inhibitors. Quercetin, curcumin, and myricetin were found to act as non-competitive allosteric inhibitors of the protease, raising a massive question about the activity of the flavonoids chemical scaffold as if they all act as non-competitive DENV protease inhibitors. This question can be answered by studying the (quantitative)-structure-activity relationship of compounds of this phytochemical class. Only two compounds were isolated from nature for the first time and were identified as anti-DENV; which include a flavanone glycoside from 
<taxonomicName _evidence="catalogs" _step="species1" box="[296,460,1349,1368]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="14" pageNumber="15" phylum="Tracheophyta" rank="species" species="bahiensis">
<emphasis bold="true" box="[296,460,1349,1368]" italics="true" pageId="14" pageNumber="15">Faramea bahiensis</emphasis>
</taxonomicName>
, and a benzofuranone derivative from 
<taxonomicName _evidence="catalogs" _step="species1" box="[154,332,1376,1395]" class="Magnoliopsida" family="Lauraceae" genus="Endiandra" kingdom="Plantae" order="Laurales" pageId="14" pageNumber="15" phylum="Tracheophyta" rank="species" species="kingiana">
<emphasis bold="true" box="[154,332,1376,1395]" italics="true" pageId="14" pageNumber="15">Endiandra kingiana</emphasis>
</taxonomicName>
, which kinetically are still to be determined whether they are competitive or non-competitive inhibitors. This type of study can be achieved through studying their 
<emphasis bold="true" box="[536,600,1432,1451]" italics="true" pageId="14" pageNumber="15">in-vitro</emphasis>
inhibition behaviour with various concentrations of the compounds at multiple concentrations of the substrate. Additionally, molecular dynamics simulations would provide a tremendous contribution to investigate the behaviour of these molecules when bound to the protease and at which binding pocket they would bind with higher affinity.
</paragraph>
<paragraph blockId="14.[100,771,819,1982]" lastBlockId="14.[818,1488,148,641]" pageId="14" pageNumber="15">
The three fatty acids which were studied and discussed recently, their results are still not conclusive. This was concluded as, up to our knowledge, they were not studied as pure isolated chemical entities, and they were only investigated 
<emphasis bold="true" box="[363,432,1683,1702]" italics="true" pageId="14" pageNumber="15">in-silico</emphasis>
and 
<emphasis bold="true" box="[477,541,1684,1703]" italics="true" pageId="14" pageNumber="15">in-vitro</emphasis>
as part of crude extracts from 
<taxonomicName _evidence="catalogs" _step="species1" box="[154,307,1711,1730]" class="Magnoliopsida" family="Myrtaceae" genus="Syzygium" kingdom="Plantae" order="Myrtales" pageId="14" pageNumber="15" phylum="Tracheophyta" rank="species" species="grande">
<emphasis bold="true" box="[154,307,1711,1730]" italics="true" pageId="14" pageNumber="15">Syzygium grande</emphasis>
</taxonomicName>
and 
<taxonomicName _evidence="catalogs" _step="species1" box="[360,547,1711,1730]" class="Magnoliopsida" family="Sapindaceae" genus="Lepisanthes" kingdom="Plantae" order="Sapindales" pageId="14" pageNumber="15" phylum="Tracheophyta" rank="species" species="fruticosa">
<emphasis bold="true" box="[360,547,1711,1730]" italics="true" pageId="14" pageNumber="15">Lepisanthes fruticosa</emphasis>
</taxonomicName>
. However, eugeniin (a glucoside) was the most potent with an IC 
<subScript attach="left" box="[487,505,1746,1760]" fontSize="6" pageId="14" pageNumber="15">50</subScript>
in the nanoscale. This might be influenced by the large molecular weight of eugeniin in comparison to the other recently reported glucosides and the abundance of the hydroxyl groups that act as hydrogen bond donors. These reasons can also apply for the interesting DENV inhibitory activities of some phenolic compounds including tatanan A (for its relatively large molecular weight), and resveratrol, anacardic acid, and cardol triene (for the presence of the hydrogen bond donors in their chemical structures). Moreover, building a pharmacophore using the chemical scaffold of the two diterpenoids (stachyonic acid A and andrographolide) can be an interesting starting point to screen libraries and databases for compounds which can match the pharmacophore and test them for their cytotoxicities and anti-DENV activities.
</paragraph>
<paragraph blockId="14.[818,1488,148,641]" pageId="14" pageNumber="15">
Still, a greater focus is highly encouraged towards tannins, alkaloids, stilbenoids, and coumarins of natural sources. Moreover, derivatives of these natural products can be designed and synthesised, which could enhance their specificity and efficacy towards the protease. Further investigations are also encouraged using cardol triene, tatanan A, pongamol, gedunin, and melatonin towards DENV NS2b/NS3pro as they were only investigated on other viral targets or without specifying a molecular target, according to our knowledge. Noteworthy, natural isolated peptides that were recently tested include four peptides from 
<taxonomicName _evidence="catalogs" _step="species1" box="[818,953,510,529]" class="Magnoliopsida" family="Fabaceae" genus="Acacia" kingdom="Plantae" order="Fabales" pageId="14" pageNumber="15" phylum="Tracheophyta" rank="species" species="catechu">
<emphasis bold="true" box="[818,953,510,529]" italics="true" pageId="14" pageNumber="15">Acacia catechu</emphasis>
</taxonomicName>
and two from fish. Most of the studies described in this review were conducted using natural products from plant extracts. Nevertheless, other sources of natural products, such as fungi, bacterial toxins, marine organisms, and animals, should also be explored towards discovering DENV NS2b/NS3pro inhibitors.
</paragraph>
<paragraph blockId="14.[818,1058,679,699]" box="[818,1058,679,699]" pageId="14" pageNumber="15">
<emphasis bold="true" box="[818,1058,679,699]" pageId="14" pageNumber="15">6. Design and methods</emphasis>
</paragraph>
<paragraph blockId="14.[818,1488,735,1145]" pageId="14" pageNumber="15">
Our review was designed to cover the recent advance in discovering the efficacy of natural products in the management of DENV infection with a special emphasis towards its protease; NS2b/NS3pro. Throughout the conducted work, PubMed, ScienceDirect, and Google Scholar were searched with the following keywords: “natural products”; “polyphenols”; “flavonoids”; terpenes”; “peptides”; “dengue”; “dengue protease”; “protease inhibitors”; “NS2b-NS3pro”; and “ 
<emphasis bold="true" box="[1390,1472,902,921]" italics="true" pageId="14" pageNumber="15">flavivirus</emphasis>
”. Databases were searched between November 2021 and April 2022 for research papers published in 2017 and later. Only English research papers were included in the current review as long as they are within the topic of interest. Published work primarily focused on synthesised derivatives from natural products was excluded. Moreover, scientific papers discussing the activity of natural products on DENV infections on other molecular targets were minimised to keep the general focus of the current review towards protease inhibitors.
</paragraph>
<paragraph blockId="14.[818,1049,1183,1202]" box="[818,1049,1183,1202]" pageId="14" pageNumber="15">
<emphasis bold="true" box="[818,1049,1183,1202]" pageId="14" pageNumber="15">Authors’ contributions</emphasis>
</paragraph>
<paragraph blockId="14.[818,1488,1239,1342]" pageId="14" pageNumber="15">Conceptualization, H.A.W. and F.G.S.; writing-original draft preparation, F.G.S. and M.A.A.; writing-review and editing, M.A.A., H.A.W. and F.G.S.; illustrations, F.G.S.; supervision, H.A.W.; project administration, H.A.W.</paragraph>
<paragraph blockId="14.[818,1160,1385,1404]" box="[818,1160,1385,1404]" pageId="14" pageNumber="15">
<emphasis bold="true" box="[818,1160,1385,1404]" pageId="14" pageNumber="15">Declaration of competing interest</emphasis>
</paragraph>
<paragraph blockId="14.[818,1488,1441,1517]" pageId="14" pageNumber="15">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</paragraph>
<paragraph blockId="14.[818,987,1553,1572]" box="[818,987,1553,1572]" pageId="14" pageNumber="15">
<emphasis bold="true" box="[818,987,1553,1572]" pageId="14" pageNumber="15">Data availability</emphasis>
</paragraph>
<paragraph blockId="14.[849,1400,1609,1628]" box="[849,1400,1609,1628]" pageId="14" pageNumber="15">No data was used for the research described in the article.</paragraph>
<paragraph blockId="14.[818,1005,1666,1685]" box="[818,1005,1666,1685]" pageId="14" pageNumber="15">
<emphasis bold="true" box="[818,1005,1666,1685]" pageId="14" pageNumber="15">Acknowledgement</emphasis>
</paragraph>
<paragraph blockId="14.[818,1487,1722,1769]" box="[849,1487,1722,1741]" pageId="14" pageNumber="15">This work was published with the support of Universiti Sains</paragraph>
<paragraph blockId="14.[818,1487,1722,1769]" box="[818,1352,1750,1769]" pageId="14" pageNumber="15">Malaysia (Grant No.: FRGS/1/2021/SKK0/USM/02/40).</paragraph>
<paragraph blockId="14.[818,928,1807,1826]" box="[818,928,1807,1826]" pageId="14" pageNumber="15">
<emphasis bold="true" box="[818,928,1807,1826]" pageId="14" pageNumber="15">References</emphasis>
</paragraph>
<paragraph blockId="14.[818,1482,1860,1981]" pageId="14" pageNumber="15">Abd Kadir, S.L., Yaakob, H., Mohamed Zulkifli, R., 2013. Potential anti-dengue medicinal plants: a review. J. Nat. Med. 67 (4), 677–689. https://doi.org/10.1007/s11418- 013-0767-y.</paragraph>
<paragraph blockId="14.[818,1482,1860,1981]" pageId="14" pageNumber="15">
Adarsh, V.B., Doddamane, K., Kumar, V.D., 2017. Role of 
<taxonomicName _evidence="catalogs" _step="species1" box="[1260,1365,1924,1938]" class="Magnoliopsida" family="Caricaceae" genus="Carica" kingdom="Plantae" order="Brassicales" pageId="14" pageNumber="15" phylum="Tracheophyta" rank="species" species="papaya">
<emphasis bold="true" box="[1260,1365,1924,1938]" italics="true" pageId="14" pageNumber="15">Carica papaya</emphasis>
</taxonomicName>
leaf product in improving the platelet count in patients with dengue fever. Int. J. Res. Med. Sci. 6 (2), 63–68.
</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Adiguna, S.b.P., Panggabean, J.A., Atikana, A., Untari, F., Izzati, F., Bayu, A., Rosyidah, A.l., Rahmawati, S.I., Putra, M.Y., 2021. Antiviral activities of andrographolide and its derivatives: mechanism of action and delivery system. Pharmaceuticals 14 (11), 1102. https://doi.org/10.3390/ph14111102.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Ahmadi, A., Hassandarvish, P., Lani, R., Yadollahi, P., Jokar, A., Bakar, S.A., Zandi, K., 2016. Inhibition of chikungunya virus replication by hesperetin and naringenin. RSC Adv. 6 (73), 69421–69430. https://doi.org/10.1039/C6RA16640G.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Alkuriji, M.A., Al-Fageeh, M.B., Shaher, F.M., Almutairi, B.F., 2020. Dengue vector control: a review for wolbachia-based strategies. Biosci. Biotechnol. Res. Asia 17 (3), 507–515. https://doi.org/10.13005/bbra/2854.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">
Alomair, L., Almsned, F., Ullah, A., Jafri, M.S., 2021. 
<emphasis bold="true" box="[510,566,361,375]" italics="true" pageId="15" pageNumber="16">In silico</emphasis>
prediction of the phosphorylation of NS3 as an essential mechanism for dengue virus replication and the antiviral activity of quercetin. Biology 10 (10), 1067. https://doi.org/10.3390/ biology10101067.
</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">
AlSalhi, M.S., Elumalai, K., Devanesan, S., Govindarajan, M., Krishnappa, K., Maggi, F., 2020. The aromatic ginger 
<taxonomicName _evidence="catalogs" _step="species1" box="[335,477,467,481]" class="Liliopsida" family="Zingiberaceae" genus="Kaempferia" kingdom="Plantae" order="Zingiberales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="species" species="galanga">
<emphasis bold="true" box="[335,477,467,481]" italics="true" pageId="15" pageNumber="16">Kaempferia galanga</emphasis>
</taxonomicName>
L. (
<taxonomicName _evidence="catalogs" _step="family" authorityName="Martinov" authorityYear="1820" box="[504,612,467,481]" class="Liliopsida" family="Zingiberaceae" kingdom="Plantae" order="Zingiberales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="family">Zingiberaceae</taxonomicName>
) essential oil and its main compounds are effective larvicidal agents against 
<taxonomicName _evidence="catalogs" _step="species1" baseAuthorityName="Bigot" baseAuthorityYear="1861" box="[555,654,488,502]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="15" pageNumber="16" phylum="Arthropoda" rank="species" species="vittatus">
<emphasis bold="true" box="[555,654,488,502]" italics="true" pageId="15" pageNumber="16">Aedes vittatus</emphasis>
</taxonomicName>
and 
<taxonomicName _evidence="catalogs" _step="species1" authorityName="Theobald" authorityYear="1901" class="Insecta" family="Culicidae" genus="Anopheles" kingdom="Animalia" order="Diptera" pageId="15" pageNumber="16" phylum="Arthropoda" rank="species" species="maculatus">
<emphasis bold="true" italics="true" pageId="15" pageNumber="16">Anopheles maculatus</emphasis>
</taxonomicName>
without toxicity on the non-target aquatic fauna. Ind. Crop. Prod. 158, 113012 https://doi.org/10.1016/j.indcrop.2020.113012.
</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Aryati, A., Wrahatnala, B.J., Yohan, B., Fanny, M., Hakim, F.K.N., Sunari, E.P., Zuroidah, N., Wardhani, P., Santoso, M.S., Husada, D., 2020. Dengue virus serotype 4 is responsible for the outbreak of dengue in east java city of jember, Indonesia. Viruses 12 (9), 913.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Balasubramanian, A., Pilankatta, R., Teramoto, T., Sajith, A.M., Nwulia, E., Kulkarni, A., Padmanabhan, R., 2019. Inhibition of dengue virus by curcuminoids. Antivir. Res. 162, 71–78. https://doi.org/10.1016/j.antiviral.2018.12.002.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Balekundri, A., Mannur, V., 2020. Quality control of the traditional herbs and herbal products: a review. Futur. J. Pharm. Sci. 6 (1), 67. https://doi.org/10.1186/s43094- 020-00091-5.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">
Barboza, R.S., Valente, L.M.M., Wolff, T., Assunçao-Miranda ˜, I., Neris, R.L.S., Guimar˜aes- Andrade, I.P., Gomes, M., 2018. Antiviral activity of 
<taxonomicName _evidence="catalogs" _step="species1" box="[537,688,786,800]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="species" species="hyacinthina">
<emphasis bold="true" box="[537,688,786,800]" italics="true" pageId="15" pageNumber="16">Faramea hyacinthina</emphasis>
</taxonomicName>
and 
<taxonomicName _evidence="catalogs" _step="species1" box="[132,260,807,821]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="species" species="truncata">
<emphasis bold="true" box="[132,260,807,821]" italics="true" pageId="15" pageNumber="16">Faramea truncata</emphasis>
</taxonomicName>
leaves on dengue virus type-2 and their major compounds. Chem. Biodivers. 15 (2), e1700393 https://doi.org/10.1002/cbdv.201700393.
</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">
Bharadwaj, S., Lee, K.E., Dwivedi, V.D., Yadava, U., Panwar, A., Lucas, S., Pandey, A., Kang, S.G., 2019. Discovery of 
<taxonomicName _evidence="catalogs" _step="species1" box="[370,515,871,885]" class="Agaricomycetes" family="Ganodermataceae" genus="Ganoderma" kingdom="Fungi" order="Polyporales" pageId="15" pageNumber="16" phylum="Basidiomycota" rank="species" species="lucidum">
<emphasis bold="true" box="[370,515,871,885]" italics="true" pageId="15" pageNumber="16">Ganoderma lucidum</emphasis>
</taxonomicName>
triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease. Sci. Rep. 9 (1), 1–12. https:// doi.org/10.1038/s41598-019-55723-5.
</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Bhatia, V., Pansare, P., 2021. Formulation development and optimization of herbal immediate release tablet for dengue. Int. J. Pharmaceut. Sci. Res. 12 (2), 897–903. https://doi.org/10.13040/IJPSR.0975-8232.12(3).897-03.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Bidet, K., Garcia-Blanco, M.A., 2018. Flaviviral RNA structures and their role in replication and immunity. In: Hilgenfeld, R., Vasudevan, S. (Eds.), Dengue and Zika: Control and Antiviral Treatment Strategies, vol. 1062. Springer, Singapore,</paragraph>
<paragraph blockId="15.[100,766,148,1948]" box="[132,213,1062,1077]" pageId="15" pageNumber="16">pp. 45–62.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Bollati, M., Alvarez, K., Assenberg, R., Baronti, C., Canard, B., Cook, S., Coutard, B., Decroly, E., de Lamballerie, X., Gould, E.A., 2010. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antivir. Res. 87 (2), 125–148. https://doi.org/10.1016/j.antiviral.2009.11.009.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Brantley, S.J., Argikar, A.A., Lin, Y.S., Nagar, S., Paine, M.F., 2014. Herb–drug interactions: challenges and opportunities for improved predictions. Drug Metab. Dispos. 42 (3), 301. https://doi.org/10.1124/dmd.113.055236.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Buhler, C., Winkler, V., Runge-Ranzinger, S., Boyce, R., Horstick, O., 2019. Environmental methods for dengue vector control - a systematic review and metaanalysis. PLoS Neglected Trop. Dis. 13 (7), e0007420 https://doi.org/10.1371/ journal.pntd.0007420.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">
Calabrese, C., Berman, S.H., Babish, J.G., Ma, X., Shinto, L., Dorr, M., Wells, K., Wenner, C.A., Standish, L.J., 2000. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res. 14 (5), 333–338. https://doi.org/ 10.1002/1099-1573, 200008)14:5 
<emphasis box="[392,405,1382,1396]" italics="true" pageId="15" pageNumber="16">&lt;</emphasis>
333::AID-PTR584
<emphasis box="[538,551,1382,1396]" italics="true" pageId="15" pageNumber="16">&gt;</emphasis>
3.0.CO;2-D.
</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Chen, C.-Y., Kao, C.-L., Liu, C.-M., 2018. The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway. Int. J. Mol. Sci. 19 (9), 2729. https://doi.org/10.3390/ijms19092729.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Chen, H., Ma, Y.-B., Huang, X.-Y., Geng, C.-A., Zhao, Y., Wang, L.-J., Guo, R.-H., Liang, W.-J., Zhang, X.-M., Chen, J.-J., 2014. Synthesis, structure–activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents. Bioorg. Med. Chem. Lett. 24 (10), 2353–2359. https://doi.org/10.1016/j.bmcl.2014.03.060.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">
Chen, J.-X., Xue, H.-J., Ye, W.-C., Fang, B.-H., Liu, Y.-H., Yuan, S.-H., Yu, P., Wang, Y.-Q., 2009. Activity of andrographolide and its derivatives against influenza virus 
<emphasis bold="true" box="[717,765,1594,1608]" italics="true" pageId="15" pageNumber="16">in vivo</emphasis>
and 
<emphasis bold="true" box="[166,217,1615,1629]" italics="true" pageId="15" pageNumber="16">in vitro</emphasis>
. Biol. Pharm. Bull. 32 (8), 1385–1391. https://doi.org/10.1248/ bpb.32.1385.
</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">
Chiow, K.H., Phoon, M.C., Putti, T., Tan, B.K.H., Chow, V.T., 2016. Evaluation of antiviral activities of 
<taxonomicName _authorityPlausibility="0.99932593" _evidence="catalogs" _step="species1" authority="Thunb." authorityName="Thunb." box="[295,492,1678,1693]" class="Magnoliopsida" family="Saururaceae" genus="Houttuynia" kingdom="Plantae" order="Piperales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="species" species="cordata">
<emphasis bold="true" box="[295,492,1678,1693]" italics="true" pageId="15" pageNumber="16">Houttuynia cordata Thunb.</emphasis>
</taxonomicName>
extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac. J. Trop. Med. 9 (1), 1–7. https://doi.org/10.1016/j.apjtm.2015.12.002.
</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Coulerie, P., Nour, M., Maciuk, A., Eydoux, C., Guillemot, J.C., Lebouvier, N., Hnawia, E., Leblanc, K., Lewin, G., Canard, B., et al., 2013. Structure-activity relationship study of biflavonoids on the Dengue virus polymerase DENV-NS5 RdRp. Planta Med. 79 (14), 1313–1318. https://doi.org/10.1055/s-0033-1350672.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" pageId="15" pageNumber="16">Dang, M., Lim, L., Roy, A., Song, J., 2022. Myricetin allosterically inhibits the dengue NS2B-NS3 protease by disrupting the active and locking the inactive conformations. ACS Omega 7 (3), 2798–2808. https://doi.org/10.1021/acsomega.1c05569.</paragraph>
<paragraph blockId="15.[100,766,148,1948]" lastBlockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">de Sousa, L.R.F., Wu, H., Nebo, L., Fernandes, J.B., da Silva, M.F.d.G.F., Kiefer, W., Kanitz, M., Bodem, J., Diederich, W.E., Schirmeister, T., et al., 2015. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies. Bioorg. Med. Chem. 23 (3), 466–470. https://doi.org/10.1016/ j.bmc.2014.12.015.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Dhiman, M., Sharma, L., Dadhich, A., Dhawan, P., Sharma, M.M., 2022. Traditional knowledge to contemporary medication in the treatment of infectious disease dengue: a review. Front. Pharmacol. 13 https://doi.org/10.3389/ fphar.2022.750494.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">
Dusi, R.G., Morais, L.d.S., Magalh˜aes, N.M.G., Albernaz, L.C., Hamilton, C.J., Espindola, L.S., 2022. Potential of garlic oil as a biopesticide against all 
<taxonomicName _evidence="catalogs" _step="species1" baseAuthorityName="Linnaeus" baseAuthorityYear="1762" box="[1386,1482,297,311]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="15" pageNumber="16" phylum="Arthropoda" rank="species" species="aegypti">
<emphasis bold="true" box="[1386,1482,297,311]" italics="true" pageId="15" pageNumber="16">Aedes aegypti</emphasis>
</taxonomicName>
life stages. Ind. Crop. Prod. 181, 114780 https://doi.org/10.1016/j. indcrop.2022.114780.
</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">
Dwivedi, V.D., Bharadwaj, S., Afroz, S., Khan, N., Ansari, M.A., Yadava, U., Tripathi, R. C., Tripathi, I.P., Mishra, S.K., Kang, S.G., 2021. Anti-dengue infectivity evaluation of bioflavonoid from 
<taxonomicName _evidence="catalogs" _step="species1" box="[1012,1148,403,417]" class="Magnoliopsida" family="Meliaceae" genus="Azadirachta" kingdom="Plantae" order="Sapindales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="species" species="indica">
<emphasis bold="true" box="[1012,1148,403,417]" italics="true" pageId="15" pageNumber="16">Azadirachta indica</emphasis>
</taxonomicName>
by dengue virus serine protease inhibition. J. Biomol. Struct. 39 (4), 1417–1430. https://doi.org/10.1080/ 07391102.2020.1734485.
</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">
Dwivedi, V.D., Tripathi, I.P., Mishra, S.K., 2016. 
<emphasis bold="true" box="[1191,1247,467,481]" italics="true" pageId="15" pageNumber="16">In silico</emphasis>
evaluation of inhibitory potential of triterpenoids from 
<taxonomicName _evidence="catalogs" _step="species1" box="[1087,1222,488,502]" class="Magnoliopsida" family="Meliaceae" genus="Azadirachta" kingdom="Plantae" order="Sapindales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="species" species="indica">
<emphasis bold="true" box="[1087,1222,488,502]" italics="true" pageId="15" pageNumber="16">Azadirachta indica</emphasis>
</taxonomicName>
against therapeutic target of dengue virus, NS2B-NS3 protease. J. Vector Borne Dis. 53 (2), 156–161.
</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Eberle, R.J., Olivier, D.S., Amaral, M.S., Willbold, D., Arni, R.K., Coronado, M.A., 2021a. Promising natural compounds against flavivirus proteases: citrus flavonoids hesperetin and hesperidin. Plants 10 (10), 2183. https://doi.org/10.3390/ plants10102183.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">
Eberle, R.J., Olivier, D.S., Pacca, C.C., Avilla, C.M.S., Nogueira, M.L., Amaral, M.S., Willbold, D., Arni, R.K., Coronado, M.A., 2021b. 
<emphasis bold="true" box="[1224,1276,637,652]" italics="true" pageId="15" pageNumber="16">In vitro</emphasis>
study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases. PLoS One 16 (3), e0246319. https://doi.org/10.1371/journal.pone.0246319.
</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Frabasile, S., Koishi, A.C., Kuczera, D., Silveira, G.F., Verri, W.A., Duarte dos Santos, C. N., Bordignon, J., 2017. The citrus flavanone naringenin impairs dengue virus replication in human cells. Sci. Rep. 7 (1), 41864 https://doi.org/10.1038/ srep41864.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Frederico, E´.H.F.F., Cardoso, A.L.B.D., Moreira-Marconi, E., de S´a-Caputo, D.d.C., Guimar˜aes, C.A.S., da Fontoura Dionello, C., Morel, D.S., Paineiras-Domingos, L.L., de Souza, P.L., Brandao-Sobrinho-Neto ˜, S., 2017. Anti-viral effects of medicinal plants in the management of dengue: a systematic review. Afr. J. Tradit., Complementary Altern. Med. 14 (4S), 33–40.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Ganji, L.V., Kanyalkar, M.A., 2019. Non-structural proteases as a target of dengue virus. J. Antivir. Antiretrovir. 11, 1–15.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">
Ghosh, I., Talukdar, P., 2019. Molecular docking and pharmacokinetics study for selected leaf phytochemicals from 
<taxonomicName _authorityPlausibility="0.9999348" _evidence="catalogs" _step="species1" authority="Linn." authorityName="Linn." box="[1047,1197,956,970]" class="Magnoliopsida" family="Caricaceae" genus="Carica" kingdom="Plantae" order="Brassicales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="species" species="papaya">
<emphasis bold="true" box="[1047,1152,956,970]" italics="true" pageId="15" pageNumber="16">Carica papaya</emphasis>
Linn.
</taxonomicName>
against dengue virus protein, NS2B/ NS3 protease. World Sci.News 124 (2), 264–278.
</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">
Halim, S.N., 2017. Aktivitas antiviral [6]-Gingerol terhadap virus dengue: studi eksperimental 
<emphasis bold="true" box="[961,1012,1020,1034]" italics="true" pageId="15" pageNumber="16">in vitro</emphasis>
pada galur sel A549. (Undergraduate degree). Univ. Diponegoro 56212.
</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">
Han, Y.-S., Penthala, 
<taxonomicNameLabel box="[980,1016,1063,1077]" pageId="15" pageNumber="16" rank="subSpecies">N.R.</taxonomicNameLabel>
, Oliveira, M., Mespl`ede, T., Xu, H., Quan, Y., Crooks, P.A., Wainberg, M.A., 2017. Identification of resveratrol analogs as potent anti-dengue agents using a cell-based assay. J. Med. Virol. 89 (3), 397–407. https://doi.org/ 10.1002/jmv.24660.
</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Hayati, R.F., Better, C.D., Denis, D., Komarudin, A.G., Bowolaksono, A., Yohan, B., Sasmono, R.T., 2021. [6]-Gingerol inhibits chikungunya virus infection by suppressing viral replication. BioMed Res. Int. 2021, 1–7. https://doi.org/10.1155/ 2021/6623400.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">
Hengphasatporn, K., Kaewmalai, B., Jansongsaeng, S., Badavath, 
<taxonomicNameLabel box="[1315,1352,1233,1247]" pageId="15" pageNumber="16" rank="variety">V.N.</taxonomicNameLabel>
, Saelee, T., Chokmahasarn, T., Khotavivattana, T., Shigeta, Y., Rungrotmongkol, T., Boonyasuppayakorn, S., 2021. Alkyne-tagged apigenin, a chemical tool to navigate potential targets of flavonoid anti-dengue leads. Molecules 26 (22), 6967.
</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Horstick, O., Boyce, R., Runge-Ranzinger, S., 2017. Dengue vector control: assessing what works? Southeast Asian J. Trop. Med. Publ. Health 48, 181–195.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Hundt, J., Li, Z., Liu, Q., 2015. The inhibitory effects of anacardic acid on hepatitis C virus life cycle. PLoS One 10 (2), e0117514. https://doi.org/10.1371/journal. pone.0117514.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Jayadevappa, M.K., Karkera, P.R., Siddappa, R.Y., Telkar, S., Karunakara, P., 2020. Investigation of plant flavonoids as potential dengue protease inhibitors. J. HerbMed Pharmacol. 9 (4), 366–373. https://doi.org/10.34172/jhp.2020.46.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Joob, B., Wiwanitkit, V., 2016. Fifth serotype of dengue virus: what we should prepare for? Med. J. Armed Forces India 72 (2), 194–195. https://doi.org/10.1016/j. mjafi.2015.11.015.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Kalita, B., Bora, S., Sharma, A., 2013. Plant essential oils as mosquito repellent - a review. Int. J. Res. Dev. Pharm. Life Sci. 3 (1), 741–747.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Kanyaboon, P., Saelee, T., Suroengrit, A., Hengphasatporn, K., Rungrotmongkol, T., Chavasiri, W., Boonyasuppayakorn, S., 2018. Cardol triene inhibits dengue infectivity by targeting kl loops and preventing envelope fusion. Sci. Rep. 8 (1), 16643 https://doi.org/10.1038/s41598-018-35035-w.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Khetarpal, N., Khanna, I., 2016. Dengue fever: causes, complications, and vaccine strategies. J. Immunol. Res. 2016, 1–14. https://doi.org/10.1155/2016/6803098.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Koe, T., 2021. Papaya leaf extract for dengue: NZ firm develops supplement as adjunctive to mosquito disease. Retrieved from. https://www.nutraingredients-asia.com/Art icle/2021/02/01/Papaya-leaf-extract-for-dengue-NZ-firm-develops-supplement-as-a djunctive-to-mosquito-disease. Feb 2021.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">Kulkarni, S.S., Canto´, C., 2015. The molecular targets of resveratrol. Biochim. Biophys. Acta, Mol. Basis Dis. 1852 (6), 1114–1123. https://doi.org/10.1016/j. bbadis.2014.10.005.</paragraph>
<paragraph blockId="15.[818,1484,148,1969]" pageId="15" pageNumber="16">
Kurniasih, N., Nuryadin, W., Harahap, M.N., Supriadin, A., Kinasih, I., 2021. Toxicity of essential oils from orange (
<taxonomicName _authorityPlausibility="NaN" _evidence="catalog+fontStyle" _step="styledSpecies" authority="L. Obbeck" authorityName="L. Obbeck" box="[1057,1232,1891,1906]" class="Magnoliopsida" family="Rutaceae" genus="Citrus" kingdom="Plantae" order="Sapindales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="species" species="sinesis">
<emphasis bold="true" box="[1057,1148,1891,1905]" italics="true" pageId="15" pageNumber="16">Citrus sinesis</emphasis>
L. Obbeck
</taxonomicName>
) and lemongrass (
<taxonomicName _authorityPlausibility="NaN" _evidence="catalogs" _step="species1" authority="L. Rendle" authorityName="L. Rendle" class="Liliopsida" family="Poaceae" genus="Cymbopogon" kingdom="Plantae" order="Poales" pageId="15" pageNumber="16" phylum="Tracheophyta" rank="species" species="nardus">
<emphasis bold="true" italics="true" pageId="15" pageNumber="16">Cymbopogon nardus</emphasis>
L. Rendle
</taxonomicName>
) on 
<taxonomicName _evidence="catalogs" _step="species1" baseAuthorityName="Linnaeus" baseAuthorityYear="1762" box="[1012,1109,1912,1927]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="15" pageNumber="16" phylum="Arthropoda" rank="species" species="aegypti">
<emphasis bold="true" box="[1012,1109,1912,1927]" italics="true" pageId="15" pageNumber="16">Aedes aegypti</emphasis>
</taxonomicName>
a vector of Dengue Hemorrhagic Fever (DHF). J. Phys. Conf. 1869 (1), 012015 https://doi.org/10.1088/1742-6596/1869/1/ 012015.
</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Kutumbarao, N.H.V., Velmurugan, D., 2016. Structural analysis and molecular modeling studies of fatty acids and peptides binding with NS2B/NS3 dengue protease. J. Emerg. Dis. Virol. 2 (4) https://doi.org/10.16966/2473-1846.121.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Kyle, J.L., Harris, E., 2008. Global spread and persistence of dengue. Annu. Rev. Microbiol. 62, 71–92.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">
Laille, M., Gerald, F., Debitus, C., 1998. 
<emphasis bold="true" box="[409,461,255,269]" italics="true" pageId="16" pageNumber="17">In vitro</emphasis>
antiviral activity on dengue virus of marine natural products. Cell. Mol. Life Sci. 54 (2), 167–170. https://doi.org/ 10.1007/s000180050138.
</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Lee, J.-C., Tseng, C.-K., Young, K.-C., Sun, H.-Y., Wang, S.-W., Chen, W.-C., Lin, C.-K., Wu, Y.-H., 2014. Andrographolide exerts anti-hepatitis C virus activity by upregulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. Br. J. Pharmacol. 171 (1), 237–252. https://doi.org/10.1111/bph.12440.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Lee, S., Yoon, K.D., Lee, M., Cho, Y., Choi, G., Jang, H., Kim, B., Jung, D.-H., Oh, J.-G., Kim, G.-W., et al., 2016. Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase. Br. J. Pharmacol. 173 (1), 191–211. https://doi.org/ 10.1111/bph.13358.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Lee, Y.K., Tan, S.K., Wahab, H.A., Rohana, Y., 2007. Nonsubstrate based inhibitors of dengue virus serine protease: a molecular docking approach to study binding interactions between protease and inhibitors. Asia Pac. J. Mol. Biol. Biotechnol. 15 (2), 53–59.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Lescar, J., Soh, S., Lee, L.T., Vasudevan, S.G., Kang, C., Lim, S.P., 2018. The dengue virus replication complex: from RNA replication to protein-protein interactions to evasion of innate immunity. In: Hilgenfeld, R., Vasudevan, S. (Eds.), Dengue and Zika: Control and Antiviral Treatment Strategies, vol. 1062. Springer, Singapore,</paragraph>
<paragraph blockId="16.[100,766,148,1969]" box="[132,233,658,673]" pageId="16" pageNumber="17">pp. 115–129.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Leung, D., Schroder, K., White, H., Fang, N.-X., Stoermer, M.J., Abbenante, G., Martin, J. L., Young, P.R., Fairlie, D.P., 2001. Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J. Biol. Chem. 276 (49), 45762–45771.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Liang, N., Sang, Y., Liu, W., Yu, W., Wang, X., 2018. Anti-inflammatory effects of gingerol on lipopolysaccharide-stimulated RAW 264.7 cells by inhibiting NF-κB signaling pathway. Inflammation 41 (3), 835–845. https://doi.org/10.1007/s10753- 018-0737-3.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Lim, H.-j., Nguyen, T.T.H., Kim, N.M., Park, J.-S., Jang, T.-S., Kim, D., 2017. Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship. Biotechnol. Lett. 39 (3), 415–421. https://doi.org/10.1007/ s10529-016-2261-6.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Lim, L., Dang, M., Roy, A., Kang, J., Song, J., 2020. Curcumin allosterically inhibits the dengue NS2B-NS3 protease by disrupting its active conformation. ACS Omega 5 (40), 25677–25686. https://doi.org/10.1021/acsomega.0c00039.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Lo, Y.-L., Liou, G.-G., Lyu, J.-H., Hsiao, M., Hsu, T.-L., Wong, C.-H., 2016. Dengue virus infection is through a cooperative interaction between a mannose receptor and CLEC5A on macrophage as a multivalent hetero-complex. PLoS One 11 (11), e0166474. https://doi.org/10.1371/journal.pone.0166474.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Luo, D., Xu, T., Hunke, C., Grüber, G., Vasudevan, S.G., Lescar, J., 2008. Crystal structure of the NS3 protease-helicase from dengue virus. J. Virol. 82 (1), 173–183.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">
Maia, J.D., La Corte, R., Martinez, J., Ubbink, J., Prata, A.S., 2019. Improved activity of thyme essential oil (
<taxonomicName _evidence="catalogs" _step="species1" box="[287,403,1147,1161]" class="Magnoliopsida" family="Lamiaceae" genus="Thymus" kingdom="Plantae" order="Lamiales" pageId="16" pageNumber="17" phylum="Tracheophyta" rank="species" species="vulgaris">
<emphasis bold="true" box="[287,403,1147,1161]" italics="true" pageId="16" pageNumber="17">Thymus vulgaris</emphasis>
</taxonomicName>
) against 
<taxonomicName _evidence="catalogs" _step="species1" baseAuthorityName="Linnaeus" baseAuthorityYear="1762" box="[474,571,1147,1161]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="16" pageNumber="17" phylum="Arthropoda" rank="species" species="aegypti">
<emphasis bold="true" box="[474,571,1147,1161]" italics="true" pageId="16" pageNumber="17">Aedes aegypti</emphasis>
</taxonomicName>
larvae using a biodegradable controlled release system. Ind. Crop. Prod. 136, 110–120. https://doi. org/10.1016/j.indcrop.2019.03.040.
</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Malarvizhi, K., 2019. A review on the various drug delivery systems of andrographolide. In: Ramyadevi, Hari, B.V. (Eds.), Phytopharmaceuticals and Drug Delivery Approaches. AVID SCIENCE, 02-13.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">
Malavige, 
<taxonomicNameLabel box="[179,216,1275,1289]" pageId="16" pageNumber="17" rank="genus">G.N.</taxonomicNameLabel>
, Fernando, S., Fernando, D.J., Seneviratne, S.L., 2004. Dengue viral infections. Postgrad. Med. 80 (948), 588–601.
</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Manohar, P., Loh, B., Nachimuthu, R., Hua, X., Welburn, S.C., Leptihn, S., 2020. Secondary bacterial infections in patients with viral pneumonia. Front. Med. 7, 420.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">
Marbawati, D., Umniyati, S.R., 2015. Effects of curcumin and pentagamavunon-0 against dengue-2 virus Infection in vero cells; an 
<emphasis bold="true" box="[450,501,1381,1395]" italics="true" pageId="16" pageNumber="17">in vitro</emphasis>
study. Procedia Environ. Sci. 23, 215–221. https://doi.org/10.1016/j.proenv.2015.01.033.
</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">
Min, B.-S., Nakamura, N., Miyashiro, H., Bae, K.-W., Hattori, M., 1998. Triterpenes from the spores of 
<taxonomicName _evidence="catalogs" _step="species1" box="[231,374,1445,1459]" class="Agaricomycetes" family="Ganodermataceae" genus="Ganoderma" kingdom="Fungi" order="Polyporales" pageId="16" pageNumber="17" phylum="Basidiomycota" rank="species" species="lucidum">
<emphasis bold="true" box="[231,374,1445,1459]" italics="true" pageId="16" pageNumber="17">Ganoderma lucidum</emphasis>
</taxonomicName>
and their inhibitory activity against HIV-1 protease. Chem. Pharm. Bull. 46 (10), 1607–1612. https://doi.org/10.1248/cpb.46.1607.
</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">
Mohd, A., Zainal, N., Tan, K.-K., AbuBakar, S., 2019. Resveratrol affects Zika virus replication 
<emphasis bold="true" box="[219,270,1509,1523]" italics="true" pageId="16" pageNumber="17">in vitro</emphasis>
. Sci. Rep. 9 (1), 14336 https://doi.org/10.1038/s41598-019- 50674-3.
</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Morchang, A., Malakar, S., Poonudom, K., Noisakran, S., Yenchitsomanus, P.-t., Limjindaporn, T., 2021. Melatonin inhibits dengue virus infection via the sirtuin 1- mediated interferon pathway. Viruses 13 (4). https://doi.org/10.3390/v13040659.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Mukhopadhyay, S., Kuhn, R.J., Rossmann, M.G., 2005. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3 (1), 13–22.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Murugesan, A., Manoharan, M., 2020. Chapter 16 - dengue virus. In: Ennaji, M.M. (Ed.), Emerging and Reemerging Viral Pathogens. Academic Press, pp. 281–359.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Nabila, N., Suada, K.N., Denis, D., Yohan, B., Adi, C.A., Veterini, S.A., Anindya, L.A., Sasmono, T.R., Rachmawati, H., 2020. Antiviral action of curcumin encapsulated in nanoemulsion against four serotypes of dengue virus. Pharm. Nanotechnol. 8 (1), 54–62. https://doi.org/10.2174/2211738507666191210163408.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Nafees, S., Zafaryab, M., Mehdi, S.H., Zia, B., Rizvi, M.A., Khan, M.A., 2021. Anti-cancer effect of gingerol in cancer prevention and treatment. Anti Cancer Agents Med. Chem. 21 (4), 428–432. https://doi.org/10.2174/1871520620666200918100833.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" pageId="16" pageNumber="17">Nasar, S., Rashid, N., Iftikhar, S., 2020. Dengue proteins with their role in pathogenesis, and strategies for developing an effective anti-dengue treatment: a review. J. Med. Virol. 92 (8), 941–955.</paragraph>
<paragraph blockId="16.[100,766,148,1969]" lastBlockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">
Nascimento, A.C., Valente, L.M.M., Gomes, M., Barboza, R.S., Wolff, T., Neris, R.L.S., Figueiredo, C.M., Assunç˜ao-Miranda, I., 2017. Antiviral activity of 
<taxonomicName _evidence="catalogs" _step="species1" box="[633,764,1933,1948]" class="Magnoliopsida" family="Rubiaceae" genus="Faramea" kingdom="Plantae" order="Gentianales" pageId="16" pageNumber="17" phylum="Tracheophyta" rank="species" species="bahiensis">
<emphasis bold="true" box="[633,764,1933,1948]" italics="true" pageId="16" pageNumber="17">Faramea bahiensis</emphasis>
</taxonomicName>
leaves on dengue virus type-2 and characterization of a new antiviral flavanone glycoside. Phytochem. Lett. 19, 220–225. https://doi.org/10.1016/j. phytol.2017.01.013.
</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">
Niranjan Reddy, V.L., Malla Reddy, S., Ravikanth, V., Krishnaiah, P., Venkateshwar Goud, T., Rao, T.P., Siva Ram, T., Gonnade, R.G., Bhadbhade, M., Venkateswarlu, Y., 2005. A new BIS-Andrographolide Ether from 
<taxonomicName _authorityPlausibility="0.99156046" _evidence="catalogs" _step="species1" authority="Nees" authorityName="Nees" box="[1203,1420,233,248]" class="Magnoliopsida" family="Acanthaceae" genus="Andrographis" kingdom="Plantae" order="Lamiales" pageId="16" pageNumber="17" phylum="Tracheophyta" rank="species" species="paniculata">
<emphasis bold="true" box="[1203,1378,233,247]" italics="true" pageId="16" pageNumber="17">Andrographis paniculata</emphasis>
Nees
</taxonomicName>
and evaluation of anti-HIV activity. Nat. Prod. Res. 19 (3), 223–230. https://doi.org/ 10.1080/14786410410001709197.
</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Niyomrattanakit, P., Winoyanuwattikun, P., Chanprapaph, S., Angsuthanasombat, C., Panyim, S., Katzenmeier, G., 2004. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation. J. Virol. 78 (24), 13708–13716. https://doi.org/10.1128/JVI.78.24.13708-13716.2004.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Oliveira, A.F.C.d.S., Teixeira, R.R., Oliveira, A.S.d., Souza, A.P.M.d., Silva, M.L.d., Paula, S.O.d., 2017. Potential antivirals: natural products targeting replication enzymes of dengue and chikungunya viruses. Molecules 22 (3), 505. https://doi.org/ 10.3390/molecules22030505.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Paemanee, A., Hitakarun, A., Roytrakul, S., Smith, D.R., 2018. Screening of melatonin, α- tocopherol, folic acid, acetyl-l-carnitine and resveratrol for anti-dengue 2 virus activity. BMC Res. Notes 11 (1), 307. https://doi.org/10.1186/s13104-018-3417-3.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Panraksa, P., Ramphan, S., Khongwichit, S., Smith, D.R., 2017. Activity of andrographolide against dengue virus. Antivir. Res. 139, 69–78. https://doi.org/ 10.1016/j.antiviral.2016.12.014.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">
Panya, A., Yongpitakwattana, P., Budchart, P., Sawasdee, N., Krobthong, S., Paemanee, A., Roytrakul, S., Rattanabunyong, S., Choowongkomon, K., Yenchitsomanus, P.-t., 2019. Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant 
<taxonomicName _authorityPlausibility="0.884853" _evidence="catalogs" _step="genera" authority="Catechu. Chem. Biol. Drug Des." class="Magnoliopsida" family="Fabaceae" genus="Acacia" kingdom="Plantae" order="Fabales" pageId="16" pageNumber="17" phylum="Tracheophyta" rank="genus">
<emphasis bold="true" box="[1261,1372,658,672]" italics="true" pageId="16" pageNumber="17">Acacia Catechu</emphasis>
. Chem. Biol. Drug Des.
</taxonomicName>
93 (2), 100–109. https://doi.org/10.1111/cbdd.13400.
</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Peng, M., Watanabe, S., Chan, K.W.K., He, Q., Zhao, Y., Zhang, Z., Lai, X., Luo, D., Vasudevan, S.G., Li, G., 2017. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin. Antivir. Res. 143, 176–185.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">
Pineda-Cortel, M.R.B., Cabantog, R.J.R., Caasi, P.M., Ching, C.A.D., Perez, J.B.S., Godisan, P.G.M., Latorre, C.M.G., Lucero, D.R., Salonga, R.B., 2019. Larvicidal and ovicidal activities of 
<taxonomicName _evidence="catalogs" _step="species1" box="[1004,1137,807,821]" class="Magnoliopsida" family="Moraceae" genus="Artocarpus" kingdom="Plantae" order="Rosales" pageId="16" pageNumber="17" phylum="Tracheophyta" rank="species" species="blancoi">
<emphasis bold="true" box="[1004,1137,807,821]" italics="true" pageId="16" pageNumber="17">Artocarpus blancoi</emphasis>
</taxonomicName>
extracts against 
<taxonomicName _evidence="catalogs" _step="species1" baseAuthorityName="Linnaeus" baseAuthorityYear="1762" box="[1261,1357,807,821]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="16" pageNumber="17" phylum="Arthropoda" rank="species" species="aegypti">
<emphasis bold="true" box="[1261,1357,807,821]" italics="true" pageId="16" pageNumber="17">Aedes aegypti</emphasis>
</taxonomicName>
. Pharm. Biol. 57 (1), 120–124. https://doi.org/10.1080/13880209.2018.1561727.
</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">
Powers, N.C., Setzer, N.W., 2016. An 
<emphasis bold="true" box="[1097,1152,850,864]" italics="true" pageId="16" pageNumber="17">in-silico</emphasis>
investigation of phytochemicals as antiviral agents against dengue fever. Comb. Chem. High Throughput Screen. 19 (7), 516–536. https://doi.org/10.2174/1386207319666160506123715.
</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">
Qamar, M.T.u., Ashfaq, U.A., Tusleem, K., Mumtaz, A., Tariq, Q., Goheer, A., Ahmed, B., 2017. 
<emphasis bold="true" box="[897,953,935,949]" italics="true" pageId="16" pageNumber="17">In-silico</emphasis>
identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach. Pak. J. Pharm. Sci. 30, 2119.
</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Qamar, M.T.u., Maryam, A., Muneer, I., Xing, F., Ashfaq, U.A., Khan, F.A., Anwar, F., Geesi, M.H., Khalid, R.R., Rauf, S.A., et al., 2019. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus. Sci. Rep. 9 (1), 1433. https://doi.org/10.1038/s41598-018-38450-1.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Raekiansyah, M., Buerano, C.C., Luz, M.A.D., Morita, K., 2018. Inhibitory effect of the green tea molecule EGCG against dengue virus infection. Arch. Virol. 163 (6), 1649–1655. https://doi.org/10.1007/s00705-018-3769-y.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Rahman, M.M., Biswas, S., Islam, K.J., Paul, A.S., Mahato, S.K., Ali, M.A., Halim, M.A., 2021. Antiviral phytochemicals as potent inhibitors against NS3 protease of dengue virus. Comput. Biol. Med. 134, 104492 https://doi.org/10.1016/j. compbiomed.2021.104492.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Rani, J.M.J., Kalaimathi, K., Vijayakumar, S., Varatharaju, G., Karthikeyan, K., Thiyagarajan, G., Bhavani, K., Manogar, P., Prabhu, S., 2022. Anti-viral effectuality of plant polyphenols against mutated dengue protein NS2B47-NS3: a computational exploration. Gene Rep 27, 101546. https://doi.org/10.1016/j.genrep.2022.101546.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">
Rao, V.B., Yeturu, K., 2020. Possible anti-viral effects of Neem (
<taxonomicName _evidence="catalogs" _step="species1" box="[1305,1441,1317,1331]" class="Magnoliopsida" family="Meliaceae" genus="Azadirachta" kingdom="Plantae" order="Sapindales" pageId="16" pageNumber="17" phylum="Tracheophyta" rank="species" species="indica">
<emphasis bold="true" box="[1305,1441,1317,1331]" italics="true" pageId="16" pageNumber="17">Azadirachta indica</emphasis>
</taxonomicName>
) on dengue virus. bioRxiv 1–4. https://doi.org/10.1101/2020.04.29.069567.
</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Reddy, K.J., Alex, M.J., 2017. In: Thomas, A. (Ed.), Regulations for Herbal Medicine - Worldwide, 1 ed., vol. 1. LAP LAMBERT Academic Publishing, Mauritius, pp. 1–83.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Rodenhuis-Zybert, I.A., Wilschut, J., Smit, J.M., 2010. Dengue virus life cycle: viral and host factors modulating infectivity. Cell. Mol. Life Sci. 67 (16), 2773–2786.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Rothan, H.A., Abdulrahman, A.Y., Sasikumer, P.G., Othman, S., Abd Rahman, N., Yusof, R., 2012a. Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells. J. Biomed. Biotechnol., 251482 https://doi.org/10.1155/ 2012/251482, 2012.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Rothan, H.A., Han, H.C., Ramasamy, T.S., Othman, S., Abd Rahman, N., Yusof, R., 2012b. Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infect. Dis. 12 (1), 1–9.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Roy, A., Lim, L., Srivastava, S., Lu, Y., Song, J., 2017. Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants. PLoS One 12 (7), e0180632. https://doi.org/10.1371/journal.pone.0180632.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Sahoo, N., Manchikanti, P., Dey, S., 2010. Herbal drugs: standards and regulation. Fitoterapia 81 (6), 462–471. https://doi.org/10.1016/j.fitote.2010.02.001.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">
Saleem, H.N., Batool, F., Mansoor, H.J., Shahzad-ul-Hussan, S., Saeed, M., 2019. Inhibition of dengue virus protease by eugeniin, isobiflorin, and biflorin isolated from the flower buds of 
<taxonomicName _evidence="catalogs" _step="species1" box="[1036,1194,1742,1756]" class="Magnoliopsida" family="Myrtaceae" genus="Syzygium" kingdom="Plantae" order="Myrtales" pageId="16" pageNumber="17" phylum="Tracheophyta" rank="species" species="aromaticum">
<emphasis bold="true" box="[1036,1194,1742,1756]" italics="true" pageId="16" pageNumber="17">Syzygium aromaticum</emphasis>
</taxonomicName>
(cloves). ACS Omega 4 (1), 1525–1533. https://doi.org/10.1021/acsomega.8b02861.
</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Salehi, B., Sharopov, F., Fokou, P.V.T., Kobylinska, A., Jonge, L.d., Tadio, K., SharifiRad, J., Posmyk, M.M., Martorell, M., Martins, N., 2019a. Melatonin in medicinal and food plants: occurrence, bioavailability, and health potential for humans. Cells 8 (7), 681. https://doi.org/10.3390/cells8070681.</paragraph>
<paragraph blockId="16.[818,1483,148,1949]" pageId="16" pageNumber="17">Salehi, B., Venditti, A., Sharifi-Rad, M., Kręgiel, D., Sharifi-Rad, J., Durazzo, A., Lucarini, M., Santini, A., Souto, E.B., Novellino, E., et al., 2019b. The therapeutic potential of apigenin. Int. J. Mol. Sci. 20 (6), 1305. https://doi.org/10.3390/ ijms20061305.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Salim, F., Abu, N.A., Yaakob, H., Kadir, L., Zainol, N., Taher, Z.M., Shahar, S., Husin, F., Amri, A.S.S., Moghaddam, E., 2018. Interaction of 
<taxonomicName _evidence="catalogs" _step="species1" box="[521,625,170,184]" class="Magnoliopsida" family="Caricaceae" genus="Carica" kingdom="Plantae" order="Brassicales" pageId="17" pageNumber="18" phylum="Tracheophyta" rank="species" species="papaya">
<emphasis bold="true" box="[521,625,170,184]" italics="true" pageId="17" pageNumber="18">Carica papaya</emphasis>
</taxonomicName>
leaves optimum extract on virus dengue infected cells. Sci. Int. 30 (3), 437–441.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Santoyo, S., Plaza, M., Jaime, L., Ibanez ˜, E., Reglero, G., Se˜norans, F.J., 2010. Pressurized liquid extraction as an alternative process to obtain antiviral agents from the edible microalga 
<taxonomicName _evidence="catalogs" _step="species1" box="[213,338,254,268]" class="Trebouxiophyceae" family="Chlorellaceae" genus="Chlorella" kingdom="Plantae" order="Chlorellales" pageId="17" pageNumber="18" phylum="Chlorophyta" rank="species" species="vulgaris">
<emphasis bold="true" box="[213,338,254,268]" italics="true" pageId="17" pageNumber="18">Chlorella vulgaris</emphasis>
</taxonomicName>
. J. Agric. Food Chem. 58 (15), 8522–8527. https://doi. org/10.1021/jf100369h.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Sarker, M.R., Khan, F., Mohamed, I.N., 2021. Dengue fever: therapeutic potential of carica 
<taxonomicName _authorityPlausibility="NaN" _evidence="document" _step="nonLabeled1" authority="L. Leaves. Front. Pharmacol." box="[183,460,319,333]" class="Magnoliopsida" family="Caricaceae" genus="Carica" kingdom="Plantae" order="Brassicales" pageId="17" pageNumber="18" phylum="Tracheophyta" rank="species" species="papaya">papaya L. Leaves. Front. Pharmacol.</taxonomicName>
12, 610912 https://doi.org/10.3389/ fphar.2021.610912.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" box="[100,734,361,375]" pageId="17" pageNumber="18">Seubsasana, S., Pientong, C., Ekalaksananan, T., Thongchai, S., Aromdee, C., 2011.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">A potential andrographolide analogue against the replication of herpes simplex virus type 1 in vero cells. Med. Chem. 7 (3), 237–244. https://doi.org/10.2174/ 157340611795564268.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Shanmugapriya, E., Ravichandiran, V., Vijey, A.M., 2016. Molecular docking studies on naturally occurring selected flavones against protease enzyme of Dengue virus. Res. J. Pharm. Technol. 9 (7), 929–932. https://doi.org/10.5958/0974- 360X.2016.00178.5.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Shetty, D., Manoj, A., Jain, D., Narayane, M., Rudrakar, A., 2019. The effectiveness of 
<taxonomicName _evidence="catalogs" _step="species1" box="[132,237,552,566]" class="Magnoliopsida" family="Caricaceae" genus="Carica" kingdom="Plantae" order="Brassicales" pageId="17" pageNumber="18" phylum="Tracheophyta" rank="species" species="papaya">
<emphasis bold="true" box="[132,237,552,566]" italics="true" pageId="17" pageNumber="18">Carica papaya</emphasis>
</taxonomicName>
leaf extract in children with dengue fever. Eur. J. Biomed. Pharmaceut. Sci. 6 (5) https://doi.org/10.2017/Dr.D.R.S.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Shimu, M.S.S., Mahmud, S., Tallei, T.E., Sami, S.A., Adam, A.A., Acharjee, U.K., Paul, G. K., Emran, T.B., Zaman, S., Uddin, M.S., et al., 2022. Phytochemical compound screening to identify novel small molecules against dengue virus: a docking and dynamics study. Molecules 27 (3), 653. https://doi.org/10.3390/ molecules27030653.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Sim, S., Ng, L.C., Lindsay, S.W., Wilson, A.L., 2020. A greener vision for vector control: the example of the Singapore dengue control programme. PLoS Neglected Trop. Dis. 14 (8), e0008428.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Simmonds, P., Becher, P., Bukh, J., Gould, E.A., Meyers, G., Monath, T., Muerhoff, S., Pletnev, A., Rico-Hesse, R., Smith, D.B., et al., 2017. ICTV virus taxonomy profile: 
<taxonomicName _evidence="catalogs" _step="family" box="[132,224,807,821]" class="Flasuviricetes" family="Flaviviridae" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="17" pageNumber="18" phylum="Kitrinoviricota" rank="family">Flaviviridae</taxonomicName>
. J. Gen. Virol. 98 (1), 2–3.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Su, X.-C., Ozawa, K., Qi, R., Vasudevan, S.G., Lim, S.P., Otting, G., 2009. NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the west nile virus NS2B-NS3 protease. PLoS Neglected Trop. Dis. 3 (12), e561. https://doi.org/10.1371/journal.pntd.0000561.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Subenthiran, S., Choon, T.C., Cheong, K.C., Thayan, R., Teck, M.B., Muniandy, P.K., Afzan, A., Abdullah, 
<taxonomicNameLabel box="[291,328,935,949]" pageId="17" pageNumber="18" rank="subSpecies">N.R.</taxonomicNameLabel>
, Ismail, Z., 2013. 
<taxonomicName _evidence="catalogs" _step="species1" box="[464,569,935,949]" class="Magnoliopsida" family="Caricaceae" genus="Carica" kingdom="Plantae" order="Brassicales" pageId="17" pageNumber="18" phylum="Tracheophyta" rank="species" species="papaya">
<emphasis bold="true" box="[464,569,935,949]" italics="true" pageId="17" pageNumber="18">Carica papaya</emphasis>
</taxonomicName>
leaves juice significantly accelerates the rate of increase in platelet count among patients with dengue fever and dengue haemorrhagic fever. Evid. Based Complementary Altern. Med., 616737 https://doi.org/10.1155/2013/616737, 2013.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Sukhralia, S., Verma, M., Gopirajan, S., Dhanaraj, P.S., Lal, R., Mehla, N., Kant, C.R., 2018. From dengue to zika: the wide spread of mosquito-borne arboviruses. Eur. J. Clin. Microbiol. Infect. Dis. 1–12.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Sulaiman, S.N., Hariono, M., Salleh, H.M., Chong, S.-L., Yee, L.S., Zahari, A., Wahab, H. A., Derbr´e, S., Awang, K., 2019. Chemical constituents from 
<taxonomicName _evidence="catalogs" _step="species1" class="Magnoliopsida" family="Lauraceae" genus="Endiandra" kingdom="Plantae" order="Laurales" pageId="17" pageNumber="18" phylum="Tracheophyta" rank="species" species="kingiana">
<emphasis bold="true" box="[595,736,1105,1119]" italics="true" pageId="17" pageNumber="18">Endiandra kingiana</emphasis>
(Lauraceae)
</taxonomicName>
as potential inhibitors for dengue type 2 NS2B/NS3 serine protease and its molecular docking. Nat. Prod. Commun. 14 (9) https://doi.org/10.1177/ 1934578X19861014, 1934578X19861014.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Supian, S., Chandradevan, M., Ahmad, M., Rozano, L., Mat Ali, M., Simoh, S., 2021. Metabolite profiling and 
<emphasis bold="true" box="[321,372,1211,1225]" italics="true" pageId="17" pageNumber="18">in vitro</emphasis>
evaluation of 
<taxonomicName _evidence="catalogs" _step="species1" box="[483,631,1211,1225]" class="Magnoliopsida" family="Sapindaceae" genus="Lepisanthes" kingdom="Plantae" order="Sapindales" pageId="17" pageNumber="18" phylum="Tracheophyta" rank="species" species="fruticosa">
<emphasis bold="true" box="[483,631,1211,1225]" italics="true" pageId="17" pageNumber="18">Lepisanthes fruticosa</emphasis>
</taxonomicName>
fruit pulp extract as inhibitor against dengue and West Nile virus NS2B-NS3 proteases. Phcog. Mag. 17 (75), 636–642. https://doi.org/10.4103/pm.pm_113_21.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Tan, Y.P., Houston, S.D., Modhiran, N., Savchenko, A.I., Boyle, G.M., Young, P.R., Watterson, D., Williams, C.M., 2019. Stachyonic acid: a dengue virus inhibitor from 
<taxonomicName _evidence="catalogs" _step="species1" box="[132,299,1317,1331]" class="Magnoliopsida" family="Lamiaceae" genus="Basilicum" kingdom="Plantae" order="Lamiales" pageId="17" pageNumber="18" phylum="Tracheophyta" rank="species" species="polystachyon">
<emphasis bold="true" box="[132,299,1317,1331]" italics="true" pageId="17" pageNumber="18">Basilicum polystachyon</emphasis>
</taxonomicName>
. Chem. Eur J. 25 (22), 5664–5667. https://doi.org/10.1002/ chem.201900591.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Tawfik, M.K., 2016. Anti-aggregatory effect of boswellic acid in high-fat fed rats: involvement of redox and inflammatory cascades. Arch. Med. Sci. 12 (6), 1354–1361. https://doi.org/10.5114/aoms.2016.60675.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Taylor-Robinson, A.W., 2016. A putative fifth serotype of dengue–potential implications for diagnosis, therapy and vaccine design. Int. J. Med. Microbiol. 1, 101. https://doi. org/10.15344/2456-4028/2016/101.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Teixeira, R.R., Pereira, W.L., Oliveira, A.F.C.d.S., Da Silva, A.M., De Oliveira, A.S., Da Silva, M.L., Da Silva, C.C., De Paula, S.O., 2014. Natural products as source of potential dengue antivirals. Molecules 19 (6), 8151–8176. https://doi.org/10.3390/ molecules19068151.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Tomar, S., Mudgal, R., Fatma, B., 2017. Chapter 6 - flavivirus protease: an antiviral target. In: Gupta, S.P. (Ed.), Viral Proteases and Their Inhibitors. Academic Press, pp. 137–161.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">
Trujillo-Correa, A.I., Quintero-Gil, D.C., Diaz-Castillo, F., Quinones ˜, W., Robledo, S.M., Martinez-Gutierrez, M., 2019. 
<emphasis bold="true" box="[360,410,1657,1672]" italics="true" pageId="17" pageNumber="18">In vitro</emphasis>
and 
<emphasis bold="true" box="[447,501,1657,1671]" italics="true" pageId="17" pageNumber="18">in silico</emphasis>
anti-dengue activity of compounds obtained from 
<taxonomicName _evidence="catalogs" _step="species1" box="[245,363,1678,1693]" class="Magnoliopsida" family="Myrtaceae" genus="Psidium" kingdom="Plantae" order="Myrtales" pageId="17" pageNumber="18" phylum="Tracheophyta" rank="species" species="guajava">
<emphasis bold="true" box="[245,363,1678,1693]" italics="true" pageId="17" pageNumber="18">Psidium guajava</emphasis>
</taxonomicName>
through bioprospecting. BMC Compl. Alternative Med. 19 (1), 298. https://doi.org/10.1186/s12906-019-2695-1.
</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">Uno, N., Ross, T.M., 2018. Dengue virus and the host innate immune response. Emerg. Microb. Infect. 7 (1), 1–11.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">van Wyk, A.S., Prinsloo, G., 2020. Health, safety and quality concerns of plant-based traditional medicines and herbal remedies. South Afr. J. Bot. 133, 54–62. https:// doi.org/10.1016/j.sajb.2020.06.031.</paragraph>
<paragraph blockId="17.[100,766,148,1927]" pageId="17" pageNumber="18">V´azquez-Calvo, A´., Jim´enez de Oya, N., Martín-Acebes, M.A., Garcia-Moruno, E., Saiz, J.- C., 2017. Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the Flaviviruses west nile virus, zika virus, and dengue virus. Front. Microbiol. 8 (1314) https://doi.org/10.3389/ fmicb.2017.01314.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">Vicente, C.R., Herbinger, K.-H., Froschl ¨, G., Romano, C.M., Cabidelle, A.d.S.A., Junior, C. C., 2016. Serotype influences on dengue severity: a cross-sectional study on 485 confirmed dengue cases in Vit´oria, Brazil. BMC Infect. Dis. 16 (1), 1–7.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">
Wachtel-Galor, S., Yuen, J.G., Buswell, J., Benzie, I.F.F., 2011. 
<taxonomicName _evidence="catalogs" _step="species1" box="[1299,1443,212,226]" class="Agaricomycetes" family="Ganodermataceae" genus="Ganoderma" kingdom="Fungi" order="Polyporales" pageId="17" pageNumber="18" phylum="Basidiomycota" rank="species" species="lucidum">
<emphasis bold="true" box="[1299,1443,212,226]" italics="true" pageId="17" pageNumber="18">Ganoderma lucidum</emphasis>
</taxonomicName>
(lingzhi or reishi): a medicinal mushroom. In: Benzie, I.F.F., Wachtel-Galor, S. (Eds.), Herbal Medicine: Biomolecular and Clinical Aspects, 2 ed. Taylor &amp; Francis, p. 175.
</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">
Wahaab, A., Mustafa, B.E., Hameed, M., Stevenson, N.J., Anwar, M.N., Liu, K., Wei, J., Qiu, Y., Ma, Z., 2022. Potential role of 
<taxonomicName _authorityPlausibility="0.99920714" _evidence="catalogs" _step="genera" authority="NS" authorityName="NS" box="[1149,1251,297,311]" class="Flasuviricetes" family="Flaviviridae" genus="Flavivirus" higherTaxonomySource="CoL" kingdom="Orthornavirae" order="Amarillovirales" pageId="17" pageNumber="18" phylum="Kitrinoviricota" rank="genus">Flavivirus NS</taxonomicName>
2B-NS3 proteases in viral pathogenesis and anti-flavivirus drug discovery employing animal cells and models: a review. Viruses 14 (1). https://doi.org/10.3390/v14010044.
</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">
Waliwitiya, R., Kennedy, C.J., Lowenberger, C.A., 2009. Larvicidal and ovipositionaltering activity of monoterpenoids, trans-anithole and rosemary oil to the yellow fever mosquito 
<taxonomicName _evidence="catalogs" _step="species1" baseAuthorityName="Linnaeus" baseAuthorityYear="1762" box="[967,1063,403,417]" class="Insecta" family="Culicidae" genus="Aedes" kingdom="Animalia" order="Diptera" pageId="17" pageNumber="18" phylum="Arthropoda" rank="species" species="aegypti">
<emphasis bold="true" box="[967,1063,403,417]" italics="true" pageId="17" pageNumber="18">Aedes aegypti</emphasis>
</taxonomicName>
(
<taxonomicName _evidence="catalogs" _step="order" box="[1074,1134,403,417]" class="Insecta" kingdom="Animalia" order="Diptera" pageId="17" pageNumber="18" phylum="Arthropoda" rank="order">Diptera</taxonomicName>
: 
<taxonomicName _evidence="catalogs" _step="family" box="[1141,1215,403,417]" class="Insecta" family="Culicidae" kingdom="Animalia" order="Diptera" pageId="17" pageNumber="18" phylum="Arthropoda" rank="family">Culicidae</taxonomicName>
). Pest Manag. Sci. 65 (3), 241–248. https://doi.org/10.1002/ps.1675.
</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">
Walton, W.E., 2007. Larvivorous fish including 
<taxonomicName _evidence="catalogs" _step="genera" authorityName="Poey in Poey" authorityYear="1854" box="[1171,1242,446,460]" family="Poeciliidae" genus="Gambusia" kingdom="Animalia" order="Cyprinodontiformes" pageId="17" pageNumber="18" phylum="Chordata" rank="genus">
<emphasis bold="true" box="[1171,1242,446,460]" italics="true" pageId="17" pageNumber="18">Gambusia</emphasis>
</taxonomicName>
. J. Am. Mosq. Control Assoc. 23 (sp2), 184–220.
</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">Wang, W.-H., Urbina, A.N., Chang, M.R., Assavalapsakul, W., Lu, P.-L., Chen, Y.-H., Wang, S.-F., 2020. Dengue hemorrhagic fever – a systemic literature review of current perspectives on pathogenesis, prevention and control. J. Microbiol. Immunol. Infect. 53 (6), 963–978.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">WHO, 2004. Guidelines for the Regulation of Herbal Medicines in the South-East Asia Region. WHO Regional Office for South-East Asia, New Delhi, pp. 1–25.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">WHO, 2022. International regulatory cooperation for herbal medicines (IRCH). Retrieved from. https://www.who.int/initiatives/international-regulatory-cooperation-for-he rbal-medicines.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">
Wiart, C., Kumar, K., Yusof, M.Y., Hamimah, H., Fauzi, Z.M., Sulaiman, M., 2005. Antiviral properties of ent-labdene diterpenes of 
<taxonomicName _authorityPlausibility="0.99156046" _evidence="document" _step="document" authority="nees" authorityName="Nees" box="[1222,1438,701,715]" class="Magnoliopsida" family="Acanthaceae" genus="Andrographis" kingdom="Plantae" order="Lamiales" pageId="17" pageNumber="17" phylum="Tracheophyta" rank="species" species="paniculata">
<emphasis bold="true" box="[1222,1397,701,715]" italics="true" pageId="17" pageNumber="18">Andrographis paniculata</emphasis>
nees
</taxonomicName>
, inhibitors of herpes simplex virus type 1. Phytother Res. 19 (12), 1069–1070. https://doi.org/10.1002/ptr.1765.
</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">Wilson, A.L., Courtenay, O., Kelly-Hope, L.A., Scott, T.W., Takken, W., Torr, S.J., Lindsay, S.W., 2020. The importance of vector control for the control and elimination of vector-borne diseases. PLoS Neglected Trop. Dis. 14 (1), e0007831.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">Xu, S., Li, H., Shao, X., Fan, C., Ericksen, B., Liu, J., Chi, C., Wang, C., 2012. Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease. J. Med. Chem. 55 (15), 6881–6887. https://doi.org/10.1021/ jm300655h.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">
Yao, X., Ling, Y., Guo, S., Wu, W., He, S., Zhang, Q., Zou, M., Nandakumar, K.S., Chen, X., Liu, S., 2018. Tatanan A from the 
<taxonomicName _evidence="catalogs" _step="species1" box="[1112,1224,935,949]" class="Liliopsida" family="Acoraceae" genus="Acorus" kingdom="Plantae" order="Acorales" pageId="17" pageNumber="18" phylum="Tracheophyta" rank="species" species="calamus">
<emphasis bold="true" box="[1112,1224,935,949]" italics="true" pageId="17" pageNumber="18">Acorus calamus</emphasis>
</taxonomicName>
L. root inhibited dengue virus proliferation and infections. Phytomedicine 42, 258–267. https://doi.org/10.1016/j. phymed.2018.03.018.
</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">Yu, B., Dai, C.-q., Jiang, Z.-y., Li, E.-q., Chen, C., Wu, X.-l., Chen, J., Liu, Q., Zhao, C.-l., He, J.-x., et al., 2014. Andrographolide as an Anti-H1N1 drug and the mechanism related to retinoic acid-inducible gene-I-like receptors signaling pathway. Chin. J. Integr. Med. 20 (7), 540–545. https://doi.org/10.1007/s11655-014-1860-0.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">Yu, S., Yan, H., Zhang, L., Shan, M., Chen, P., Ding, A., Li, S.F.Y., 2017. A review on the phytochemistry, pharmacology, and pharmacokinetics of amentoflavone, a naturally-occurring biflavonoid. Molecules 22 (2), 299. https://doi.org/10.3390/ molecules22020299.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">
Yusof, R., Clum, S., Wetzel, M., Murthy, H.M.K., Padmanabhan, R.J., 2000. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids 
<emphasis bold="true" box="[1239,1290,1211,1225]" italics="true" pageId="17" pageNumber="18">in vitro</emphasis>
. J. Biol. Chem. 275 (14), 9963–9969.
</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">Zainal, N., Chang, C.P., Cheng, Y.L., Wu, Y.W., Anderson, R., Wan, S.W., Chen, C.L., Ho, T.S., AbuBakar, S., Lin, Y.S., 2017. Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection. Sci. Rep. 7, 42998 https://doi.org/10.1038/srep42998.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">Zakaria, I.I., Salin, N.H., Amanah, A., Othman, S., Khairuddin, F., Khawory, M.H., Wahab, R.A., Rahaman, M.R.A., Chern, P.P., Johari, N.A., et al., 2019. Potential antiviral compounds from Malaysian plant natural product repository and database (MyNature50000) for DENV2. Biotechnol. Biotechnol. Equip. 33 (1), 379–389. https://doi.org/10.1080/13102818.2019.1578184.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">Zandi, K., Boon-Teong, T., Sam, S.-S., Wong, P.-F., Mustafa, M.R., AbuBakar, S., 2011. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol. J. 8 (1), 1–11. https://doi.org/10.1186/1743-422X-8-560.</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">
Zheng, D.S., Chen, L.S., 2017. Triterpenoids from 
<taxonomicName _evidence="catalogs" _step="species1" box="[1199,1343,1508,1522]" class="Agaricomycetes" family="Ganodermataceae" genus="Ganoderma" kingdom="Fungi" order="Polyporales" pageId="17" pageNumber="18" phylum="Basidiomycota" rank="species" species="lucidum">
<emphasis bold="true" box="[1199,1343,1508,1522]" italics="true" pageId="17" pageNumber="18">Ganoderma lucidum</emphasis>
</taxonomicName>
inhibit the activation of EBV antigens as telomerase inhibitors. Exp. Ther. Med. 14 (4), 3273–3278. https://doi.org/10.3892/etm.2017.4883.
</paragraph>
<paragraph blockId="17.[818,1484,148,1629]" pageId="17" pageNumber="18">
Zhu, Q., Bang, T.H., Ohnuki, K., Sawai, T., Sawai, K., Shimizu, K., 2015. Inhibition of neuraminidase by 
<taxonomicName _evidence="catalogs" _step="genera" authorityName="P.A.Karsten" authorityYear="1881" box="[990,1073,1593,1607]" class="Agaricomycetes" family="Ganodermataceae" genus="Ganoderma" kingdom="Fungi" order="Polyporales" pageId="17" pageNumber="18" phylum="Basidiomycota" rank="genus">
<emphasis bold="true" box="[990,1073,1593,1607]" italics="true" pageId="17" pageNumber="18">Ganoderma</emphasis>
</taxonomicName>
triterpenoids and implications for neuraminidase inhibitor design. Sci. Rep. 5 (1), 13194 https://doi.org/10.1038/srep13194.
</paragraph>
<paragraph blockId="18.[303,771,142,305]" pageId="18" pageNumber="19">Fadi G. Saqallah is a Ph.D. candidate at the Discipline of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, University of Science, Malaysia. He obtained his M.Sc. degree in Pharmaceutical Sciences from Applied Science Private University, Jordan in 2017. He is still paving his way through the world of science, powered by his passion to learn and share his knowledge. His research interests include pharmaceutical chemistry, phytochemistry, and molecular modelling.</paragraph>
<paragraph blockId="18.[302,770,489,610]" pageId="18" pageNumber="19">
Manal A. Abbas obtained her Ph.D. degree from The University of Jordan in 2011. She is a full professor at the Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University. She has more than 33 publications. Her research interests include the efficacy and mechanism of action of natural compounds 
<emphasis bold="true" box="[629,680,596,610]" italics="true" pageId="18" pageNumber="19">in-vitro</emphasis>
and 
<emphasis bold="true" box="[717,765,596,610]" italics="true" pageId="18" pageNumber="19">in-vivo</emphasis>
.
</paragraph>
<paragraph blockId="18.[1020,1489,142,305]" pageId="18" pageNumber="19">Habibah Abdul Wahab obtained her Ph.D. degree in pharmaceutical technology from and King’ s College London, UK. Currently, she is the Dean at the School of Pharmaceutical Sciences, University of Science, Malaysia. She also co-chairs the Malaysian Pharmacists Society. She has more than 230 published papers. Her research interests include natural products chemistry, computer aided drug design, and nano-delivery systems.</paragraph>
</document>